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The mucosal immune barrier is composed of several distinct layers and 
protects the human body for harmful elements in the lumen of the intestine. 
The first line of defense is composed of a physical barrier composed of a mucus 
layer [1] and an epithelial layer [2] as depicted in the Figure 1 copied from van 
Vliet, 2010 [3]. The mucus layer prevents direct contact between microbiota 
and luminal pathogens with the underlying epithelial cells. The epithelial cells 
are interconnected by tight junctions and are not permeable for molecules 
larger than 3 kDa to prevent uncontrolled immunological responses [4, 5]. 
The mucus layer and epithelial lining are, together, considered to be the gate-
keeper of the human body. Specialized immune cells are located in between 
the epithelial layer. These are specialized mononuclear phagocytes cells that 
push their dendrites through the interconnected epithelium and protrude into 
the lumen to sample antigens [6, 7]. In additions specialized lymphocytes, 
the so-called intra-epithelial cells (IECs) are located in between the epithelial 
layer to destroy any pathogens or other harmful threats that might enter 
the space underneath the epithelial layer, i.e. the so-called lamina propria. 
The lamina propria is the largest immune cells carrying dimension of the 
human body where a multitude of specialized cells can be found. In case of 
antigen sampling CD103 positive macrophages are responsible for transport 
of antigens to the mesenterial lymph nodes to present their cargo to T-cells 
in order to form either regulatory or pro-inflammatory responses. Figure 1 
illustrates the complexity of the gastrointestinal immune barrier that will 
be further discussed in more detail below. Processes in the gastrointestinal 
immune barrier are highly regulated to form appropriate responses against 
pathogens and tolerogenic responses to food antigens and the 100 trillion 
bacteria harboring our intestine. Any disturbances in the balance between 
responses against pathogens and tolerance against food antigens and 
microbes leads to disease. Imbalances in the responses have been implicated 
in a wide range of the ever growing list of typical Western diseases such as 
allergies, asthma, inflammatory bowel diseases, type-2 diabetes [8]. Also 
the gastrointestinal immune barrier is essential in preventing pathogen 
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infections. It is also considered to be a target in the fight against antibiotic 
resistant organisms. A well-functioning intestinal immune barrier may 
reduce use of antibiotics and thereby reduce chances on development of 
antibiotic resistant bacteria. Stimulation of the immune barrier by specific 
food components has therefore gained renewed attention in the past years 
[8-10]. Also, stimulation of the gastrointestinal immune barrier may enhance 
efficacy of vaccination against pathogens. This is relevant as vaccination 
is proposed in the fight against pathogens as alternative for antibiotics. 
Unfortunately, many vaccination protocols such as against Salmonella are 
not very efficacious and require novel approaches to protect animals and 
humans against infection with this pathogen. This stimulation of mucosal 
immunity to enhance clearance of pathogens without affecting the tolerance 





Figure 1. Gut barrier is composed of diff erent and complementary assets. 
The epithelial lining and the mucus layer serve as physical barrier, that is ensured by 
tight junctions, to protect the host. The epithelium is composed of diff erent cell types 
such as enterocytes, goblet cells that produce mucins to make up the loose mucus 
layer in the ileum and the thick one in the colon. Receptors expressed at the surface 
of the epithelial cells such as TLRs and NLRs will sense specifi c PAMPs and trigger 
activation and/or inhibition of the NF-κB pathway leading to induction of pro- or 
anti-infl ammatory responses from immune cells. Immune responses are ensured by 
dendritic cells, macrophages, neutrophils and lymphocytes which release cytokines 
and chemokines to communicate and further initiate innate as well as adaptive 
responses. Dendritic cells are remarkable for their capacity to express tight-junction 
like properties in order to extend their dendrites through the epithelium without 
cause barrier damages. PAMP, pathogen associated molecular pattern; HSP’s, heat 
shock proteins, SCFA, short chain fatty acids, NLR, NOD-like receptors; TLR, Toll-
like receptors. Image copied and adapted from van Vliet MJ, Harmsen HJM, de Bont 
ESJM, Tissing WJE (2010) The Role of Intestinal Microbiota in the Development 





Sensing of luminal antigens
A crucial step in keeping the balance between pro-inflammatory and 
tolerogenic responses is sensing of luminal antigens. It ensures development 
of appropriate tolerance towards commensal microbes and adequate 
inflammatory responses against pathogens. Many players are involved to 
make up for a complex immunity in mammals [7, 11]. In this paragraph we 
are elaborating on the different levels of protection and recognition that 
the immune system has developed to face bacterial threats after they enter 
the gut lumen. A particular interest is given to the ileum structure with 
emphasize on tight junction protein complexes of epithelial cells, but also on 
the different cell types and receptors that are involved in intestinal mucosal 
immune regulation.
- Barrier: tight junctions 
As outlined in the introduction the intestinal epithelial cells (IECs) and the 
mucus are part of the gate keeping system of the intestine. IECs compose 
the gut lining and have different phenotypes and serve various function 
that range from nutritional uptake, hormone signalling to detoxification/
metabolisation and mucus production [2]. IECs are highly specialized cells 
that include, for instance, mucus production by goblet cells, hormone release 
by Paneth cells, antigens transport by Microfold cells and barrier function 
by enterocytes [12]. The mucus produced throughout the gastrointestinal 
tract forms a thick layer that insures the first physical barrier separating 
exogenous factors from the host cells and protecting the IECs [13]. However, 
the mucus layer in the ileum is thin and lose to facilitate nutrients absorption 
making this part of the intestines [14]. Beneath the mucus layer, the IECs 
are decorated with complex structures named glycocalix [15]. Made of 
sugar molecules called glycans, the glycocalix is part of the epithelial cells 
cytoskeleton and prevents transcellular displacement of microbes towards 
the host lamina propria [16]. However, these structures are only present 
on the apex of the cells and the integrity of the epithelium itself is mostly 





that are also related to the cells’ cytoskeleton [17]. Tightness of the IECs to 
form an impermeable barrier is crucial to prevent paracellular translocation 
of food and microbial antigens which is associated with multiple diseases 
[18]. Gastrointestinal barrier dysfunction is indeed observed in illnesses that 
range from chronic inflammatory diseases [19], metabolic syndrome [20], 
celiac disease [21], to pathogenic infections [22-24]. 
 However, increasing permeability of the gut barrier is also a tool of 
the body to help curing some of these illnesses [18]. Opening the barrier 
might change the hydrostatic water pressure by which fast enhancement of 
the luminal water content may occur. This induces diarrhea and clearance of 
the pathogens [25]. 
 Signaling via release of cytokines and chemokines to initiate rapid 
and efficacious immune reactions will determine the intensity and duration 
of infection, inflammation and restoration of normal functions [26, 27]. 
Enterocytes themselves are targets for pathogenic invasion strategies via, for 
instance, acceleration or inhibition of enterocytes apoptosis [28]. Proteins 
known to contribute to the tightness of the epithelium have been extensively 
reviewed and the most commonly investigated belong to occluding, junction-
adhesion-molecules or zonula occludens proteins [29].
- Immune cell types
As outlined in the introduction, numerous immune cells can be found 
within and beneath the gut lining, as depicted in Figure 2. IECs which 
are specialized in signaling are M cells, specifically located in structures 
called Payer’s Patches which can be found in the ileum. These cells are 
specialized in antigen sampling [30]. Moreover, some immune cells that 
are part of mononuclear phagocytes can sample within the lumen and are 
located in very close vicinity of IECs [6], this type of immune cells will be 
further detailed. In the context of such high levels of interactions between 
IECs and immune cells, communication between these various subtypes 
of cells has been developed and is being referred to as cross-talk. Cross-
talk is crucial to establish and maintain homeostasis, tolerance towards 
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commensal microbiota  and appropriate reactions towards pathogens [31, 
32]. These functions are assured by both a collaboration between innate 
and adaptive immune responses [33]. Annunziato, F, et al. describes three 
types of cell-mediated immunity, in the first, ILCs, NK cells and cytotoxic 
T-cells are involved, the second type involves basophile, eosinophils and 
mast cells while the third type targets mostly neutrophils, epithelial cells 
and mononuclear phagocytes such as macrophages and dendritic cells. 
This type 3 immunity is therefore typically involved in protection against 
bacterial and viral infections. Mononuclear phagocytes are actors of innate 
immunity. However, the intercalating CX3CR1+ mononuclear phagocytes 
are specific for direct sampling into the lumen [34]. CX3CR1+ dendritic cells 
(DCs) are main actors for induction of Treg because of high release of the IL-
10 cytokines [35]. Extension of the protrusions through the gut lining does 
not provoke permeability and is a safe and controlled way for the immune 
system to anticipate possible threats [6]. Other DCs that serve establishment 
of immune tolerance are the bona fide migratory type characterized by 
CD103+, that colonize the lamina propria in small and large intestines. This 
DC type is not able to sample soluble antigens but will receive them from 
CX3CR1+ mononuclear phagocytes [32]. DCs and macrophages are therefore 
called antigen presenting cells (APCs) as they capture antigen to further 
initiate a specific immune skewing. Presentation of antigens to naïve T-cells, 
together with a signaling molecule released by any immune cell, will lead to 
differentiation and activation of T-cells towards cytotoxic, or helper types 
[36]. This process is at the basis for developing adaptive immunity which is, 
for instance, at the basis on vaccination. Unlike native mechanisms, adaptive 
ones have to be acquired. This happens through time as new antigens are 
presented to educate T cells and B cells. Memory will then build-up together 





Figure 2. Mucosal immune responses and immune cells present in 
intestinal-lumen interface. Plasma cells that participate in immune mucosal 
response include neutrophils and macrophages which are actors in innate response 
against pathogens like Salmonella. Anti-microbial peptides (AMPs) are secreted by 
Paneth cells along with secretory immunoglobulin A (sIgA) which can neutralize 
pathogens for instance. The innate lymphoid cells (ILCs) can be found in the 
lamina propria awaiting to diff erentiate. The microfold (M) cells located above the 
follicle-associated epithelium (FAE) which include the immune specifi c structure 
called Payer’s patches. The antigens can also be directly sampled by Dendritic 
cells in the gut lumen. Sampled antigens are transfer to local antigen presenting 
cells (APC) that might then interact directly with T cells. Alternatively, antigen or 
antigen-loaded APCs might gain access to draining lymph, with subsequent T-cell 
recognition in the mesenteric lymph nodes (MLNs). T cells which have recognized 
antigen fi rst in the MLN might also disseminate from the bloodstream throughout 
the peripheral immune system resulting in systemic responses towards mucosal 
immune stimulation. 





Recognition of the numerous types of molecules that circulate in the gut lumen 
is orchestrated by receptors expressed on the epithelial cells but especially on 
cells specialized in sampling such as mononuclear phagocytes [27]. These 
receptors, call pathogen recognition receptors (PRRs), include dectins, 
lectins, NODs and Toll-like receptors (TLRs). The last category, the TLRs, 
is of particular interest because it includes a broad diversity of receptors, in 
humans there are 7 known TLRs, and is highly expressed on most immune 
cells [38]. Their role in immunity has already been extensively studied [39]. 
Activation of TLRs can have positive consequences for the host as these 
receptors are essential to induce inflammatory cytokines and chemokines to 
recruit and activate the immune cells that can battle microbial infections [27]. 
TLR2 is the main receptor involved in recognition of Gram-positive bacteria as 
it binds to lipoproteins and lipoteichoic acid [40, 41]. More specifically, lactic 
acid bacteria, such as lactobacilli, activate TLR2.6 [42]. Interestingly, TLR2 
activation is required for IgG production by B cells to fight Salmonella Typhi 
and build-up memory, although Salmonella is a gram-negative bacteria [43]. 
TLR3 is known to initiate antiviral immunity and previous research showed 
that IECs overexpress TLR3 when challenged with viruses which allows cells 
to detect viruses and acquire resistance [44, 45]. The activation of TLR4 leads 
to the release of critical pro-inflammatory cytokines necessary to activate the 
innate immune system [46]. Furthermore, TLR4 activation was found to 
regulate LPS-induced increases in intestinal tight-junction permeability and 
intestinal inflammation though the FAK/MyD88/IL-1R–associated kinase 4 
signaling pathway [47, 48]. TLR5 recognizes flagellin and mediates barrier 
dysfunction [49]. On the other hand, TLR5 activation was found to induce 
secretory IL-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-
associated tissue damage [50] showing versatile effects on host health. 
TLR7 is a key part of the viral sensing and defense as it reacts to ssRNA 
and its activation was found, in the intestines, to enhance IL-22 mediated 
colonization resistance against vancomycin-resistant enterococcus [51]. 





demonstrates that TLR8 reacts to RNA degradation products [52]. TLR8 has 
received more attention due to their efficiency in activating inflammatory 
immune responses providing opportunities to use TLR8 agonists as vaccine 
adjuvants [53]. Lastly, TLR9 is activated by unmethylated CpG sequences 
bacterial and viral DNA [54]. A study indicated the importance of TLR9 apical 
signaling in IECs in the maintenance of colonic homeostasis, regulation of 
tolerance and inflammation [55]. Activation of these receptors is not the only 
way to regulate the immune response. Inhibition of various of these TLRs 
have indeed been found to benefit the host. For instance, lactobacilli strains 
can reduce TLR3 induced intestinal injury by inhibiting TLR3 activation [45]. 
Generally, the roles of TLRs activation and/or inhibition is crucial in many 
therapies [56] and hold promises from improving chronical inflammatory 
diseases [57] or to support immunity in for example vaccination efficacy [53].
When something goes wrong
Perturbation and weakening of immune responses is often observed during 
intestinal dysbiosis that, as mentioned earlier, can lead to numerous 
disorders. Perturbations in the host responses are characterized by impaired 
cross-talk between the host cells leading to inflammatory processes [58] and 
are associated with loss of microbiota stability [59]. Long term loss of such 
intestinal symbiont is critical and associated with a broad range of illnesses 
from inflammatory bowel diseases and colorectal cancer to disorders with 
more systemic effects such as diabetes, metabolic syndrome and atopy [60, 
61]. However, acute stress such as pathogenic or parasitic infections can 
also trigger dysbiosis and weaken immune responses leading to increase 
development of latent pathogens and opportunistic species [62].
- Pathobionts: opportunistic species and western diseases
Western diets are proven to favor the development of opportunistic species 
such as Clostridium because of lack of competition by other microbiota 
species. By definition, pathobionts are members of the symbiotic community 
which relative abundance can dramatically increase during imbalance 
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becoming, then, pathogenic for the host [63]. Typical resident members 
that are considered to be pathobionts are such as Clostridium difficile 
or Klebsiella oxytoca but also facultative anaerobes belonging to the 
Gammaproteobacteria and Enterobacteriaceae like the proteobacteria 
Escherichia coli [63]. The diversity of microbiota is directly connected to how 
our microbiota is being fed. As a consequence imbalances can be modulated 
by the host’s dietary habits [64]. Statovci, D. et al. outlines the complex 
network between nutrients, microbial alterations and abnormal immune 
responses associated with inflammatory bowel diseases (IBD) and atopic 
disorders. Patients suffering from IBD have typically decreased Firmicutes 
and Bacteroidetes while Enterobacteriaceae are increased [65]. In asthmatic 
children, relative abundance of Faecalibacterium, Lachnospiria, Veillonella, 
Rothia and Clostridium neonatale were decreased [66, 67]. In general terms, 
decreased gut microbiota diversity often leads to an increase in opportunistic 
pathogens [68], and the ratio Firmicutes to Bacteroidetes is an indicator for 
the general health status of the host [69] and during intestinal imbalance, 
not only opportunistic species, but also pathogenic species can create health 
problems to the host. 
- Pathogens: focus on enteropathogens
A very sensitive period with higher risk for intestinal dysbiosis is weaning. 
During the vulnerable neonatal phase, infants are protected by maternal 
antibodies until the time of weaning. When weaning comes too abruptly, as 
it is done in pig farms, loss of microbiota diversity can occur [70]. Insuring a 
more stable microbiota composition around the time of weaning might also 
be key in developing better strategies to prevent opportunistic and pathogenic 
colonization after weaning. Above pathobionts, zoonotic pathogens are 
a real threat for livestock and possible source of foodborne diseases in 
humans. The most frequent pathogens isolated from pigs are E. coli, 
Listeria monocytogenes, Yersinia enterocolitica, Campylobacter jejuni and 
Salmonella the last two being the most frequent [71]. A typically fatal post 





a virulent serotype of E. coli [72]. L. monocytogenes is of particular threat 
as it can grow at low temperatures [73]. Salmonella colonization of piglets 
often occurs during the weaning period [72] and is associated with increased 
shedding, spreading throughout pig herds and is, ultimately, contaminating 
pork meat [74]. The most frequent serovar is S. enterica Typhimurium [71]. 
Salmonellosis is considered to be a major food-borne illness as it causes 
diarrheal diseases in over 130 million humans yearly (http://www.who.
int/mediacentre/factsheets/fs139/en/) and is responsible for 9.3% of 225 
foodborne outbreaks in Europe [74]. 
- Antibiotics and vaccination, most efficacious yet limited
Vaccination is considered to be one of the best approach to prevent infections 
and therefore decrease the use of antibiotics and antimicrobial agents, which 
helps to reduce the development of resistance against these agents. The global 
health issues associated with antibiotic resistant species have led to tighter 
regulations on antibiotics administration. In 2006, the European Union 
totally banned the sub-therapeutic use of antibiotics in livestock feeding [75] 
(http://europa.eu/rapid/press-release_IP-05-1687_en.htm). 
This ban, however, has led to increase the use of antimicrobial agents in 
daily feed formulation and a rise of resistant Salmonella in pigs subsequently 
occurred [76]. Therefore, there is an urgent need for alternative strategies to 
prevent infection with Salmonella in livestock. Vaccination and improvement 
of feed strategies to support immunity of livestock are two examples of these 
strategies. Vaccination of piglets against Salmonella occurs via the oral route 
but is not fully effective as it confers only 20 to 50% protection [74, 77]. 
However, vaccination is still effectively lowering mortality associated with 
Salmonella Typhimurium (STM) and reduces transfer to humans [78, 79]. 
Although the vaccines have limited efficacy [80, 81] and require several doses 
[79, 82, 83], they might ultimately delete STM from livestock pigs [84] when 
new means are developed to enhance their effects. Conceivable approaches 
to increase efficacy of vaccination might be simultaneous administration of 
dietary supplements such as pre- and probiotics that are known to enhance 
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immunity [77, 85-90]. These pre- and probiotics have also been recognized 
as a mean to increase performance and well-being of piglets post-weaning 
and to decrease diarrhea [91-93]. 
Formation of maintenance of the gastrointestinal immune 
barrier function via microbiota and direct interactions
Developing and acquiring a functional, balanced immunity is the basis of 
living healthy. This process is not only complex but also takes time. However, 
early life is the most intense period as both the core microbiota and host 
immune system must build, in harmony, the stable foundation for later life 
performances.
- Immunity develops in early life and programs for life
Immune development will undergo some critical phases, especially around 
the time of weaning. During gestation and after birth, the neonates benefit 
from the indirect protection transmitted by their mother, via antibodies 
present in milk and, as weaning occurs, the infant immunity further develops 
to become fully autonomous. This process will take from a few weeks to 
several years depending of the species. In the case of humans, weaning 
occurs in average around the age of 6 months and is very progressive, while 
in farming piglets weaning is usually forced and abrupt. Early and abrupt 
weaning are accompanied by a peak of stress [72, 94] and the immune 
system is not only highly challenged by all the newly faced antigens but also 
by being deprived from the antibodies source, the mother’s milk [95]. Coping 
with abrupt weaning is therefore a risky period for piglets that encounter 
more infections, diarrhea, loss of appetite and drawback in weight gain [70]. 
As for humans, even though such stressor is avoided, the development 
phase of infants’ immune system is still of high importance as consequences 
from early impairments can be suffered from much later in life [96]. Very 
common health issues such as celiac disease [97] and food allergies [98] to 
specific diseases like corticolimbic abnormalities [99] are linked to early 





- Colonization is the major factor: in humans and pigs
Early life is a critical phase during which microbes colonize the infants gut and 
settle down as different communities, that will evolve as a stable ecosystem, 
fight to conquer the most suitable niche. This process has been extensively 
studied in the past decades [59] and typically undergoes the following 
pattern. At birth, an anaerobic environment is created in the infants’ gut 
with colonization by facultative anaerobes species such as Staphylococcus-, 
Enterococcus-, and Lactobacillus-like species [100]. After the first week 
of life species like Bifidobacterium, Bacteroides, and Clostridium further 
diversify the gut microbiota [100]. After 5 months, the average age at which 
slow introduction of solid food starts, Bacteroidetes species slowly become 
predominant [101]. The process in early life is somewhat similar in porcine 
livestock. The colonization process of the intestines evolves rapidly after 
birth to reach an adult-like composition by 3 to 4 weeks post weaning. 
The adult pig microbiota is typically composed of Clostridium, Blautia, 
Lactobacillus, Prevotella, Ruminocaccus, Roseburia, the RC9 gut group 
and Subdoligranulum at the genus level [102, 103]. Bacteroides is the most 
abundant at birth; however, the proportion of Bacteroides decreased as the 
piglets age, while the proportion of Prevotella increased until becoming 
the most abundant genus at the post-weaning stage [104]. In parallel, the 
host intestinal immune system develops and matures [105]. Interactions 
between microbes and the developing gut are then considered critical, and 
perturbations might be associated with later impaired immune function 
[106, 107], as for humans.
How microbiota and barrier function can be managed by 
dietary fibers and health-associated bacterial species
The consumption of dietary fibers has been associated with great health 
benefits [108, 109]. In general, high daily intake of dietary fibers can reduce 
the risk of developing numerous diseases such as colorectal cancer [110], 
cardiovascular diseases [111], type-2 diabetes [112] and several gastrointestinal 
disorders [113]. Furthermore, increased consumption of dietary fibers 
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appears to improve immune function [114-116] and support treatment of 
IBD for instance but can also counterbalance the dysbiosis and deleterious 
effects induced by western diets [117, 118] or antibiotics. Moreover, a specific 
category of health beneficial dietary fibers are the prebiotics. Carbohydrates 
that qualify for as prebiotics are molecules that can be used as a substrate 
that is selectively utilized by host microorganisms conferring a health benefit 
[119]. Measuring prebiotic effects often refers to increased abundance of lactic 
acid bacteria or increased production of health-associated metabolites such 
as short chain fatty acids (SCFA). As already mentioned, another trigger of 
dysbiosis is the weaning period, and as supporting maturation of microbiota 
development and boosting immunity in early life are particularly interesting 
strategies [10, 120-123], this could also support health through weaning 
stress. Increased prebiotic intake was shown to reduce risk of obesity [123] 
developing infections and allergies [10]. Although most studies have so far 
focused on the effect of dietary fibers on the gut microbiota as fermentation 
of dietary fiber leads to production of health beneficial compounds such as 
vitamins [124] and SCFA [125], recent investigations also started to unravel 
direct immune effects on intestinal and immune cells [126]. We will further 
focus on a selection of potential prebiotics such as inulin-type fructans and 
resistant starches. Besides, consumption of live microorganisms such as 
lactic acid bacteria has been associated with great health benefits [127]. The 
concept of probiotics has been developed to qualify those microorganisms 
that, ingested in adequate amounts, will positively impact the host, mostly 
via microbiota based changes [128]. Particular interest will be given to 
lactobacilli strains. Finally, combining both pre and probiotics could be a 
more elaborated way to support host health by providing a wider array of 
health effects and/or supporting the growth and settlement of probiotic 
species taken that they would consume the combined prebiotic. This is 
referred to as synbiotic effect [129].
- Inulin type fructans





microbial community. Therefore, ITF are recognized prebiotic dietary fibers 
[119] that are utilized and fermented by the intestinal microbiota leading to 
production of beneficial metabolites such as SCFA [130] and have been shown 
to support bifidobacterial growth and activity [131]. However, direct effects 
of ITFs and fructooligosaccharides (FOS) have also been shown with barrier 
protective effects, this was accomplished by activation of host cell signaling in 
the intestinal epithelium independently of microbiota [132]. Moreover, long-
chain ITF (lcITF) reinforced barrier function via upregulated tight-junction 
proteins in diabetic mice [116] and in mice with acute pancreatitis [133]. 
Importantly, in vitro comparison of short and long-chain ITF has shown 
chain-length dependent effects on T84 barrier function [134]. Moreover, 
chain length will also influence the type of immunomodulation that can 
either be pro- or anti-inflammatory [135]. Also, lcITF was found to enhance 
T-helper 1 (Th1) cells in PPs of mice independently of microbiota [136]. 
Such effect on Th1 skewing and increased pro-inflammatory response after 
lcITF dietary intervention was also observed in humans during vaccination 
protocols [137, 138]. Therefore, lcITF might be instrumental in supporting 
other Th1 based vaccination protocols such as STM [139].
- Starches
Other dietary fibers regarded as prebiotics are resistant starches (RSs) that 
are classically considered to solely elicit health through fermentation by the 
gut microbiota. Diet rich in type-3 RS strongly promoted Ruminococcus 
bromii (R-ruminococci), that made up 17% of the total bacteria while 
volunteers in the control group had only 3.8% [140]. Similarly, in pigs, high 
RS diet stimulated butyrate-producers and reduced relative abundance of 
pathogenic members such as E. coli and Pseudomonas spp [141] which all 
together suggest for a healthier gut. Butyrate production is indeed associated 
with protection of the gut barrier [142] and considered to be responsible 
for decreased gut permeability observed in animals fed resistant starch in 
experimental colitis [143, 144]. Studies evaluating health effect of resistant 
starches on barrier function are scarce, and possible direct effects of resistant 
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starches have only been demonstrated so far on immune receptors and cells 
[145]. It was recently shown that RSs can directly interact with the immune 
system as proven by binding and activation of Toll-like receptors (TLRs) 
[145]. Moreover, RSs were also found to modulate cytokine secretion profiles 
of dendritic cells (DCs) and skewing of T-cells [145].
- Lactobacilli
Direct introduction of live Lactobacillus acidophilus, has, on the other hand, 
been associated with enhanced health status [40, 146], improved resistance 
to diseases [147, 148], reduced shedding of pathogens [149] and of reduction 
of disease symptoms in pigs [150, 151], and support of intestinal immunity 
[90, 152, 153]. All these interventions, including vaccination, have been 
applied orally which implies that the vaccine and or feed ingredients interact 
with the microbiota of the piglets. Beneficial microbes can also be actors in 
maintaining barrier function. Lactobacilli are particularly recognized for 
their protective effects against barrier dysfunction associated with pathogen 
infection. L. acidophilus for example has been shown to considerably reduce 
traveler’s diarrhea [154], and L. plantarum protects against ileac barrier 
dysfunction by increasing production of zonula occludens (ZO)-1 and 
transmembrane protein occludin in vivo [155, 156]. In vitro it was found that 
effects and mechanisms of preventing barrier disruption of lactobacilli are 
strain and species dependent. L. acidophilus and L. plantarum were effective 
in competing against Salmonella Typhimurium (STM) and Escherichia coli 
[157]. These lactobacilli adhered to epithelial cells, preventing attachment 
and even displacing the pathogens from the surface of the epithelial cells. 
Other lactobacilli, such L. reuteri, L. casei, L. rhamnosus, L. paracasei, L. 
johnsonii prevented infection by enhancing tight junction protein expression 
against lipopolysaccharide (LPS)-induced disruption, a virulent molecule 
carried by STM and E. coli [158, 159]. Some lactobacilli have also been shown 
to modulate enterocytes inflammation related signaling. L. rhamnosus and 
L. casei suppressed Clostridium difficile-induced IL-8 production by colonic 





induced IL-8 synthesis [161]. Other species that have shown effects on 
epithelial barrier is L. casei. It has been shown that L. casei prevented 
lipopolysaccharide (LPS)-induced disruption of the gut barrier, a virulent 
molecule carried by STM and E. coli [158, 159]. L. casei has also been shown 
to modulate enterocytes inflammation related signaling as it suppressed 
Clostridium difficile-induced IL-8 production by colonic epithelial cells 
[160]. Another candidate, although much less studied, is L. brevis that 
showed adhesion to Caco-2 cells [162] and fermentation products isolated 
from L. brevis suppressed mouse small intestinal permeability [163]. Finally, 
L. acidophilus maintained barrier integrity during inflammation [164] and 
was also shown to prevent adherence of pathogens to the intestinal epithelium 
by, for instance, decreasing luminal pH, secretion of antimicrobial peptides 
and blocking bacterial adhesion to human intestinal epithelial cells [165, 
166]. Furthermore, another way by which lactobacilli could be supportive in 
combatting and/or preventing STM infection is by supporting vaccination 
efficacy. L. acidophilus, for instance, was also shown to induce Th1 cytokines 
in mice [167], increase IFN-γ producing T cells, and reduce Treg in gnotobiotic 
pigs [168] all being necessary factors to combat STM. 
Rational and outline of this thesis
Based on current knowledge, long chain inulin and the three species of 
lactobacilli: L. acidophilus, L. brevis and L. casei were selected and tested in 
vitro to evaluate if, beside their pre and probiotic effects on microbiota, these 
agents can directly affect mucosal immunity as the level on barrier function 
and in the context of pathogenic stress (Chapter 2) but also if synergistic 
effects could be observed when long-chain inulin is being combined with 
a lactobacillus combination (Chapter 3). Effects on immunity could help 
during pathogenic but also other type of stresses that lead to intestinal 
dysbiosis, such as weaning. Therefore, these pre and probiotics were further 
tested in vivo in piglet where the development of the gastrointestinal system 
can be influenced by the ingredients and how this could be reflected at a 
systemic level as measured by adaptive immunity via a vaccination protocol 
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(Chapter 4). Evaluating the direct immune effects in vivo required to assess 
possible effects on microbiota development (Chapter 5). Finally, the in vitro 
platform used to select the synbiotic combination for the in vivo trial was 
further applied to assess if other ingredients commonly used in food and feed 
(i.e. resistant starches) can be used as well to support immune development. 
Chapter 2 - In Chapter 2, we investigated whether long-chain inulin and 
lactobacilli strains have specific effects on gut barrier integrity, Salmonella 
clearance and enterocytes stress response. We studied strain specific effects 
by comparing Lactobacillus casei W56, Lactobacillus brevis W63 and 
Lactobacillus acidophilus W37. Inulin are known to have effects on barrier 
function in vivo and in vitro but these effects depend on the chain-length 
distribution and have not been tested in Caco-2 cells before. Lactobacilli 
are known to have strong strain specific differences and some were found to 
strengthen Caco-2 barrier via effects on tight-junction proteins. Moreover, 
some strains also had protective effects against enteropathogenic bacteria. 
Therefore, we performed a microarray on Caco-2 exposed to these different 
agents in order to assess the range of their possible effects on epithelial cells 
and followed transepithelial electric resistance as measure of barrier integrity. 
Finally, possible functional effects of the array results were assessed with a 
pathogenic stress model where Caco-2 incubated with immune active agent 
are exposed to Salmonella.
Chapter 3 – In this chapter we investigate possible synergistic ‘direct’ effects 
of L. acidophilus W37 and long-chain inulin. L. acidophilus W37 was selected 
for further in vitro tests as it has been found to have more pronounced effects 
on epithelial cells than other Lactobacilli strains in Chapter 2. Moreover, 
in Chapter 2, long-chain inulin had no effect on barrier function suggesting 
that health effects observed in vivo might be due to other immune related 
effects. We wanted to test the direct immune effects of these two agents on 
immune cell receptors and on cytokine production by the immune cells and 
assess the potential of a combination of these two agents. In Chapter 3 we 
therefore investigated whether these agents can activate pattern recognition 





also investigate if activation of these receptors can predict effects on immune 
cells responses in dendritic cells with and without intestinal epithelial cells 
cross-talk. 
Chapter 4 – This chapter combines the knowledge obtained in chapters 
2 and 3 where we demonstrated that L. acidophilus W37 enhances barrier 
function and protects against Salmonella induced damages, and that the 
combination of long-chain inulin and L. acidophilus W37 has unique 
synergistic direct immune effects on TLR2 and 3 activation as well as on 
DCs cytokine production during cross-talk with Caco-2 cells. In chapter 4 
we therefore aimed at assessing the possible predictive outcome of these in 
vitro models in an in vivo model of piglets. Inulin is known to support T 
helper 1 based vaccination protocols in humans while L. acidophilus W37 
protects against Salmonella-induced stress. We tested if these effects could 
be confirmed in piglets that were vaccinated and challenged with Salmonella 
Typhimurium. Pathogen stress is a burden for society. Oral vaccination is an 
option but is not very efficacious. We investigated if the unique combination 
of the probiotic L. acidophilus W37 with the prebiotic long-chain inulin 
would create a unique combination where innate and adaptive immunity are 
both boosted in early life to enhance vaccination efficacy as well as protection 
against pathogenic stress later in life.
Chapter 5 - The combination long-chain inulin and L. acidophilus W37 has 
shown to enhance efficacy of Salmonella vaccination in Chapter 4. In Chapter 
5 we investigated the changes of fecal microbiota composition as possible 
mechanisms for enhanced efficacy of the oral vaccination. As Chapter 2 and 
3 suggest that alone and combined the long-chain inulin and L. acidophilus 
W37 immune active agents have direct effects on epithelial and immune cells 
at the levels of the gut mucosa we investigated whether the effects observed in 
vivo in Chapter 4 were not solely attributable to microbiota-driven changes. 
We studied whether the synbiotic effects of long-chain inulin combined with 
L. acidophilus W37 can be direct through targeting of immune cells aside of 
microbiota changes.
Chapter 6 - Here we applied a technology platform that potentially 
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can identify other compounds that can be applied to enhance efficacy of 
vaccination or enhance immune responses against pathogens. As starches 
are important components in feed and food we studied effects of resistant 
starches with different structural traits and characterized their crystallinity, 
particle size, dextrose equivalent, degree of polymerization and molecular 
weights. We investigated their effects on TLR activation, stimulation of 
immune cells as done in Chapter 3, and also studied possible effects on T 
helper cells skewing as indication for possible effects on mucosal vaccination.
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Scope: Salmonellosis is a prevalent food-borne illness that causes diarrhea 
in over 130 million humans yearly and can lead to death. There is an urgent 
need to find alternatives to antibiotics as many salmonellae are now multidrug 
resistant. As such, specific beneficial bacteria and dietary fibers can be an 
alternative as they may prevent Salmonella Typhimurium (STM) infection 
and spreading by strengthening intestinal barrier function. Methods and 
results: We tested whether immune active long-chain inulin-type fructans 
and/or L. acidophilus W37, L. brevis W63 and L. casei W56 can strengthen 
barrier integrity of intestinal Caco-2 cells in the presence and absence of 
a STM. Effects of the ingredients on intestinal barrier function were first 
evaluated by quantifying trans-epithelial electric resistance (TEER) and 
regulation of gene expression by microarray. Only L. acidophilus had effects 
on TEER and modulated a group of 26 genes related to tight-junctions. 
Inulin-type fructans, L. brevis W63 and L. casei W56 regulated other genes, 
unrelated to tight junctions. L. acidophilus also had unique effects on a 
group of 6 genes regulating epithelial phenotype towards follicle-associated 
epithelium. L. acidophilus W37 was therefore selected for a challenge with 
STM and prevented STM-induced barrier disruption and decreased secretion 
of IL-8. Conclusion: L. acidophilus W37 increases TEER and can protect 
against STM induced disruption of gut epithelial cells integrity in vitro. Our 
results suggest that selection of specific bacterial strains for enforcing barrier 
function may be a promising strategy to reduce or prevent STM infections.
Abstract
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Entero-pathogens such as Salmonella Typhimurium (STM) actively disrupt 
gastrointestinal barrier function. STM does this to enhance epithelium 
permeability as a strategy to infect the host [1, 2]. It produces virulence factors 
that manipulate the actin cytoskeleton of the epithelial host cells, leading to 
impairment of the barrier function and promoting bacterial internalization 
[3-5]. This leads to translocation of the pathogen into the lamina propria 
facilitating further infection of the host and inducing salmonellosis. This 
is a major health care concern as salmonellosis is a prevalent food-borne 
illness that causes diarrheal diseases in over 130 million humans yearly 
(http://www.who.int/mediacentre/factsheets/fs139/en/) and is still 
increasing in Europe [6]. These frequent infections as well as the 
multiresistance to antibiotics [7] of STM makes it imperative that innovations 
are developed to fight STM. Limiting barrier disruption during or before STM 
infection to avoid invasion may be such an effective alternative therapy for 
antibiotics but requires careful selection of food ingredients with gut barrier 
protective effects.
 Beneficial microbes can be actors in maintaining or stimulating 
barrier function, and may counteract pathogen-infection such as that of 
STM. Lactobacilli are particularly recognized for enhancing intestinal barrier 
function [8] and to confer protective effects against multiresistant pathogens 
[9]. A lactobacilli that has anti-pathogenic effects is L. acidophilus. Various 
L. acidophilus strains support intestinal immune barrier function [10-
12] and have been shown to improve resistance to pathogens [13], and to 
reduce pathogen induced traveler’s diarrhea in humans [14]. In vitro, L. 
acidophilus was shown to reduce STM adherence to epithelial cells [15]. It is 
not known whether L. acidophilus also exerts protective effects on pathogen 
infection such as STM via modulation of tight junctions and, consequently, 
via enhancement of barrier function. 
 Another interesting species that can modulate tight junctions and 
may therefore be instrumental in the fight against STM is L. casei. It has 
been shown that L. casei prevented lipopolysaccharide (LPS)-induced 
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disruption of the gut barrier, a virulent molecule carried by STM [16, 17]. 
L. casei has also been shown to modulate enterocyte inflammation related 
signaling as it suppressed Clostridium difficile-induced IL-8 production by 
colonic epithelial cells [18]. Another candidate, although much less studied, 
is L. brevis that can adhere to Caco-2 cells [19]. Also, fermentation products 
isolated from L. brevis suppressed mouse small intestinal permeability [20] 
and may thereby reduce STM infection.
 Although less extensively studied than beneficial bacteria, other 
food-based ingredients that can contribute to strengthening barrier function 
are dietary fibers [21]. For instance, inulin and fructooligosaccharides (FOS) 
have recently been shown to enhance barrier function [22] and protect 
against barrier dysfunction [23]. Moreover, long-chain inulin-type fructans 
(lcITF) reinforced barrier function via upregulated tight-junction proteins 
in diabetic mice [24] and in mice with acute pancreatitis [25]. As such a 
protective effect of lcITF on gut barrier disruption may prevent spreading of 
STM.
 We hypothesized that specific beneficial bacteria and dietary fibers 
can support barrier integrity in the event of STM infection, thereby limiting 
the spreading by strengthening intestinal barrier function and/or enterocyte 
cytokine response towards the infection. To this end, we tested lcITF and 
three different bacterial strains in our study on barrier (dys)function of 
intestinal Caco-2 cells in the presence and absence of an STM infection. 
Lactobacilli strains were L. acidophilus W37, L. brevis W63 and L. casei W56. 
Effects of the ingredients on intestinal barrier function were first evaluated 
by quantifying trans-epithelial electric resistance (TEER) and regulation of 
gene expression by microarray. The food ingredient with most effects on 
TEER and gene expression was then selected to evaluate if increased TEER 
remains during a challenge with STM and if it is accompanied by different 
cytokine response.
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Ingredients and Salmonella cultures in Caco-2 experiments
LcITF with DP10-60 (Frutafit® TEX!; Sensus, Cosun, Roosendaal, The 
Netherlands) were solubilized at 0.5 mg/mL in medium and filtered (0.2 
mm) to eliminate possible contaminations. The ITF was characterized by 
high-performance anion exchange chromatography coupled with pulsed 
electrochemical detection, which was performed on an ICS5000 system 
(Thermo Fisher Scientific, Waltham, MA, USA), equipped with a Dionex 
CarboPac PA-1 column (2 × 250 mm) in combination with a Carbopac PA-1 
guard column (2 × 50 mm) (Supplementary Figure S1)
 Glycerol stocks of Lactobacillus acidophilus W37 (LaW37), 
Lactobacillus brevis W63 (LbW63), and Lactobacillus casei W56 (LcW56) 
(Winclove Probiotics, Amsterdam, The Netherlands) were produced from 
bacteria grown anaerobically overnight in MRS medium. Upon use, glycerol 
stocks were washed with PBS and resuspended in Dulbecco’s modified Eagle’s 
medium (DMEM; Gibco-Invitrogen, Bleiswijk, The Netherlands), brought 
to 37°C, to reach 107 CFU/mL. DMEM contained 4.5 g/L glucose, 0.58 g/L 
glutamine, no pyruvate, and was supplemented with 10% heat inactivated 
fetal calf serum (hiFCS) (Hyclone Perbio, Etten-Leur, The Netherlands). 
 Salmonella Typhimurium (STM) DT12 was provided by Trouw 
Nutrition (Boxmeer, The Netherlands). STM was grown in Brain-Heart 
Infusion (BHI) medium (Becton, Dickinson and Company, Le Pont de Claix, 
France) until stationary phase, then washed in PBS, and standardized OD 
value was used for further dilution to 5x106 CFU/mL, as confirmed with CFU 
count on BHI plates. The ingredients used for the experiments were prepared 
freshly.
Caco-2 cell culture and trans-epithelial electric resistance
ATCC derived Caco-2 ATCC-HTB37 cells were cultured in DMEM. Cells 
were used within passage numbers 30 to 40 to ensure for stability of TEER 
throughout the different repetitions, and 330,000 were seeded on ThinCert 
transwells with 33.6 mm2 membranes and 0.4 μm pores in 24-well suspension 
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culture plates. Cells were grown for 21 days at 5% CO2 and 37°C. Wells were 
selected for experiments when TEER reached 330 Ohm*cm2 with a variation 
< 10 % between wells. Apical (150 μL) and basolateral (700 μL) medium were 
replaced three times per week and on the day prior to the experiment.
TEER was measured before the stimulation with lcITF and lactobacilli 
using a MilliCell-ERS Ώ meter (Millipore, Molsheim, France). Medium was 
then refreshed with or without the ingredients on the apical side. TEER was 
determined directly and at 1, 3 and 6 hours after exposure to ingredients 
to determine the integrity of the confluent monolayer. Per experiment, each 
condition was performed in triplicate, and after 6 hours incubation, the 
Caco-2 cells were lysed in TRIzol (Invitrogen, Life Technologies, Bleiswijk, 
Netherlands) and the triplicates were pooled for RNA isolation. Experiments 
were repeated 2-3 times, to obtain independent biological triplicates. For 
each time-point we calculated the delta (%) as compared to t=0 for each 
single well, in which t=0 was set to 100%. These deltas were then compared 
between wells exposed to compounds (lactobacilli strains and lcITF) and 
medium control to determine statistical significance per time point.
Salmonella Typhimurium challenge of Caco-2 cells exposed to 
L. acidophilus W37
Caco-2 cells were cultured as described above but grown on ThinCert 
transwells of 3 μm pores to allow bacterial translocation. LaW37 was 
incubated on the apical side of the Caco-2 cells for 20h, and TEER was 
measured at 1, 3 and 17 hours during incubation with LaW37. STM strain 
DT12 was then added for 45 min after which the Caco-2 cells were washed 
in PBS, and subsequently, medium was refreshed with one containing 100 
μg/mL gentamicin (DMEMgenta). Overnight incubation led to the recovery of 
TEER post challenge, which was measured after 80 min, 4 and 20 hours in 
DMEMgenta. Apical medium of pooled replicates was collected, centrifuged 
20 min at 12,000 g, at 4°C, and the supernatant was stored at -80°C for IL-8 
measurement.
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Total RNA was isolated as reported previously [26]. Total RNA was quantified 
with the Nano-drop® ND-1000 Spectrophotometer (Thermo Scientific, 
Wilmington, DE, USA) at OD260 nm and the purity was expressed with 
OD260 nm / OD280 nm. The quality and integrity of the RNA was confirmed 
on a 1 % agarose gel and visualizing the 18S and 28S bands with glyxol dye. A 
fixed amount of 1000 μg of total RNA was used to synthesize cDNA according 
to manufacturer’s instructions (BioRad iScript™ cDNA Synthesis kit ref). 
Incubation in a PCR block (MyCycles™ thermal cycler, Biorad) followed the 
program: 5 min at 25⁰C; 30 min at 42⁰C; 5 min at 85⁰C. The resultant single-
stranded cDNA was diluted in 40 μL of Nuclease free Milli-Q water, a pool 
of all samples was diluted in 20 μL to be used as standards, and they were all 
stored at -20⁰C until further use.
Microarray
RNAs of each independent Caco-2 experiment were hybridized to Affymetrix 
Human Gene 1.1 ST arrays according to standard Affymetrix protocols as 
described previously [26]. Quality control of the datasets was performed 
using Bioconductor packages [27] integrated in an on-line pipeline [28]. 
Array data were normalized using the Robust Multiarray Average (RMA) 
M-estimator method [29, 30], probe sets were defined according to Dai et al. 
[31]. Furthermore, universal expression code analysis was performed [32], 
which is a standardized score used to describe an active/inactive state of a 
gene in a sample. The Bioconductor UPC package was used to assign a score 
to each gene in each array. Data from all microarrays can be accessed online 
on GEO database with accession number GSE115022. Cells were considered 
to have the potential to express a gene if that gene had a UPC value greater 
than 0.5 in at least one array [33]. To identify differential gene expression 
induced by LaW37, LcW56, LbW63, and lcITF paired-wise comparison 
analyses were performed (treatment versus control medium) and genes with 
a LIMMA raw p-value <0.05 were selected for further data analyses.
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 To gain insight into the biological role of the genes which were 
differently expressed between Caco-2 cells incubated with control medium 
or different lactobacilli strains, we performed Ingenuity Pathway Analysis 
(Ingenuity System). As described previously [34], Ingenuity uses a 
comprehensive expert-curated repository of biological interactions and 
functional annotations that follow the gene ontology (GO) annotation 
principle. GO annotations are used by ingenuity in order to investigate, 
among others, overrepresented biological functions. The Ingenuity output 
includes biological functions and signaling pathways with statistical 
assessment of the significance of their representation based on Fisher’s Exact 
Test. Here, this test calculates the probability that genes participate in a given 
biological function relative to their occurrence in all other biological function 
annotations.
Statistical analysis
TEER values of all repetitions, expressed as delta for each time-point and 
normalized for time, were treated as one assay. All TEER data were normally 
distributed as confirmed by the Kolmogorov-Smirnov test. Statistical 
differences were analyzed using two-way ANOVA (analysis of variance) 
with LSD post hoc test. Data are expressed as mean ± standard error of the 
mean (SEM). p-values <0.05 were considered to be statistically significant 
and p<0.1 was defined as a trend. The data were analyzed with IMB SPSS 
Statistics 22 (IMB analytics, Armonk, NY, USA). IL-8 data were analyzed 
using the same procedure but with Tukey’s post hoc and the analysis was 
performed in GraphPad Prism version 7.0a (GraphPad Software, Inc., La 
Jolla, CA, USA). 
Results
The aim of this study was to determine whether a dietary fiber (lcITF) and 
different strains of lactobacilli, i.e. LaW37, LcW56 and LbW63, influence 
intestinal mucosal homeostasis by modulating enterocytes and epithelial 
cytokine responses. Effects of lcITF and lactobacilli on intestinal barrier 
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function was tested on monolayers of Caco-2 cells, first without a challenge, 
and later combined with a barrier disrupting pathogen, STM DT12. Also, 
possible attenuating effects of the food ingredients on cytokine responses of 
Caco-2 cells were studied with this pathogen. 
L. acidophilus W37 impacts barrier function via tight-junction 
related genes
First, we determined in vitro the potential impact of lcITF and of the three 
Lactobacillus strains LaW37, LbW56, LcW63 at 1x107 CFU/mL on the TEER 
of Caco-2 epithelial cells. TEER is a measure for intestinal barrier integrity. 
lcITF had no effect on TEER during 6 hours of incubation. Also, the strains 
LcW63 and LbW56 had almost no effect on TEER. They both decrease TEER 
by 4% after 3 hours incubation (LcW63 p=0.03; LbW56 p=0.02) but no 
difference was observed after 6 hours (Figure 1). On the contrary, LaW37 
enhanced TEER by 15% (p<0.01) after 6 hours (Figure 1).
 To gain insight in the cause and pathways involved in this TEER 
enhancement by LaW37 in an unbiased way, we performed genome-wide 
gene expression analysis on Caco-2 cells treated with lcITF and with all 
three lactobacilli strains. Genes differentially expressed are all listed in 
Supplementary File 1 with additional FDR values. In addition, data from all 
microarrays can now be accessed online on GEO database with accession 
number GSE115022.
 The lcITF regulated n=128 (FC -1.65 – 1.48) genes but these were 
not related to tight junction regulation, nor to epithelial-immune interaction 
parameters. Changes of pathways in Caco-2 cells were mainly related 
to energy metabolism. Changes occurred at the level of genes involved in 
amino-acids breakdown pathways, especially the gene TAT related to 
tyrosine was increased, as indicated by upregulation of AUH, UBAC2 and 
TAT genes and downregulation of USP40. Moreover, translation initiation, 
TCA cycle, OxPhos and fatty-acid oxidation, were all decreased. Typical genes 
downregulating fatty-acid oxidation were AUH, ECI2, SDHB, SDHD and 
NDUFV2. LcITF could therefore be involved in reducing energy metabolism.
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Figure 1: Eff ect of lactobacilli strains on TEER of Caco-2 cells. 21-days 
diff erentiated Caco-2 cells were incubated with L. acidophilus W37, L. brevis 
W63 and L. casei W56 for 6 hours. TEER was measured after 0, 1, 3, and 6 hours 
incubation, values were normalized based on the time-point t = 0 hour measurement 
and are expressed as delta variation compared to DMEM control for each time-point, 
which was set to 100%. Statistically signifi cant diff erence compared to control were 
assessed with SPSS statistics using ANOVA followed by LSD test with * p<0.05.
 Lactobacilli LcW63 and LbW56 regulated respectively n=92 (FC -1.45 
– 1.69) and n=98 (FC -1.70 – 1.38) diff erentially expressed genes compared 
to DMEM controls (p<0.05). Changes were not related to tight junction 
regulation, or to epithelial-immune interaction parameters. Changes 
occurred at the level of metabolism and coagulation with direct eff ects of 
LbW63 on two genes, PLAUR and FGA, indicating possible upregulation of 
growth factor signalling. Moreover, LbW63 upregulated two genes, PDIA3 
and FCER1G, involved in lipid metabolism related processes. On the other 
hand, LcW56 diff erentially regulated two genes, GLUD1 and NT5C3A, 
involved in amino-acid metabolism, however the direction was unclear. 
Besides, LcW56 also induced changes in cell proliferation with upregulation 
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of EGF and downregulation of growth hormone signaling genes PRKD3 
and GHR. Moreover, upregulation of genes PRKD3, SCNN1A and PDIA3 by 
LcW56 suggested an effect on control of processes related to blood pressure 
while upregulation of EGF, PRKD3 and THPO suggested changes at the 
levels of inflammation and blood coagulation and upregulation of EGF and 
PRKD3 indicated increased micropinocytosis signalling. 
 LaW37 exposure to Caco-2, however, induced differential regulation 
of 2743 genes (p<0.05). The fold changes ranged from -2.37 to 3.62 
compared to DMEM control. Most genes modulated by LaW37 were related 
to inflammation and bacterial stimulation of the epithelial layer. As shown on 
Figure 2, LaW37 impacted barrier function, a set of 26 genes involved in the 
regulation of tight junctions were upregulated e.g. CLDN 3, -4, Rab13. These 
stimulatory effects on barrier function and possible changes in epithelium 
morphology seem to be highly specific for LaW37 as they were not found in 
Caco-2 cells incubated with other ingredients. Moreover, LaW37 seems to 
impact epithelial-immune interactions via TNF receptor signaling as we found 
a down-regulation of the canonical NF-κB pathway (Figure 3) as shown by 
downregulation of genes TNFRSF1A, TIRAP, PIK3R1, FADD, GHR, FGFR4, 
RIPK1, SIGIRR, UBE2N, TRADD, AKT2, ARAF, PRKACA and upregulation 
of NFKBIA. On the other hand, the non-canonical pathway (NF-κB2) seems 
to be upregulated as indicated by upregulation of the typical gene NF-κB2. 
A consequence of which is expected to be on IL-8 regulation as shown by 
differential expression of 17 genes related to IL-8 production, namely JUN, 
IQGAP1, PAK2, NOX1, ITGAV, ITGB2, MAP2K1, PIK3R1, PIK3CB, CCND3, 
FOS, GNAI2, PIK3CA, RHOT1, ROCK1, PRKCI, GNG. Besides, LaW37 
also upregulated a group of six, previously described, markers of follicle-
associated epithelium (FAE) [35]. As shown in Figure 4, CCL20, CCL28, 
CLDN4, CXCL16, LAMB3 and TNFRSF9, were substantially upregulated. 
Another strong effect of LaW37 was observed at the level of protein regulation 
(Figure 5). Although no pathway was clearly targeted, tRNA charging was 
downregulated with 16 genes related to mitochondrial and cytosolic changes; 
14 genes related to translation initiation were differentially expressed; 
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19 genes related to mitochondrial ribosomal changes were downregulated; 11 
genes related to cytosolic ribosomal changes were differentially expressed; 
N-glycosylation was downregulated with 14 genes concerned; O-glycosylation 
was strongly enhanced with 26 genes upregulated (Figure 5). For instance, 
decreased amino-acid biosynthesis was observed with downregulation of 
genes CARS2, YARS2, FARSA, TARS, MARS2, MARS, FARS2, PARS2, 
HARS, CARS, RARS, SARS2, VARS, WARS, EARS2, and downregulation 
of mTORC signalling was observed with differential expression of the 
genes RPS26, PRKAA1, RICTOR, IRS1, EIF4A2, EIF3B, PIK3R1, PIK3CB, 
ULK1, PIK3CA, PPP2R5A, RPS29, TSC2, PPP2CB, RHOT1, MLST8, PRKCI, 
EIF4A3, RND3, EIF4G1, RPS6KA4, RPS6KB2, KRAS, AKT1S1, RHOT2, 
MTOR, VEGFA, DDIT4, RPS27A, INSR, AKT2, PDGFC, PRKCD, NAPEPLD, 
RPTOR, PLD2, RHOF, RRAS, PRKAB2. Increased cell proliferation, survival 
and apoptosis was observed with upregulation of the genes IRF1, APAF1, 
CRABP2, CASP9, FADD, CRABP1, TNFRSF10D, TNFRSF10B, TIPARP, 
PARP1, CFLAR, ZC3HAV1, PARP3, TNKS2 and PA. This was combined with 
decreased cell cycle control as indicated by downregulation of CDK4, MCM7, 
CDC45, MCM2, CDK2, MCM3, ORC5, CDK5, MCM5. Finally, upregulation 
of JUN, MAP2K5, MAFK, MAP2K1, PIK3CB, FOS, JUND indicated increased 
oxidative stress response possibly leading to reduction of oxidative damage. 
Together, these results indicate that LaW37 might exert different stimulatory 
effects on Caco-2 including enhancement of intestinal barrier function by 
stimulating tight junction-related processes.
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Figure 2. LaW37 is the only strain that enhanced tight-junction related 
gene expression in Caco-2 cells. Heat-map showing the relative expression of 
tight-junction related gene that differed significantly between Caco-2 incubated with 
control medium and the three lactobacilli strains. Colors indicate relative expressions 
normalized per gene (per row) that are statistically significantly different compared 
to control medium with a paired-wise LIMMA raw t-test and p<0.05. Dark green 
is a decreased fold change, the darkest the red the higher the increased fold change 
compare to medium control and black indicates no statistically significant change.
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Figure 3: Overview of differential gene expression within NF-κB pathway 
induced by LaW37 in Caco-2 cells. Effects of 6 hours incubation of Lactobacillus 
acidophilus W37 (LaW37) (107 CFU/mL) on Caco-2 genes related NF-κB pathway 
signaling indicate a downregulation of this pathway. Red indicates upregulation and 
green indicates downregulation (p<0.05).
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Figure 4: FAE markers of array data are specifically enhanced with 
LaW37. Effect of lactobacilli strains (107 CFU/mL) on Caco-2 genes related to follicle 
associated epithelium (FAE) markers. Heatmap of differential gene expression; red 
indicates upregulation, green indicates downregulation (p<0.05).
Figure 5: Gene expression specifically modulated by LaW37 in relation 
to protein metabolism in microarray data compared to LbW63 and 
LcW56. Effect of lactobacilli strains (107 CFU/mL) on Caco-2 genes related to tRNA 
changes, translation initiation, translation elongation, ribosomal proteins and post-
translational modifications. Heatmap of differential gene expression; red indicates 
upregulation, green indicates downregulation (p<0.05). 
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LaW37 protects Caco-2 function as measured by decreased IL-8 
production during Salmonella Typhimurium challenge
Due to the LaW37 induced enhancement of tight-junction related gene 
expression, we further tested if the capacity of LaW37 to increase TEER would 
be maintained during STM challenge and if it was connected to changes in 
immune function. This intra- and para-cellular invading pathogen is known 
to use barrier disruption as a mechanism to invade the host [36, 37].
Cells were challenged with STM which induced a drop in TEER of 
24% (p<0.01) compared to medium control (Figure 6). Although this drop 
was similar in terms of intensity for the cells pretreated for 17 hours with 
LaW37, it accounted for only 3.9 % (p<0.05) decrease when compared to 
medium control. This suggests that a higher TEER acquired prior to challenge 
thanks to the exposure to this strain will have beneficial effect of during STM 
infection as compared to cells that were not exposed to LaW37.
Lactobacillus acidophilus attenuates Salmonella-induced stress of epithelial cells 




Figure 6. Increased TEER of Caco-2 cells with LaW37 is maintained 
during STM challenge. TEER values are displayed as average with SEM of 
triplicates Caco-2 wells grown on transwells for 21 days and are expressed as % of 
DMEM control with n=3. STM DT12 7.5x105 CFU/tw challenge (as indicated by the 
arrow) was applied for 45 min after O/N incubation (17 hours) of Caco-2 cells with 
LaW37 107 CFU/transwell. TEER was measured throughout the O/N incubation, 
before and after the challenge, and after O/N recovery in gentamicin medium (45h). 
ANOVA with LSD post hoc was used to evaluate statistically signifi cant diff erences 
(p<0.05) compared to medium control at each time-point and p<0.05 are indicated 
by *. SEM are displayed only on the positive side for the non-challenged samples and 
on the negative side for the samples challenged with STM.
Furthermore, we measured the concentration of IL-8 chemokine 
released in the medium as measure for enterocytes stress response during 
STM in vitro infection. Exposure of Caco-2 to STM for 45 min led to 6-fold 
higher IL-8 production (p<0.0001) than medium control (Figure 7). This was 
partially prevented by LaW37, as production of IL8 was only 3-fold higher 
(p=0.04) compared to LaW37 control. This indicates that LaW37 not only 
prevents damage to barrier function but also protects from STM-induced 
stress response potentially via interference in the NF-κB pathway.
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Figure 7. Incubation of Caco-2 with LaW37 lowers STM-associated release 
of IL-8 post challenge. Average IL-8 levels released in the apical medium during 
an O/N recovering period after STM challenge in Caco-2 diff erentiated for 21 days are 
expressed in pg/mL. Standard deviations are displayed and statistically signifi cant 
diff erences, analyzed with ANOVA followed by Tukey’s multiple comparisons test, 
are indicated by * when p<0.05.
Discussion
In this study, we demonstrated profound species dependent eff ects of L. 
acidophilus W37 (LaW37) on Caco-2 cells. We selected three strains with 
reported anti-pathogenic eff ects [15, 17, 18, 38]. Only one of the 3 tested 
bacterial strains had the capacity to enhance barrier function via upregulation 
of tight-junction related genes. Moreover, we show that long-chain ITF did 
not impact Caco-2 cells barrier integrity. The strain that enhanced barrier 
function, i.e. LaW37, reduced the impact of Salmonella Typhimurium (STM) 
stress by increasing TEER and decreasing IL-8 secretion. Our data therefore 
confi rms our hypothesis that specifi c bacterial strains can attenuate STM 
induced barrier disruption. 
 In presence of lcITF, TEER was unaff ected. Our microarray analysis 
shows that lcITF had no eff ects on tight junctions in vitro in Caco-2 cells. 
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This corroborates findings in human gut epithelial T84 cells [39] in which 
only shorter chain ITF influenced barrier function. In vivo studies [25, 40], 
however, do demonstrate effects of lcITF on barrier function. This might be 
explained by microbiota driven effects [40] rather than by direct effects of 
lcITF. Despite absence of effects on tight junction genes we found that lcITF 
triggered differential regulation of 128 genes in the gut epithelial Caco-2 
cells. To the best of our knowledge, it is the first time that such a direct effect 
of lcITF on gut epithelial cells is reported.
 The strains L. brevis W63 and L. casei W56 were ineffective in 
enhancing TEER and even lowered TEER to some extent. Accordingly, we 
observed no major changes in Caco-2 gene expression. On the other hand, as 
expected from the observed enhancement of TEER in Caco-2 cells by LaW37, 
increased regulation of tight-junction gene expression was observed in our 
microarray analysis. LaW37 upregulated 26 genes related to barrier integrity 
that range from members of the claudins with upregulation of CLDN4, 15, 
and 16, and striatin STRN to occludins, but also proteins that are not usually 
checked for, such as the anchoring filament protein Laminin 5, particularly 
important as it was upregulated by 3 genes, LAMA3, LAMB3 and LAMC2. In 
addition, we found upregulation of tight-junction related genes that can be 
involved in more processes than regulation of barrier function. The PRKCI 
gene for instance plays a general protective role against apoptosis is also 
involved in NF-κB activation, cell survival, differentiation and polarity, and 
contributes to the regulation of microtubule dynamics in the early secretory 
pathway.
 Interestingly, we show here that a more extensive investigation of 
tight-junction regulation is important as the most commonly investigated 
genes are claudin-1, occludin and ZO-1 [16, 17, 41-43] and were not differently 
regulated by LaW37. Other studies have shown effects of various L. acidophilus 
strains, however not LaW37, on barrier integrity and on claudin-1, occludin 
and ZO-1 [16, 17, 41-43]. Also, another strain of L. acidophilus had no effect 
on TEER nor on tight-junctions [44]. This suggests that within L. acidophilus 
species effects on TEER and tight-junctions is strain dependent and studying 
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a broader set of related genes is needed to determine the mechanisms of 
action of bacterial strains.
 In addition to effects on barrier integrity, LaW37 influenced another 
2,700 genes. Many of these effects were immune related and were observed 
at 3 levels. First, LaW37 had a strong effect on TNF receptor signalling via 
decrease of the canonical NF-κB pathway. Secondly, LaW37 increased the 
non-canonical NF-kB pathway (NF-kB2), which could suggest an increase of 
lymphogenesis by the epithelial layer as previously observed with segmented 
filamentous bacteria [45]. Downregulation of NF-κB pathways as a mean 
to reduce pathogenic inflammation, including Salmonella, was previously 
reported for other strains of L. acidophilus [46, 47].
 Another notable observation connected to immune effects is related 
to changes in gene expression responsible for the formation of follicle 
associated epithelium (FAE)-like cells. A group of 6 previously described 
FAE markers [35], namely CCL20, CCL28, CLDN4, CXCL16, LAMB3 and 
TNFRSF9, were substantial upregulated. This might indicate that LaW37 
stimulates differentiation of enterocytes into FAE-like phenotype, a typical 
lining present on top of Peyer’s patches. The FAE structures contribute to 
antigen sampling by sensing luminal pathogens and releasing cytokine/
chemokine signals that attract and activate DCs [48]. This possible effect of 
LaW37 to trigger epithelial cells differentiation has never been described so 
far from a Lactobacillus bacterium.
 Non-immune related functions that were differentially regulated 
by LaW37 are numerous and concerned decreased protein translation with 
downregulation of amino-acid biosynthesis and the mTORC signalling 
pathway. This was combined with increased cell proliferation, survival and 
apoptosis but also decreased cell cycle control, suggesting an increased cell 
turnover. Although studies investigating lactobacilli effects on cell turnover 
are very scarce, another Lactobacillus has been reported to induced apoptosis 
in gastric cancer cells by inhibiting NF-κB and mTOR-mediated signaling 
[49]. As we observed such effects by LaW37 on genes involved in apoptosis 
and regulation of both NF-κB and mTOR signaling pathways of intestinal 
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cells, LaW37 might be instrumental in regulating abnormal behaviors in 
colonic cells for instance. 
 Pre-incubation of Caco-2 cells with LaW37 prevented STM-induced 
barrier disruption because of higher TEER level prior to challenge, and 
decreased cytokine stress responses of the epithelial cells. Release of 
IL8 by epithelial is known to attract neutrophils but also granulocytes to 
facilitate removal of STM [50], and is a common marker to evaluate the 
efficacy of lactobacilli to have therapeutic effects on epithelial cells during 
enteropathogenic infections [51]. Our results show that IL-8 was strongly 
decreased by LaW37 in combination with a preserved barrier integrity. This 
corroborate the differential expression of 17 genes related to IL-8 production. 
Moreover, our array data also indicate a decreased inflammatory state 
with downregulated NF-κB gene expression which was specific for LaW37. 
Therefore, we concluded that that STM-induced inflammation was reduced 
in vitro by LaW37, as previously shown for other strains [15, 17, 18, 47].
 In conclusion, screening of different lactobacilli strains on TEER in 
Caco-2 cells in the absence and presence of STM led to demonstration of 
strain dependent effects of lactobacilli on TEER and on gene expression. 
Only one of the three tested lactobacilli had effects on barrier integrity, and 
we confirmed that the selected lactobacilli, LaW37, attenuated STM induced 
barrier disruption as a consequence of an enhanced TEER prior to challenge. 
This potent effect of LaW37 makes it a relevant candidate to protect against 
enteropathogens such as Salmonella. Also, our data shows that prevention 
of barrier dysfunction by bacteria is strain dependent and may involve tight 
junction genes that are not conventionally measured. A broader screening 
of relevant genes might eventually lead to identification of novel bacterial or 
fiber formulations that effectively prevent enteropathogen induced barrier 
disruption. The strategy of measuring effects of lactobacilli and dietary fibers 
on gut TEER in the presence of absence of STM might lead to new therapeutic 
strategies to reduce STM infection and may thereby contribute to reduction 
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Scope: Synbiotic effects of dietary fibers and lactobacilli are usually 
explained by synergistic modulation of gut-microbiota. New insight 
however has demonstrated that both dietary fibers and lactobacilli can 
directly stimulate immune cells and benefit consumer-immunity. Here we 
investigated synergistic effects of immune-active long-chain inulin (lcITF) 
and L. acidophilus W37 (LaW37) on dendritic cells (DCs). Methods and 
results: Effects of lcITF and LaW37 alone or combined were studied on 
Toll-like receptor (TLRs) signaling and cytokine secretion by DCs in the 
presence and absence of media of intestinal epithelial cell (IEC) exposed to 
the ingredients. Also, we investigated the effects on DC-responses against 
Salmonella Typhimurium (STM). Synergistic effects were observed on 
TLR2 and 3. Synergistic effects were not always pro-inflammatory. LaW37 
was strongly pro-inflammatory while cytokine-responses were regulatory 
when combined with lcITF. Exposure of DCs to IECs-medium changed 
the DCs response which revealed synergistic enhancing effects of lcITF/
LaW37 on production of IL-6 and IL-8. DCs response in presence of STM 
and LaW37 were so strong that lcITF had no additional effect. Conclusion: 
We demonstrated that synbiotic effects of dietary fibers and bacteria are 
not limited to effects on gut microbiota but can also occur by synergistically 
directly stimulating IECs and/or immune cells.
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Both consumption of dietary fibers and of beneficial bacteria such as 
lactobacilli have been associated with health benefits including lowering 
symptoms of inflammatory diseases such as inflammatory bowel disease [1-3], 
and infections with enteropathogens such as Salmonella Typhimurium (STM) 
[4]. Despite those widely accepted beneficial effects of these food ingredients, 
the mechanisms behind these health effects are still not fully elucidated. 
It has been shown that consumption of dietary fibers and lactobacilli may 
lower circulating cytokines [5-9], and that some combinations of fibers and 
bacteria may have synergistic effects in humans [3, 10, 11]. There is an urgent 
need for studies to better understand the cellular processes involved in these 
beneficial immune effects of dietary fibers and/or beneficial bacteria [12], as 
it may lead to design of more effective strategies to prevent and/or manage 
inflammatory diseases.
 Classically, beneficial effects of food ingredients have been attributed 
to effects on gut microbiota and stimulation of its beneficial fermentation 
products such as short-chain fatty acids (SCFAs) [13]. However, evidence is 
accumulating that immune active food ingredients such as dietary fibers and 
bacteria can also directly interact with the intestinal immune system [14-17]. 
For example, we have shown that inulin type fructans (ITF) can stimulate 
TLRs on intestinal epithelial cells (IECs) [18, 19] and on immune cells 
resulting in NF-kB/AP-1 activation and modulation of cytokine release from 
immune cells [17]. Similar immune effects via pattern recognition receptors 
have been reported for lactobacilli [14, 16, 20]. As a consequence of these 
interactions with pattern recognition receptors, these food ingredients may 
be instrumental for example in management of Salmonella Typhimurium 
(STM) infection as this enteropathogen uses TLRs [21], especially TLR2, 4 
and 5, to invade the host [22]. 
 An important intestinal immune cell type involved in sensing of 
beneficial food ingredients are dendritic cells (DCs). DCs are one of the first 
immune cell types to come into contact with food compounds in the gut lumen 
[23, 24]. Their role is to sense and phagocyte antigens and subsequently 
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trigger adequate immune responses in other cells, such as T cells [23]. In the 
intestine DCs are located on strategic immune signaling locations such as in 
the lamina propria, mesenteric lymph nodes and between IECs, where they 
continuously encounter luminal antigens [25]. These luminal antigens may 
initiate different types of immune responses in DCs. The type of initiated 
response is determined by the composition of the antigen [26] and (co)
stimulation in the gut lumen of the innate immune receptors such as TLRs 
[17, 27]. In DCs, activation of specific pattern recognition receptors led to 
different cellular response which can regulate innate and adaptive immunity 
[23, 24].
 The DCs in the intestine experience crosstalk with the IECs which are 
the first cells to encounter beneficial food components such as dietary fibers 
and lactobacilli [25]. These IECs release, to be characterized, regulatory 
factors upon encounter of dietary fibers that attenuate inflammatory 
responses in DCs [28]. This anti-inflammatory effect is dietary fiber type 
dependent and may even change T-cell responses in a dietary fiber specific 
way [17]. Similar effects have also been shown with bacterial food components 
such as lactobacilli and are strain-dependent [29, 30]. However, possible 
direct synbiotic effects of dietary fibers and bacteria such as lactobacilli on 
immune cells have never been studied. Synbiotic effects are up to now mainly 
attributed to synergistic effects on microbiota [31-33]. 
 Here we studied possible direct synergistic effects of ITF and 
lactobacilli on DC immune responses. This was done by directly exposing 
DCs to the food ingredients in the presence and absence of media obtained 
from cultures of IECs that were exposed to the food ingredients for 20 hours. 
This design allows us to conclude whether factors released by IECs during 
exposure to lcITF or a Lactobacillus strain modulate DC responses. We 
chose L. acidophilus as study subject as this bacterium is known to modulate 
immune responses by modulating TLRs [7, 20, 34]. Another reason to choose 
L. acidophilus was that we also studied the effects of ITF and lactobacilli 
alone and combined in an experimental setup where IECs were infected 
with STM. L. acidophilus is known to compete with STM for adhesion on 
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IECs [35, 36] and to induce direct immune effects which can support DCs 
response towards the enteropathogen [35, 37]. This allows us to conclude 
whether ITF and/or lactobacilli can be instrumental in management of STM 
by directly interacting with intestinal cells. 
Material and methods
Ingredients and Salmonella Typhimurium culture
L. acidophilus strains W37 (LaW37) (Winclove Probiotics, Amsterdam, The 
Netherlands) was produced anaerobically at 37°C, in modified MRS broth. 
Glycerol stocks were washed with PBS and resuspended in culture medium, 
brought to 37°C, to reach 107 CFU/mL. 
 Long-chain inulin type fructans (lcITF) with DP10-60 (Frutafit® 
Tex!, Sensus, Cosun, Roosendaal, The Netherlands) was solubilized at 10 
mg/mL in culture medium at 37°C and further diluted in medium to 5, 1 and 
0.5 mg/mL. The ITF was characterized by high-performance anion exchange 
chromatography coupled with pulsed electrochemical detection, which was 
performed on an ICS5000 system (Thermo Fisher Scientific, Waltham, MA, 
USA), equipped with a Dionex CarboPac PA-1 column (2 × 250 mm) in 
combination with a Carbopac PA-1 guard column (2 × 50 mm) (Supporting 
Information Figure S1). The solution was 0.2 mm filtered to eliminate 
possible bacterial contaminations. Endotoxin concentrations in the filtered 
lcITF solutions were measured using the Limulus Amoebocyte Lysate (LAL) 
that was carried out according to the manufacturers protocol from Pierce 
LAL Chromogenic Endotoxin Quantitation Kit, Thermo Scientific (Pierce 
Biotechnology, Rockford, USA). Concentrations of endotoxins in lcITF 
filtered solutions fell below 0.3 x 10-3 endotoxin units mg-1 (0.002 ng/mL), 
which is too low to influence the results of the present study.
Salmonella Typhimurium DT12 (STM) was provided by Trouw 
Nutrition (Boxmeer, The Netherlands). STM was grown in Brain-Heart 
Infusion (BHI) medium until stationary phase, was washed in PBS, and 
diluted so that final concentration was 7.5x105 CFU / transwell (tw).
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HEK-Blue SEAP reporter cell assays
The human acute monocytic leukemia reporter cell line (THP-1) (InvivoGen, 
Toulouse, France) expresses endogenously, as previously described [18, 38], 
the human Toll-like receptors (TLRs) and an inserted construct for Secreted 
Embryonic Alkaline Phosphatase (SEAP) coupled to the NF-κB and the 
AP-1 transcription factor responsive promoter. This cell line also carries an 
extra insert for MD2 and CD14 that boosts TLR signaling. Furthermore, we 
used 7 different Human Embryonic Kidney (HEK)-BlueTM reporter cell lines 
expressing one of human TLR2, 3, 4, 5, 7, 8 and 9 (InvivoGen, Toulouse, 
France). All 7 cell lines also carried the inserted construct SEAP coupled to 
NF-κB/AP-1 promotor. Upon activation by their respective agonists, NF-κB is 
transferred to the nucleus, the SEAP gene is expressed and can be measured 
in the supernatant using QuantiBlue reagent (InvivoGen, Toulouse, France).
THP-1 cells were kept at a concentration of 5x105 cells/mL and 
cultured in RPMI1640 supplemented with 10 % heat-inactivated Fetal Calf 
Serum (hiFCS), 1.5 g/L NaHCO3 (Boom B.V. Meppel, The Netherlands), 
2 mM L-glutamine, 4.5 g/L glucose, 10 mM HEPES, 1 mM sodium pyruvate 
and 50 U/mL penicillin / 50 μg/mL streptomycin, all purchased from 
Sigma Aldrich Chemie B.V. (Zwijndrecht, The Netherlands) and 100 μg/
mL Normocin (InvivoGen). HEK-blue cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) culture media (Lonza, Basel, Switzerland) 
with 10% hiFCS, 2 mM L-glutamine, 4.5 g/L glucose, 50 U/mL penicillin / 
50 μg/mL streptomycin, all from Sigma-Aldrich and 100 μg/mL Normocin 
(InvivoGen). The culture medium was supplemented with selection antibiotics 
to maintain stable expression of the PRR genes (see Table 1). HEK-Blue cells 
were grown to approximately 80% confluence and were passaged three times 
in their respective selection media prior to any experiment, all according to 
manufacturer’s instructions. 
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Table 1: Culturing specifi cities and agonists used in the HEK-Blue 
reporter assays.
Stimulation of reporter cells with LaW37, lcITF and their 
combination
The HEK-Blue reporter cell lines were seeded according to Table 1 in 200 
μL/well in a 96 wells fl at bottom culture plate and cultured overnight. The 
following day, medium was refreshed with 100 μL medium containing lcITF 
at 0.5, 1, 5 or 10 mg/mL, LaW37 at 104, 105 or 106 CFU/well, in combination at 
the following ratio: 106 CFU/well / 10 mg/mL; 106 CFU/well / 5 mg/mL; 105 
CFU/well / 10 mg/mL; 105 CFU/well / 5 mg/mL, or with the relevant agonist 
(Table 1), and medium was used as negative control. For the inhibition 
assays, 10 μL of the corresponding agonist (Table 1) was added together with 
LaW37 and/or lcITF. THP-1 cells were incubated with and without addition 
of 50 μM Pepinh-MyD88 (InvivoGen).
 After 24 hours of incubation at 37⁰C 5% CO2, the supernatant of 
the cells was diluted 1:4 with QuantiBlue solution. After 1-hour incubation, 
a colorimetric measurement was performed at 650 nm on a Bio-Rad 
Benchmark Plus microplate spectrophotometer reader (Bio-Rad Laboratories 
B.V, Veenendaal, the Netherlands) using Bio-Rad Microplate Manager 
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5.2.1 software. This color change was presented as fold-change of NF-κB 
activation. The assay was performed at least five times and each condition 
was performed in triplicates.
Caco-2 cell culture and Salmonella Typhimurium challenge
ATCC derived Caco-2 cells (HTB-37, 2012) were cultured in DMEM (Gibco-
Invitrogen, Bleiswijk, The Netherlands) with 4.5 g/L glucose, 0.58 g/L 
glutamine, no pyruvate, and supplemented with 10% hiFCS (Hyclone Perbio, 
Etten-Leur, The Netherlands). Cells were used within passage numbers 30 
and 60, and 330,000 were seeded on ThinCert transwells with 33.6 mm2 
membranes and 3 μm pores in 24-well suspension culture plates. Cells were 
grown for 21 days at 5% CO2 and 37°C. Apical (150 μL) and basolateral (700 
μL) medium were replaced three times per week and on the day prior to the 
experiment.
LaW37 and lcITF were prepared within an hour prior to the 
experiment. Medium was then refreshed with or without the ingredient on 
the apical side. Each condition was tested in triplicate, and experiments were 
repeated 6 times, on different days. After 20 hours incubation, the Caco-2 
cells were challenged with STM for 45 min after which the cells were washed 
in PBS apically and basolaterally, and subsequently refreshed with medium 
containing 100 μg/mL gentamicin (DMEMgenta) on both sides. Basolateral 
medium of pooled replicates was collected after 4 hours and the supernatant 
was stored at -80°C for further experiments.
DCs stimulation
To evaluate the direct immune effects of lcITF and/or LaW37 on intestinal 
cells we used dendritic cells (DCs) and Caco-2 epithelial cells. DCs were 
purchased from MatTek (MatTek Corporation, Ashland, MA, USA) and were 
generated from CD34+ progenitor cells harvested from umbilical cord blood 
which express HLA-DR, CD83 and CD86, phenotypic maturation markers 
[17]. The DCs resemble features of DCs found the in the gastrointestinal tract, 
such as presenting antigens to T-cells, and have therefore been previously 
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used in in vitro systems mimicking the gastrointestinal track [14-17]. We 
compared exposure of DCs to the ingredients with and without addition of 
Caco-2 spent medium (Caco-SM). The design for this series of experiments 
is described in Figure 1. These experiments were performed 6 times, as 
previously described [17, 18, 39], on different days. 
 DCs stimulation experiments were conducted with 2 different 
settings. First, DCs seeded onto a 96-well plate (40,000 DCs/well) were 
incubated with 5 mg/mL of lcITF and/or 107 CFU/mL of LaW37. After 20 
hours, DCs spent medium of triplicates were pooled and stored at -80°C until 
further analysis (Figure 1A).
 Next, we performed the same assay to which we added Caco-SM. 
This Caco-SM was collected from fully differentiated Caco-2 cells grown on 
transwells as previously described and exposed to the same ingredient for 
20 hours. In this experiment, the DCs are exposed concomitantly to both the 
ingredients and the Caco-SM collected after Caco-2 cells were themselves 
exposed to that same ingredient in a 1:10 ratio. After DCs were stimulated for 
20 hours, the spent medium of triplicates were pooled and stored at -80°C 
until further analysis (Figure 1B). 
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Figure 1. Experimental design for DCs stimulation with lcITF, LaW37 
and lcITF/LaW37, in absence (A) and presence (B) of Caco-SM, with (C) 
and without STM challenge. Eff ects of long-chain inulin type fructans (lcITF), 
L. W37 (LaW37) and lcITF/LaW37 on dendritic cells (DCs) directly exposed to these 
ingredients for 20 hours (A) was compared to a cross-talk situation where DCs are 
also exposed to the spent medium collected from Caco-2 cells (Caco-SM). For this 
purpose, Caco-2 cells were cultured on transwells for 21 days in a separate plate 
and were incubated for 20 hours with lcITF, LaW37 or lcITF/LaW37. The Caco-
SM collected was then transferred to the DCs that were separately cultured (B). In 
this setting DCs are exposed concomitantly to this Caco-SM and the corresponding, 
freshly prepared, ingredient. At last, Caco-2 cells were challenged for 45 min to S. 
Typhimurium (STM) and the same experiment was repeated (C).
Furthermore, this experiment was repeated after exposure of  Caco-2 
to STM. In this experiment, Caco-2 cells pre-incubated for 20 hours with 
ingredients, were challenged with STM for 45 min as described above (2.4). 
The spent medium collected in the basolateral compartment is then referred 
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to as Caco-SM-STM. Afterwards we proceed as in the previous experiment 
and stimulated DCs for 20 hours with a simultaneous exposure to Caco-SM-
STM and the corresponding ingredient. Spent medium of DCs collected from 
triplicates were pooled and stored at -80°C until analysis (Figure 1C).
Luminex analysis of cytokines and chemokines from DCs
The kit Magnetic Luminex© premixed cytokine assay (R&D systems Inc, 
Minneapolis, USA) was customized to simultaneously measure the following 
molecules in spent medium from DCs: IL-12/23 p40, IL-1ra, IL-1β, IL-6, 
MCP-1/CCL2, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-10 and TNF-α. 
 Luminex assays were performed according to the manufacturer’s 
instructions. Briefly, a concentration series of cytokine standards were 
prepared for the appropriate concentration range. The undiluted microparticle 
cocktail specific for DCs was added to each well (50 μL/well), washed, and 
standards, negative controls, and samples were all incubated O/N at 4°C 
shaking (duplos, 50 μL/well). After incubation, the plate was washed three 
times, a biotin antibody cocktail was added to each well (50 μL/well) and the 
plate was further incubated while shaking for 1 hour at room temperature 
(RT). The plate was washed 3 times and streptavidin-phycoerythrin was 
added to each well (50 μL/well). After 30 minutes incubation shaking at RT, 
the plate was washed three times and the microparticles in were resuspended 
in 100 μL of wash buffer. Fluorescence was then measured within 90 minutes 
using a Luminex® analyzer MAGPIX and xPONENT 4.2 for MAGPIX 
software (Luminex Corporation, ‘s-Hertogenbosch, The Netherlands).
ELISA analysis of IL-8 produced by DCs
IL-8 was measured in spent medium from DCs using a human CXCL8/
IL-8 DuoSet ELISA ELISA kit (R&D systems), performed according to 
manufacturer’s instruction. In short, 96-well plates (R&D systems) were 
coated with capture antibodies at a concentration of 4 μg/mL O/N at RT 
after which the plates were washed with a filtered block buffer containing 
1% BSA (Sigma Aldrich). Samples were diluted 1:4 and incubated for 2 hours 
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after which the detection antibody was added at a concentration of 20 ng/
mL and incubated for 2 hours. Reaction with 40-fold diluted Streptavidin-
Horse Radish Peroxidase occurred afterwards for 20 min and was followed 
by 20 min reaction with 3,3’,5,5’-Tetramethylbenzidine (Sigma Aldrich) that 
was stopped with Carboxylic acid (BioLegend Inc., San Diego, CA, USA). 
Plates were thoroughly washed 3 three times with wash buffer containing 
0.05% TWEEN. Optical density was immediately estimated at 540 nm 
with subtraction of 450 nm background using Bio-Rad Benchmark Plus 
microplate spectrophotometer reader. Data were processed using GraphPad 
Prism version 7.0a (GraphPad Software, Inc., La Jolla, USA).
Statistical analysis
THP-1 and HEK-blue cells TLRs data were normalized compared to medium 
control so that medium equals 1, and activation value can be expressed 
as fold-change induction of NF-κB/AP-1 compared to medium. The data 
were not normally distributed as confirmed by the Kolmogorov-Smirnov 
test. Statistical differences were analyzed using Kruskal-Wallis followed by 
Dunn’s post hoc test. Cytokines data were normally distributed as confirmed 
by the Kolmogorov-Smirnov test and ANOVA was applied followed by LSD 
test. p-values <0.05 were considered to be statistically significant and p<0.1 
was a trend. Cytokines data are expressed as average (pg/mL) ± SEM. All 
data were analyzed with GraphPad Prism.
Results
The aim of this study was to determine whether direct immune effects 
of dietary fibers such as lcITF and a lactic acid bacterium like LaW37 are 
synergistic and modulates mucosal immunity during infection with an 
enteropathogen by directly interacting with immune receptors. We first 
established possible activation of crucial pathogens recognition receptors, 
the TLRs. Next, we investigated whether these effects were associated with 
immune cell signaling in DCs, and whether this response was modulated 
by factors released by IECs after Caco-2 were challenged or not with STM. 
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At last, we evaluated the effects of the ingredients on DCs with and without 
STM challenge.
Immune receptors are specifically reacting to LaW37, lcITF and 
their combination has synergistic effects
As both lcITF and lactobacilli have been shown to signal on immune cells via 
TLRs [18, 20], we first investigated possible synergistic effects on reporter 
cell-lines expressing TLR2, 3, 4, 5, 7, 8 and/or 9. Activation by lcITF was 
observed in TLR2, 3 and 5 expressing cell lines. Therefore, only these results 
are shown in Figure 2. LcITF had a strong dose-dependent activating effect 
on TLR2 (Figure 2A) up to 3.5-fold (p<0.0001) at 5 mg/mL. Activation 
of TLR3 was reaching 1.5-fold (p=0. 001) at 5 mg/mL (Figure 2B). LcITF 
induced activation of TLR5 was dose-dependent (Figure 2C) with a 5.6-fold 
increase (p<0.0001) at 5 mg/mL. 
LaW37 statistically significantly activated TLR2 in a dose-dependent 
way inducing a1.4-fold increase at 106 CFU/mL (p=0.003) and a 8.2-fold 
increase (p<0.0001) at 107 CFU/mL (Figure 2A). A trend towards increase 
of TLR3 was observed at 106 CFU/mL (1.2-fold; p=0.07) and a statistically 
significant increase reached 5.5-fold at 107 CFU/mL (p=0.0002) (Figure 2B). 
The combination lcITF/LaW37 had synergistic effects in TLRs. 
The combination activated TLR2 in a dose-dependent manner with a 
5.7-fold increase at 5 mg/mL / LaW37 106 CFU/mL (p=0.003) and 11.4-fold 
increase at lcITF 10 mg/mL / LaW37 106 CFU/mL (p<0.0001) (Figure 2A). It 
also activated TLR3 in a synergistic way. LcITF 10 mg/mL / LaW37 106 CFU/
mL led to 6.1-fold increase (p<0.0001) (Figure 2B). LcITF/LaW37 statistically 
significantly activated TLR5 in a dose-dependent manner (Figure 2C), this 
however did not differ from what was observed for lcITF alone.
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Figure 2. NF-κB/AP-1 activation in HEK-Blue reporter cell lines 
expressing TLR2 (A), 3 (B) or 5 (C) by lcITF, LaW37 and lcITF/LaW37. 
Agonists used were respectively Heat Killed Lysteria Monocytogenes, Poly (I:C) 
Low Molecular Weight and Salmonella Typhimurium fl agellin. Long-chain inulin 
type fructans (lcITF) was tested at 0.5, 1, 5 and 10 mg/mL, and L. acidophilus W37 
(LaW37) was tested at 104, 105 and 106 CFU/mL. n=5 performed in triplicates. 
Statistical signifi cances compared to medium were assessed by Kruskal-Wallis with 
Dunn’s test and * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, and # p<0.1. 
Figure 3. NOT IN PUBLISHED VERSION. Inhibition of TLR2, 5 and 8 
revealed synergistic eff ects of the combination lcITF/LaW37. Prevention 
of NF-ΚB/AP-1 activation by appropriate agonist in HEK-Blue reporter cell lines 
expressing TLR2, 3 or 5. Agonist were respectively HKLM, STM fl agellin and 
ssRNA40/LyoVec, and control medium was used as positive control. Statistical 
signifi cances were assessed by Kruskal-Wallis followed by Dunn’s test and statistically 
signifi cant diff erences compared to agonist are represented by * with p<0.05, ** 
p<0.01, *** p<0.001, **** p<0.0001. lcITF = long-chain inulin type fructans was 
tested at 10, 5, 1 and 0.5 mg/mL, and LaW37 = L. acidophilus W37 was tested at 106, 
105 and 104 CFU/mL. n=5 with triplicates.
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LaW37 stimulates a pro-infl ammatory phenotype in DCs while 
lcITF/ LaW37 attenuates the response in DCs 
After confi rming immune signaling via TLRs and synergistic eff ects of lcITF 
and LaW37, we studied the eff ect of lcITF and LaW37 on DCs to determine 
the fi nal eff ects on immune signaling (Figure 1A). We investigated the eff ects 
of lcITF, LaW37 and their combination on human IL-12/23 p40, IL-1ra, IL-
1β, IL-6, IL-8, MCP-1/CCL2, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-10 
and TNF-α production (Table 2).
 The production of IL-1β, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-
12.23p40 and IL-10 was below detection levels at all occasions. There was no 
statistically signifi cant eff ect of lcITF on DCs. This was diff erent for LaW37. 
LaW37 statistically signifi cantly increased CCL-2/MCP-1 (p=0.022), IL-6 
(p=0.001) and TNF-a (p=0.001) compared to unstimulated DCs (Table 2). 
Finally, the combination lcITF/LaW37 statistically signifi cantly increased 
TNF-a (p=0.026) and tended to increase CCL-2/MCP-1 (p=0.084) (Table 2). 
In general, the eff ects of the combination lcITF/LaW37 were milder than 
those observed for LaW37 as pro-infl ammatory IL-6 (p=0.019) and TNF-α 
(p=0.027) were statistically signifi cantly higher enhanced by LaW37 than by 
lcITF/LaW37.
Table 2. Eff ect of direct exposure of lcITF, LaW37 and lcITF/LaW37 on 
DC cytokine responses. Eff ects of 5 mg/mL long-chain inulin type fructans 
(lcITF), 107 CFU/mL Lactobacillus acidophilus W37 (LaW37) and lcITF/LaW37 on 
IL-1ra, IL-6, IL-8, MCP-1/CCL2, and TNF-α production was measure by Luminex in 
medium of DCs directly exposed to ingredients for 20 hours. Data are averages with 
SEM values of 6 repetitions, with triplicates. Statistical signifi cances of diff erences 
compared to unstimulated DCs were tested in GraphPad Prism ANOVA with LSD 
test and *** p<0.001, * p<0.05 and # p<0.1. 
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DC responses to lcITF and/or LaW37 are modulated by intestinal 
epithelial cells
As it is well known that IECs derived factors are essential for modulating 
responses of DCs when exposed to dietary fibers [17, 25], we repeated the 
experiment to investigate whether IECs spent medium (Caco-SM), collected 
after 20 hours exposure to lcITF, LaW37 or lcITF/LaW37, can modulate the 
DCs response (Figure 1B). This was done by incubating DCs in a 1:10 ratio 
of Caco-SM for 20 hours. We abandoned cocultures of IECs and DCs and 
preferred to include Caco-SM instead with DCs as this set up allows us to 
exclusively measure the DCs response. We investigated the effects of lcITF, 
LaW37 or lcITF/LaW37 on human IL-12/23 p40, IL-1ra, IL-1β, IL-6, MCP-1/
CCL2, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-10 and TNF-α production 
in spent medium from DCs as presented in Table 3.
 First, we assessed the effect on DCs of the Caco-SM itself and 
compared cytokine levels to that of unstimulated DCs. As shown in Table 3, 
there was no statistically significant difference for the tested cytokines. 
Next, we exposed DCs to both the ingredients and Caco-SM after 
Caco-2 cells were themselves exposed for 20 hours to the same ingredients. 
The production of IL-1β, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-
12.23p40 and IL-10 was below detection levels at all occasions. There was 
no statistically significant difference for lcITF. This was different for LaW37. 
LaW37 statistically significantly increased the pro-inflammatory chemokine 
IL-8 (p<0.0001) and tended to increase TNF-a (p=0.064) and IL-1ra 
(p=0.105) compared to DCs exposed to unstimulated Caco-SM (Table 3). 
Finally, the combination lcITF/LaW37 statistically significantly increased 
IL-8 (p<0.0001), TNF-a (p=0.0035) and IL-6 (p=0.023) (Table 3). The 
combination lcITF/LaW37 had stronger effects on pro-inflammatory 
cytokines than LaW37 alone and increased the production of the pleiotropic 
IL-6 but not of the anti-inflammatory IL-1ra, which was the opposite for 
LaW37 alone. Moreover, synergistic effects by lcITF/LaW37 were observed 
on IL-8 production as IL-8 tended to be higher enhanced by lcITF/LaW37 
than by LaW37 (p=0.055) and lcITF (p<0.0001) alone.
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Table 3. Eff ect of direct exposure of lcITF, LaW37 and lcITF/LaW37 on 
DC cytokine responses in the presence of IEC-media. The eff ects of 5 mg/
mL long-chain inulin type fructans (lcITF), 107 CFU/mL Lactobacillus acidophilus 
W37 (LaW37) and lcITF/LaW37 on IL-1ra, IL-6, IL-8, MCP-1/CCL2, and TNF-α 
production by DCs after 20 hours exposure to the ingredients combined with Caco-
2 intestinal epithelial cells (IECs) medium (Caco-SM) was measured by Luminex. 
Caco-2 cells were incubated 20 hours, on beforehand, with lcITF, LaW37 or lcITF/
LaW37. Data are averages with SEM values of 6 repetitions, with triplicates. Statistical 
signifi cance of diff erences compared to DCs exposed to unstimulated Caco-SM were 
tested in GraphPad Prism ANOVA with LSD test and **** p<0.0001, ** p<0.01, * 
p<0.05 and # p<0.1. 
STM challenge of Caco-2 cells lowers TNF-α responses in DCs 
response
Next, we applied a STM challenge to Caco-2 cells to study eff ect of lcITF, 
LaW37 or lcITF/LaW37 on STM induced infl ammatory responses in IECs. 
STM is an enteropathogen capable of escaping the immune recognition, 
invading epithelial cells and being internalized by DCs [40, 41]. We repeated 
the above experiment on DCs but added a 45 min STM challenge of Caco-2 
cells after they were pre-incubated for 20 hours with lcITF, LaW37 or lcITF/
LaW37 (Figure 1C). The medium collected from the basolateral side of the 
Caco-2 culture exposed to both ingredients and STM is further referred to as 
Caco-SM-STM. 
As control, we fi rst analyzed the cytokine levels produced by DCs 
after exposure to Caco-SM-STM in the absence of ingredients by measuring 
production of human IL-12/23p40, IL-1ra, IL-1β, IL-6, MCP-1/CCL2, 
CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-10 and TNF-α after 20 hours 
incubation. This was compared to responses of DCs that were exposed to 
Caco-SM without Salmonella Typhimurium exposure. When DCs were 
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exposed to Caco-SM-STM, the production of IL-1β, CCL3/MIP-1α, CCL-5/
RANTES, IFN-γ, IL-12/23p40 and IL-10 was below detection levels at all 
occasions. As presented in Table 4, challenge of Caco-2 with STM did not 
induce any statistically significant change in CCL-2/MCP-1, IL-1ra, IL-6 or 
IL-8. However, TNF-α was reduced from 10 pg/mL in medium control to 
over 4 pg/mL (p<0.0001) in DCs exposed to Caco-SM-STM compared to 
DCs exposed to Caco-SM control (Table 4).
 Next, we analyzed the effects on DCs of lcITF, LaW37 and lcITF/
LaW37 on STM challenged IECs. We therefore repeated this experiment with 
pre-incubation of Caco-2 cells to lcITF, LaW37 or lcITF/LaW37 for 20 hours 
prior to the 45 min STM challenge. This Caco-SM-STM was then exposed 
to DCs cultured separately in a 1:10 ratio. DCs were concomitantly exposed 
to Caco-SM-STM and freshly prepared lcITF, LaW37 or lcITF/LaW37. DCs 
response was analyzed by measuring production of human IL-12/23 p40, IL-
1ra, IL-1β, IL-6, MCP-1/CCL2, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-10 
and TNF-α after 20 hours incubation. Production of IL-1β, CCL3/MIP-1α, 
CCL-5/RANTES, IFN-γ, IL-12/23p40 and IL-10 was below detection level at 
all occasions. As presented in Table 4, lcITF had no statistically significant 
effect on any of the detectable cytokines and chemokines. This was different 
for LaW37. LaW37 increased all detectable cytokines and this was statistically 
significant for CCL-2/MCP-1 (p=0.004), IL-6 (p=0.007), IL-8 (p<0.0001) 
and TNF-a (p=0.0001) but not for IL-1ra. The same was observed for the 
combination lcITF/LaW37.
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Table 4. Eff ect of direct exposure of lcITF, LaW37 and lcITF/LaW37 on DC 
cytokine responses in the presence of IEC-media exposed to Salmonella 
Typhimurium DT12 (STM) in combination with the ingredients. The eff ects 
of 5 mg/mL long-chain inulin type fructans (lcITF), 107 CFU/mL L. acidophilus 
W37 (LaW37) and lcITF/LaW37 on IL-1ra, IL-6, IL-8, MCP-1/CCL2, and TNF-α 
production by DCs after 20 hours exposure to the ingredients combined with Caco-2 
intestinal epithelial cells (IECs) medium (Caco-SM-STM) was measured by Luminex. 
Caco-2 cells were incubated 20 hours, on beforehand, with lcITF, LaW37 or lcITF/
LaW37 and challenged with STM for 45 min. Data are averages with SEM values 
of 6 repetitions, with triplicates. Statistical signifi cance of diff erences compared to 
DCs exposed to Caco-SM-STM, without ingredients, were tested in GraphPad Prism 
ANOVA with LSD test and **** p<0.0001, *** p<0.001 ** p<0.01 and * p<0.05. 
Discussion
Our study shows for the fi rst time, to the best of our knowledge, that dietary 
fi bers and bacterial supplementation can synergistically infl uence immunity 
by directly interacting with immune cell receptors, and eventually modulate 
DC responses. This might be another mechanism for synbiotic eff ects than 
the microbiota driven and indirect modulation of immunity so far observed 
in other studies [31-33]. Also, our study shows that DCs directly exposed 
to LaW37 or lcITF/LaW37 react diff erently than DCs that are also exposed 
to IECs media. In the fi rst case, direct eff ects of LaW37 were dampened by 
addition of lcITF, while enhancing eff ects on IL6 and IL8 were observed in 
presence of IECs. 
 The selected dietary fi ber lcITF showed direct stimulatory eff ects 
on TLR2, 3 and 5. Eff ects on TLR2 and 5 were dose-dependent as reported 
before [18]. Despite this observation, direct stimulation of DCs did not lead 
to any change in cytokine and chemokine production. This can be explained 
by diff erential and simultaneous stimulation of pattern recognition receptors 
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leading to activation of several downstream pathways, bringing regulatory 
and pro-inflammatory responses into balance, as reported before [17, 38]. 
Another factor could be due to varying expression of TLRs as different DC 
population may have different phenotypic reactions to TLR activation [42]. 
Despite absence of immune stimulation of DCs by lcITF we decided to test 
effects of lcITF in the context of a STM infection of IECs as lcITF stimulates, as 
shown in our study, TLR5. The main ligand for TLR5 is flagellin, a pathogenic 
molecule expressed by STM. Unfortunately, during STM infection lcITF did 
not enhance DCs responses.
 Stimulatory effects of the Lactobacillus strain LaW37 were observed 
on TLR2 and 3. This corroborates observation of others [7]. TLR2 activation 
should be explained by production of lactic acid and presence of lipoteichoic 
acid on LaW37, which are both specific ligands of TLR2 [20, 34]. Although 
change of pH and production of lactic acid were not quantified, acidification 
of the medium was not observed during stimulation of the cells suggesting 
low metabolic activity of LaW37. Notably, however, the potential of LaW37 to 
activate TLRs is specific as not all lactobacilli were reported to activate TLRs, 
e.g. L. paracasei [14]. The effects of LaW37 on direct immune stimulation 
were confirmed by exposing DCs to LaW37 which resulted in enhanced 
production of the chemokine CCL-2/MCP-1 and the pleiotropic IL-6. It also 
tended to increase the pro-inflammatory cytokine TNF-α which is a more 
general feature of lactic acid producing bacteria [43]. Moreover, in this same 
study, effects of L. acidophilus were shown to be specific and particularly 
efficient at increasing expression of HLA-DR, CD40 and CD86 DCs surface 
maturation markers [43] which are also present on the DCs used in our study 
and could explain the pro-inflammatory effects.
 IEC media modulated responses of DCs exposed to LaW37. Production 
of the pro-inflammatory cytokines and chemokines IL-8 and TNF-α was 
increased in the presence of IEC media after Caco-2 cells were exposed to 
LaW37. Moreover, it implies that bacteria such as L. acidophilus may have 
other effects on IECs than dietary fibers as in a previous study we showed 
that dietary fibers exclusively attenuate immune responses in DCs [17]. Our 
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observation is in line, however, with studies of others demonstrating the 
capability of lactobacilli to induce pro-inflammatory responses in vivo [6] 
and in DCs [44]. Notably, induction of IL-8 in DCs was not observed unless 
Caco-SM was present suggesting that induction of IL-8 production by DCs is 
likely to be a consequence of IEC derived factors induced by lactobacilli.
 The combination of lcITF and LaW37 had synergistic effects on TLR2 
and 3 activation which suggest that the mechanisms behind synbiotic effects 
might also include synergistic effects on immune receptors such as TLRs. 
As effects on inflammatory responses of combined stimulation of pattern 
recognition receptors is difficult to predict [15], we also performed studies of 
synbiotic effect on immune response of DCs. Direct exposure to lcITF/LaW37 
led to increased CCL-2/MCP-1 and TNF-α. This increase was statistically 
significantly lower than for LaW37 alone. This indicates that lcITF/LaW37 
together give different responses in DCs and thus have synergistic effects 
which can be attenuation of inflammatory responses and induction of more 
regulatory responses. Interestingly, this has already been shown on IECs, 
also with a combination of lcITF and L. acidophilus [45].
 Synergistic effects of lcITF/LaW37 were also observed when Caco-
SM was added to DCs. LcITF/LaW37 induced production of IL-8 and 
TNF-α. IL-8 increase was higher for the combination than for LaW37 alone. 
Moreover, lcITF/LaW37 also induced IL-6 production, which was unique to 
the combination. To study whether the observed synergistic effects can have 
any functional meaning, DCs were, next, exposed to IECs infected with STM. 
After STM challenge, lcITF/LaW37 increased CCL-2/MCP-1, TNF-α, IL-8 
and IL-6 production by DCs. There was no difference compared to LaW37. 
This is different than the results of Huang et al. where gene expression of IL-8 
and TNF-a in IECs during STM challenge was decreased by L. acidophilus 
alone or combined with lcITF [45]. Our experiments solely focused on DCs 
responses which were not directly exposed to STM, as we mimicked the in 
vivo situation where DCs are protected by the IECs. Therefore, during STM 
challenge, DCs in our experiments were not under a pro-inflammatory 
setting unlike the IECs used in Huang et al. study which might explain such 
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differences. Another difference is that the combination used by Huang et 
al. had stronger effects than L. acidophilus alone [45] which suggests that 
synbiotics can have a synergistic effect during STM infection, although 
no synergistic effect could be shown in our study. Moreover, in our study, 
LaW37 already strongly enhanced CCL-2/MCP-1, TNF-α, IL-8 and IL-6 that 
it is likely that no significant effect of the modest cytokine enhancing dietary 
fiber lcITF can be measured. 
 In conclusion, we demonstrated that synbiotic effects of the dietary 
fiber lcITF and lactic bacteria LaW37 occurred by synergistically activating 
immune receptors. In general, LaW37 displayed pro-inflammatory effects on 
DCs no matter the conditions which is likely due to its capacity to stimulate 
TLR2 and 3. The combination lcITF/LaW37 was found to synergistically 
activate specific TLRs and had unique effects on DCs cytokine profiles. 
However, during STM challenge, no added effects of the combination were 
observed which should probably be explained by the strong effects of LaW37 
on DCs cytokine response in the presence of STM infection. This demonstrates 
for the first time, to the best of our knowledge, that synbiotic effects of dietary 
fibers and bacteria are not limited to effects on gut microbiota but can also 
occur by synergistically directly stimulating IECs and/or immune cells. The 
final outcome of such a synergistic effect depends on the strength by which 
the individual ingredient modulates immune responses.
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Figure S1. Long-chain inulin-type fructan (lcITF; Frutafit® TEX!) 
HPAEC profile. Peaks represent fructose (F) and glucose (G) monomers, dimers 
and fructans oligomers present in the formulation of lcITF. GFn and Fn chains 
respectively terminated by a glucose or fructose molecule with n the number of 
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Scope: Long-chain inulin (lcITF) and Lactobacillus acidophilus W37 
(LaW37) are food ingredients known to modulate immunity. Here we tested 
whether lcITF alone or combined with LaW37 can enhance vaccination 
efficacy against Salmonella Typhimurium (STM) in neonatal piglets. 
Conceivably, this is an effective, cheap strategy to lower STM burden in 
society. Methods and results: Ingredients were given daily from day 2 
after birth until sacrifice. Piglets were weaned on day 24 and vaccinated 
with Salmoporc STM®. To evaluate protection against STM, animals were 
challenged with this pathogen before sacrifice. Zootechnical parameters 
were measured daily to study animal well-being. Blood was sampled prior 
and post vaccination to quantify antibody titers, innate immune cells, T cells 
and memory T cells. Diarrhea was significantly lower in lcITF and lcITF/
LaW37 groups compared to controls. Moreover, lcITF/LaW37 enhanced 
vaccination efficacy as evidenced by increased antibody levels, kinetic was 
influenced by wild-type STM contamination. T helper cells were enhanced 
in the lcITF group, but not in lcITF/LaW37. Finally, frequency of memory 
T cells in animals tended to be increased in lcITF and lcITF/LaW37 groups. 
Conclusion: These results demonstrate that piglet health benefited from 
both lcITF and lcITF/LaW37 supplementations but vaccination was only 
enhanced by lcITF/LaW37 administration.
Abstract
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Enteropathogenic Salmonellae, such as Salmonella enterica enterica 
Typhimurium (STM), is a prevalent pathogenic agent of food-borne illnesses 
worldwide, invading and eventually causing necrosis of the intestines [1]. 
The infection leads to severe diarrhoea and sometimes generalized sepsis 
depending on the overall health status of the host. Salmonellosis affects over 
90 million people yearly [2] with about 3 million deaths as a consequence. 
STM, on its own, accounts for 12% of the deaths after food poisoning in the 
European Union [3].
 Pigs represent a major reservoir of STM for the human population 
[4, 5]. Pigs carry STM asymptomatically but can become ill when they have 
an immature or weakened immune system, which might happen for example 
after abrupt weaning. Intensive sub-therapeutic antibiotic doses were added 
to feed as management tool to maintain health at weaning until 2006 to 
protect the piglets from becoming ill and to prevent contamination of meat 
[6, 7]. Although effective in preventing disease, this ultimately led to an 
increased prevalence of multidrug-resistant STM in pigs. As a consequence, 
nowadays the fight against multi-drug resistant STM is not only focused on 
humans but also on livestock [7].
 Vaccination is considered to be one of the best measure to control 
endemic Salmonella [8]. Unfortunately, vaccination protocols against 
Salmonella need improvement as they confer only 20 to 50% protection 
[8]. Despite this, vaccination is still effectively lowering mortality associated 
with STM and reduces transfer to humans [8]. Although the vaccines have 
limited efficacy [9] and require several doses [10, 11] before protective 
titres are developed, they might ultimately delete STM from livestock 
pigs [8]. Conceivable approaches to increase efficacy of vaccination might 
be simultaneous administration of dietary supplements such as pre- and 
probiotics that are known to enhance immunity [12–16]. These pre- and 
probiotics have also been recognized as a mean to increase performance and 




 Inulin-type fructans (ITF) are recognized prebiotic dietary fibers 
[20]. They are utilized and fermented by the intestinal microbiota leading to 
production of beneficial metabolites such as short-chain fatty acids (SCFA) 
and support the growth of beneficial Bifidobacterium communities [19]. As 
previously described by us in Vogt et al. [20], they are also immunomodulatory 
in addition to their indirect prebiotic effects [20–22]. More specifically, long-
chain ITF (lcITF) may be instrumental in supporting immunity against STM 
as they trigger a type 1 helper T-cells (Th1) skewing during vaccination [20, 
23]. We therefore hypothesized that lcITF might support other Th1 based 
vaccination protocols such as STM [24].
 Another ingredient that might be supportive in preventing STM 
infection is the probiotic strain Lactobacilus acidophilus W37 (LaW37). This 
probiotic was shown to prevent adherence of pathogens to the intestinal 
epithelium by, for instance, decreasing luminal pH, secretion of antimicrobial 
peptides and blocking bacterial adhesion to human intestinal epithelial 
cells [25, 26]. Furthermore, in vitro studies have demonstrated that the 
strain LaW37 maintained barrier integrity during inflammation [27, 28]. In 
addition, L. acidophilus was also shown to induce Th1 cytokines in mice [29], 
to increase IFN-γ producing T-cells, and to reduce Treg in gnotobiotic pigs 
[30]. Interestingly, a recent study even showed synergistic effects of inulin 
combined with a Lactobacillus to eliminate STM [31].
 We therefore hypothesized that lcITF and LaW37 combined might be 
uniquely supporting oral vaccination efficacy against STM, and might help 
to decrease weaning associated stress. In the present study, we evaluate the 
effect of lcITF supplementation, alone or combined with LaW37, on STM oral 
vaccination efficacy in neonate piglets. A suboptimal dose of the vaccine was 
given to facilitate read out of beneficial effects of the dietary supplementation 
on the STM vaccination. Supplementation started two days after birth. 
Piglets received one dose of the oral vaccine on day 25 after birth so that 
immunity had time to develop. A STM challenge was applied on day 52 after 
birth for 3 consecutive days. During the whole trial, we followed zootechnical 
health parameters as measure for the well-being of the piglets. Above all, we 
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determined development of several immune parameters such as frequency of 
T-cells subsets, NK-cells and antibody titers against STM.
Material and methods
Supplements, vaccine and challenge compounds
Long chain inulin type fructan (Frutafit® TEX! Sensus, Roosendaal, the 
Netherlands) (lcITF) isolated from chicory roots was provided by Sensus 
Cosun (Roosendaal, The Netherlands). The ITF was characterized by 
high-performance anion exchange chromatography coupled with pulsed 
electrochemical detection (HPAEC-PED), which was performed on an 
ICS5000 system (Thermo Fisher Scientific, Waltham, MA, USA), equipped 
with a Dionex CarboPac PA-1 column (2 × 250 mm) in combination with a 
Carbopac PA-1 guard column (2 × 50 mm) (Supplementary Figure S1) [20, 
22, 23].
 Lactobacillus acidophilus W37 (LaW37) was obtained from Winclove 
Probiotics, Amsterdam, The Netherlands.
 Salmonella Typhimurium (STM) strain DT12 was isolated from 
pig mesenteric lymph nodes [32]. Inoculum were prepared as previously 
described [33]. In short, bacteria were grown from glycerol stocks in Brain-
Heart Infusion medium at 37⁰C until stationary phase. Cell count was 
confirmed with plating on Columbia Blood Agar medium.
 Salmoporc STM ® is an oral live attenuated porcine vaccine licensed 
in Europe (IDT Biologica, Dessau-Roßlau, Germany). The lot number used 
was 0161213, and vaccine suspension was prepared freshly, according to 
manufacturer’s instructions, prior to administration.
Experimental procedures
Fifty Hypor*Maxter new born female piglets from twenty sows were housed 
at Trouw Nutrition Research & Development Centre (Sint Anthonis, The 
Netherlands). Piglets were randomly assigned to one of the four treatment 
groups (Table 1), namely 1. placebo non-vaccinated (CTRL/NV), 2. placebo 
vaccinated (CTRL/V), 3. inulin vaccinated (lcITF/V) and 4. lcITF combined 
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with L. acidophilus vaccinated (lcITF/LaW37/V) with n=12 in control and 
n=13 in supplement groups. Group sizes were determined based on power 
calculation as described in the DEC protocol (DEC 2012.III.05.041). To avoid 
confounding eff ects such as genetic background, maternal antibodies and 
diff erences in microbiota, four piglets from the selected sows were cross-
fostered after 24 hours, on day 1 after birth, before assignment to the 
treatment groups. Cross-fostering of these selected piglets occurred within 
12-14 piglets standardized litters, and each sow fostered four piglets that 
received the same treatment in order to avoid cross-contamination. The 
researchers and farm technicians carried out blind handling and analysis. 
Table 1. Treatment groups.
Suckling piglets were kept together with their fostering mother, each sow 
being housed in farrowing pens with steady temperature, humidity and light. 
No supplemental feed was supplied to the piglets. From weaning on, these 
piglets were individually housed at the health care unit. Animals accessed 
ad libitum water and feed which was a synthetic diet low in fi ber adapted 
from Houdijk et al. [34] (Supplementary Tables S1 and S2) and produced 
by Trouw Nutrition. Animal experiments were performed after receiving 
approval from the DEC committee (DEC 2012.III.05.041) and all experiments 
were performed in accordance with relevant guidelines and regulations of 
the Dutch legislation Experiments on Animals Act (Wod).
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 Supplementations of lcITF or lcITF/LaW37 were administered daily 
to the selected piglets by oral gavage, starting on day 2 after birth. LcITF in 
sterile PBS was administered at 0.114 g/kg body weight (BW). Lyophilized 
LaW37 was used in a fixed dose of 5x109 CFU per piglet. It was added to 
the lcITF within 1 hour prior to gavage. Glucidex 2 (Roquette Corporate, 
Lestrem, France) and starch carrier served as placebo for the control groups.
 Piglets were weaned 24 days after birth, and one day later they 
received one dose of Salmoporc STM ® oral vaccination that consisted 
of approximately 109 CFU per piglet. As of day 52 after birth, the specific 
responses against Salmonella were tested by oral administration of 109 CFU 
of STM DT12 per piglet (GD Animal Health, Deventer, The Netherlands) [35] 
suspended in 1 mL PBS for three constitutive days: 52, 53 and 54. 
 Blood was collected 5 times from the jugular vein on days 23, 25, 42, 
52, 55 after birth (Figure 1), at a set time early in the morning prior to any 
other handling of the animals, for antibody titre and flow cytometric analysis. 
Nine milliliters of blood were collected at these time points with sterile 
S-Monovette lithium-heparinized tubes (Sarstedt AG & Co, Numbrecht, 
Germany). 
 Fecal samples were collected on day 23 prior to weaning and 
vaccination, on day 52 prior to challenge and at 24, 30, 48 and 72 hours post 
STM challenge for STM present CFU count.
 Zootechnical parameters are described in Supplementary File S1 and 
included the following factors. Health status and diarrhea of the animals were 
evaluated daily. Appetite was rated only in weaner piglets and feed intake 
was calculated by weighing the feed left, on days 30, 33, 38, 45 after birth, 
and daily during the Salmonella challenge on days 52, 53 and 54 after birth. 
The body weight was measured at birth, 24 hours after birth, on days 10, 17, 
23, 30, 33, 38, and 45 after birth, prior to challenge with STM, and at the 
moment of sacrifice. Feed efficiency was calculated in weaner piglets as ratio 
of feed intake and weight gain. Finally, rectal temperature was measured on 
day 25, prior to vaccination, and repeatedly after 2h, 4h, 6h and 24h following 
the administration of the vaccine and daily during the STM challenge. 
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 On day 55 after birth, the animals were euthanized with an overdose 
of barbiturate by intra-cardiac injection following a stratified randomization 
sequence. From each animal, tonsils, ileum, and feces were taken for CFU 
count of STM.
Salmonella occurrence in piglet feces and tissues
Absence or presence of STM in piglets’ feces was determined on day 24, prior 
to vaccination, and on day 52, prior to challenge. Furthermore, during the 
challenge, live STM was quantified in feces collected at 24, 30, 48, and 72 
hours after the beginning of the challenge and at sacrifice (day 55). Salmonella 
colonies were counted as previously described [35] and expressed as CFU/
gram. Of each sample, two presumptive Salmonella colonies were confirmed 
by qPCR for both Salmonella and STM. When no colonies were observed in 
the lowest dilution plates, the samples were screened for Salmonella presence 
(qualitative) after pre-enrichment by the conventional Modified Semi-Solid 
Rappaport Medium / Xylose Lysine Deoxycholate method [34]. One colony 
on the Xylose Lysine Deoxycholate plate was again confirmed by qPCR. 
 Typing was performed on random colonies isolated from feces, 
preceding the challenge, to discriminate vaccine strain from possible 
contamination. This was performed by Netherlands National Institute for 
Public Health and the Environment (RIVM, The Netherlands) following 
an optimized multiple-locus variable number tandem-repeat assay for 
characterization of STM as previously described [36]. 
Combined dietary supplementation of long chain inulin and Lactobacillus acidophilus in 
neonate piglets supports oral vaccination efficacy against Salmonella Typhimurium
117
4
-Figure 1. Experimental design. Female piglets were cross-fostered at one day 
after birth. Oral gavages of placebo, inulin (lcITF) or lcITF/L. acidophilus (LaW37) 
started on day 2, and were continued daily until sacrifice. Piglets weaned on day 
24 were vaccinated the next day. Finally, challenge with Salmonella Typhimurium 
(STM) was given daily on days 52, 53 and 54 after birth, via oral gavage. The animals 
were sacrificed on day 55 after birth. Blood samples (drops) were collected on days 
24, 26, 44 (20 days post vaccination), prior and post STM challenge.
Flow cytometry analysis 
Granulocytes and monocytes (CD172b+), NK cell (CD56+), T lymphocytes 
(CD3+), cytotoxic T-cells (CD3+CD8+) and T helper cells (CD3+CD4+) 
were stained in whole blood. Expression of CD45RO (memory T-cells) was 
measured within the CD8+ and CD4+ subsets. Specification of the antibodies 
used is shown in Supplementary Table S3 and gating strategy is shown on 
Supplementary Figure S2. See Supplementary File S2 for procedure.
Serology
The blood was centrifuged at 2000 g for 10 min and plasma was stored 
at -80 ⁰C until further use. Detection of anti-Salmonella antibodies was 
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performed with Salmotype Pigscreen ELISA according to the manufacturer’s 
instruction (Labordiagnostic Leipzig, Leipzig, Germany). Specific IgG levels 
were calculated using a reference standard method and are presented as S/P 
values.
Statistical analysis
D’Agostino & Pearson normality test was used to determine distribution of 
the data in GraphPad Prism version 7.0a (GraphPad Software, Inc., La Jolla, 
USA). The zoological, clinical parameters, and Salmonella quantification 
in feces, tonsils and ileum samples were tested in a Proc mixed procedure 
of SAS according to the following equation:  
where T is the treatment effect for each group (1,2,3,4), S the presence of 
Salmonella contamination in feces on day 52 (yes, no), and recipient sow that 
fostered the piglet is taken as a random factor. Feces consistency, qualitative 
Salmonella data and health scores were analyzed with a χ2 homogeneity 
test of the GENMOD procedure in SAS. Antibody titer was analyzed with 
Kruskal-Wallis followed by Dunn’s multiple comparison test; flow cytometry 
data was analyzed with one-way ANOVA, followed by a LSD post-hoc, all 
in GraphPad Prism. Data within a time-point was defined as independent 
while data recorded for a specific animal throughout time was analyzed as 
paired. P-values of 0.05 or smaller were considered statistically significant 
and p-values between 0.05 and 0.1 were defined as a trend.
Results
Vaccination and supplementations with lcITF or lcITF/LaW37 
affect well-being 
Piglets were Salmonella free prior to vaccination (Supplementary Table 
S4). However, when repeating the test on piglets’ feces prior to STM DT12 
challenge on day 52 after birth, we found in 40% of the animals the presence 
of wild-type Salmonella which was identified as STM (Supplementary 
Table S4) and therefore considered in the analysis below. They were not 
excluded from the study as natural infections also occur in farming practice 
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and might impact vaccination efficacy.
 LcITF alone or combined with LaW37 was studied for its vaccination 
efficacy enhancing effects in piglets. However, we also monitored well-being 
to ensure that combining vaccination and oral supplements has no unwanted 
side effects. Mostly positive effects were observed. The most pronounced 
beneficial effects were found in health condition parameters (Supplementary 
Table S5) as diarrhea, occurrence and severity, was reduced (Figure 2). 
LcITF significantly improved the health condition before weaning (p=0.029) 
(Supplementary Table S5) which was not observed when combined with 
LaW37. Post weaning, lcITF also increased feeding efficiency (p=0.034). 
Weaning stress diarrhea severity and occurrence were decreased by both 
lcITF and lcITF/LaW37 (p=0.011) (Figure 2). Vaccination decreased the 
general health score (p<0.0001), and lowered the appetite (p=0.004) of 
weaner piglets (Supplementary Table S5) and this could not be attenuated 
by lcITF or lcITF/LaW37.
 Wild-type STM naturally infected animals had more diarrhea than 
uninfected animals during the whole post-weaning period (p=0.040) (day 23 
to 51 after birth) which was beneficially impacted by both lcITF and lcITF/
LaW37 supplementations (p=0.011). 
 Shedding of live STM in feces, a mean for spreading of STM, was not 
influenced by lcITF or lcITF/LaW37 nor by the wild-type STM contamination 
(Supplementary Table S6). However, upon challenge with STM DT12, a 
lower STM invasion was found in the ileum tissue of naturally infected pigs 
(2.7 CFU/mL) compared to uninfected animals (3.4 CFU/mL; p=0.016). 
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Figure 2. Weaning associated and STM-induced diarrhea at challenge 
were less frequent and less severe in inulin (lcITF) and lcITF/L. 
acidophilus (LaW37) treated piglets. Non-vaccinated animals had significantly 
higher diarrhea than the lcITF/Vaccinated and the lcITF/LaW37/Vaccinated groups. 
Daily scores were combined as incidence of diarrhea for a weekly period, during 
the STM-challenge, and for the total post-weaning period. Feces consistency was 
analyzed with a χ2 homogeneity test of the GENMOD procedure in SAS. Significant 
differences (p<0.05) are indicated by *. Data are expressed as mean ± SEM. 
Only LcITF/LaW37 enhanced efficacy of STM vaccination
Supplementation with lcITF and lcITF/LaW37 impacted efficacy of 
vaccination in an ingredient specific fashion. Figure 3 shows the specific 
antibody responses against STM after vaccination. The combined supplement 
lcITF/LaW37 had a strong impact on vaccination efficacy but not lcITF. 
Interestingly, vaccination efficacy stimulation was different in naturally 
infected animals (Supplementary Figure S3) where lcITF/LaW37 had a 
significantly faster start of antibody build-up compared to all other groups, 
although it was equal to the other vaccinated groups at the end of the study.
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Figure 3. Enhancement of antibody titers after vaccinated by inulin/L. 
acidophilus (lcITF/LaW37) in uninfected animals. Arrow indicates the start 
of the challenge with STM and dotted line the threshold of responders. Significant 
differences with CTRL/NV tested with Kruskal-Wallis, followed by a Dunn’s test in 
GraphPad Prism (p<0.05), are indicated by *. CTRL = control; NV = non-vaccinated; 
V = vaccinated. Data are expressed as mean ± SEM.
Frequency of peripheral NK and T cells
Besides effects on vaccination efficacy, we tested whether other immune 
processes were impacted by the treatments. NK cells were studied as they 
are known to be enhanced by lcITF supplementation [23] and are innate 
cells reacting acutely to infections [37]. The only effect that we found was 
observed in animals naturally infected by wild-type STM. Two days prior to 
vaccination (Figure 4), cytotoxic NK CD56dim cells in the lcITF group rose 
by twofold (p=0.0022). 
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Figure 4. Frequency of NK CD56dim cells is increased prior to vaccination 
on day 24 after birth in animals naturally infected by STM that received 
lcITF. * indicates p < 0.05 using one-way ANOVA, followed by a LSD post-hoc 
correction. CTRL = control; lcITF = inulin; LaW37 = Lactobacillus acidophilus. Data 
are expressed as mean ± SEM.
Another type of NK cell involved in pathogen responses is the immature 
CD56bright population. Frequencies of this population were similar for all 
groups until the moment of challenge with STM DT12 (Figure 5). Effects were 
only observed in uninfected animals. NK CD56bright frequencies decreased 
in a statistically significant manner upon challenge, between days 52 and 55, 
for the CTRL/NV, CTRL/V and lcITF/V groups (p=0.0071) but not for lcITF/
LaW37/V (p=0.568). 
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Figure 5. NK CD56bright decrease is prevented by lcITF/LaW37 
supplementation. Data prior (day 52) and post (day 55, end of study) STM 
challenge in uninfected animals are shown. Percentage NK CD56bright of total CD3- 
cell population is shown. * indicates p<0.05 and # is a trend with p<0.1 using one-way 
ANOVA, followed by a LSD post-hoc comparison. CTRL = control; lcITF = inulin; 
LaW37 = L. acidophilus.
We also quantified cytotoxic and helper T cells after the STM DT12 challenge. 
No differences could be observed in frequency of cytotoxic T lymphocytes 
(CD3+ CD8+) (CTLs) until the last day of the study (day 55). CTLs frequency 
was decreased in the lcITF/V group compared to CTRL/V (p=0.011), this 
was prevented with lcITF/LaW37/V (p=0.115) supplementation (Figure 6). 
This was similar in naturally infected animals.
 Th cells frequency increased in the lcITF group compared to CTRL/
NV (p=0.004), CTRL/V (p=0.028), and lcITF/LaW37/V (p=0.014) groups 
(Figure 6). This was similar in naturally infected animals.
 CD45RO+ memory T cells can be found in the CTLs and the Th 
populations and were analyzed separately. Effects of the supplements in 
uninfected animals were only observed on day 55, i.e. post STM challenge 
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(Figure 7, only T-cell population of day 55 is shown). The lcITF/LaW37/V 
treatment tended to increase memory CTLs frequency by 2-fold compared to 
CTRL/V (p=0.111) (Figure 7A). In the Th compartment (Figure 7B), effect of 
the supplements was similar for lcITF/V and lcITF/LaW37/V groups, where 
a trend of enhancement of CD45RO+ was observed (p=0.073). There was no 
difference at this time-point in naturally infected animal.
Figure 6. LcITF lowers cytotoxic T cells (A) frequency while enhancing 
T helpers (B) in uninfected animals at the end of the study. Cytotoxic and 
T helper cells expressed as percentage of total T-cell population after vaccination 
and different treatments on day 55. * indicates p<0.05 and # is a trend with p<0.1 
using one-way ANOVA, followed by a LSD post-hoc correction. CTRL = control; 
lcITF = inulin; LaW37 = L. acidophilus.
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Figure 7. Frequency of CD45RO+ memory T cells within the CTLs (A) and 
Ths (B) is enhanced in lcITF/LaW37 uninfected animals at the end of the 
study. CD45RO+ memory T cells expressed as percentage of total CTL (A) and total 
Th (B) on day 55. # indicates a trend with p<0.1 using one-way ANOVA, followed by 
LSD post-hoc correction.; lcITF = inulin; LaW37 = L. acidophilus.
Discussion
Here we show for the first time, to the best of our knowledge, that a combination 
of a dietary fiber (lcITF) and a Lactobacillus strain (LaW37) can enhance 
oral vaccination efficacy in neonatal pigs, and at the same time contribute 
to increase well-being of the piglets. Animals had enhanced survival rates, 
improved general health before weaning, better feeding efficiency during 
weaning stress and were less susceptible to weaning associated diarrhea. 
Antibody titers against Salmonella (STM) were doubled by the lcITF/LaW37 
supplementation. Our data therefore shows that this combination uniquely 
supports immunity and might be instrumental in preventing STM infections 
in piglets, i.e. a major reservoir for human STM infections [4, 38].
 Health scores prior to weaning and feeding efficiency during weaning 
stress were improved in lcITF group only. LcITF with or without LaW37 
decreased weaning and STM challenge-driven diarrhea, both in terms of 
severity and occurrence. This improvement was not influenced by a natural 
wild-type STM infection. Reduction of diarrhea is an important observation 
as its prevention is a critical parameter to avoid spreading of diseases within 
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pig herds and is also a major issue during abrupt weaning [39]. Moreover, 
piglets’ death is also more pronounced in this weaning period [40, 41], and 
was, in our study, less frequent in the animals supplemented with lcITF and 
lcITF/LaW37. As mentioned, lcITF is held responsible for most of these 
beneficial effects as addition of LaW37 had no further beneficial effect on 
health status, but actually decreased efficacy of lcITF to support feeding 
efficiency during weaning stress. 
 Presence of live STM in feces of infected piglets, also referred to as 
shedding, holds the risk of spreading STM in pigs via fecal-oral route, and 
ultimately to humans via meat consumption. Shedding should therefore 
be as low as possible. Shedding was not reduced by the vaccination nor by 
intervention with lcITF or lcITF/LaW37. This is in contrast with a study 
that reported that inulin reduced STM shedding [13]. This study however 
does not report on the chemical structure of the inulin. As inulin has strong 
chain length dependent effects [20, 22, 23], chemistry differences might 
explain the discrepancies in findings. Also, lactobacilli fermented feed has 
been reported to reduce STM shedding, but this was observed in 28 days old 
piglets that consumed the treatment for only 3 days prior to challenge with 
another strain than the one used in our study [16]. In both cases, reduction 
of shedding was mild. Our data supports the idea that reduction of shedding 
depends on the type of dietary supplement and STM applied.
 A relevant observation and reason not to exclude the animals 
naturally infected with wild-type STM from this study was that natural 
infection hardly impacted the outcome of zootechnical parameters, diarrhea, 
antibody titer and frequency of NK and T-cells. Moreover, it is reasonable to 
assume that wild-type STM infection occurs in practice during vaccination. 
Vaccination enhancing effects were observed faster in lcITF/LaW37 with 
naturally infected animals and was not observed anymore at the end of the 
study. Faster build-up is, however, also considered to be advantageous in 
the fight against STM. While studies on ITF during vaccination protocols are 
scarce, many vaccination trials have been investigating lactobacilli effects. 
Most studies were using systemic vaccination protocols with variable success 
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[42, 43]. To a lesser extent, probiotics have been tested in mucosal vaccination 
protocols, and all have obtained promising results [44–47] which are in line 
with our study.
 During an infection, the immune system of piglets is likely to undergo 
a faster development [48] which might explain the difference in some 
immune parameters between naturally infected and uninfected animals. For 
example, NK CD56dim enhancements in blood during wild-type STM natural 
infection might be caused by enhanced immune maturation as this cytotoxic 
NKCD56dim is referred to as ‘matured’ NK cell type that differentiates 
from the NK CD56bright [49]. These animals did not have more symptoms 
(diarrhea and fever) than animals with lower levels of NK CD56dim. This 
enhancement of cytotoxic NK CD56dim, however, only occurred in lcITF 
treated piglets and not in combination with LaW37. A possible explanation 
is that LaW37 exerts, as previously reported, a Treg stimulatory effect [30] 
that could dampen lcITF effects as Treg are known to inhibit NK cells [50]. 
Another example is that lcITF supplemented animals that were uninfected by 
wild-type STM did not build antibodies while they did in naturally infected 
animals. Differences in maturity could explain such change as young adults 
positively reacted to long-chain inulin during a vaccination protocol but did 
not to short-chain inulin [23].
 Analysis of T-cells showed that lcITF alone and combined with 
LaW37 confer different effects on T cells, and these are time-point specific. 
After challenge with STM DT12, the number of circulating CTLs decreased 
in animals treated with lcITF compared to the CTRL/V group. However, 
the number of T helpers increased in both lcITF and lcITF/LaW37 groups, 
although it was only statistically significant for lcITF alone compared to both 
CTRL groups. In general, Th increase was higher with lcITF supplementation 
compared to the other groups. Although we have not identified which 
population of Th cells were specifically increased, it is in line with previous 
findings such as Th1 skewing by lcITF in vitro [20], in mice [51] and in humans 
[21, 23, 52], which was identified as a requisite condition of immunity against 
Salmonella [24]. Wild-type STM natural infection did not influence this. 
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 Chronic dietary intervention on neonatal piglets with lcITF and lcITF/
LaW37 is not only safe, it is also efficacious in supporting vaccination efficacy, 
which might help to reduce the therapeutic antibiotic treatments thereby 
limiting the undesirable effects associated with it. Despite the immaturity 
of the immune system of piglets, the combination lcITF/LaW37 strongly 
enhanced oral STM vaccination efficacy in the neonates. Also, weaning stress 
was reduced by this ingredient combination as well as by lcITF alone. Our data, 
however, also emphasizes, again [53], the importance of carefully selecting 
dietary supplements for enforcing specific desired immune responses [53] as 
lcITF is beneficial to prevent weaning-associated diarrhea but not to support 
vaccination efficacy while LaW37 had no additional effect on diarrhea but 
strongly enhanced vaccination efficacy. Remarkably, lcITF increased NK 
CD56dim population under natural infection. The data presented here 
illustrates that effects of food ingredients on immunity are very specific and 
cannot be effective without a rational design [21, 23, 53].
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Health status of the animals was evaluated daily by the same blinded and 
trained farm technician throughout the whole study. Behavior, body condition 
and skin condition were monitored. Animals drop-out was also reported. 
Behavior was rated on a scale from 0 to 4 where 0 is a communicative, 
alert and playful piglet while an apathetic and passive behavior is rated 4, 
intermediate scales are 1 a calm animal, 2 a slow animal and 3 a listless 
animal. To evaluate that, the researcher observed the interaction between 
the piglets within a litter and curiosity towards himself and other litters. 
The body condition was rated on a scale from 0 to 4 where 0 is a healthy 
animal with excellent physical condition, a good fleshiness rounded shape 
of the back and clear development of the ham. A sick animal would be rated 
4 being really thin with visible backbone without flesh and showing signs of 
dehydration. Intermediate scores were 1 for intermediate animals without 
much ham development, 2 for thin animals without much flesh on the back 
and the ribs and 3 meagre animals with visible backbone. This scale was based 
on a portfolio so that all the conditions described above were illustrated by 
example pictures. Scores displayed in the tables are % of the incidence of 
scores 1+2+3+4.
 Diarrhea was scored daily in the morning (DMS-00446 SRC Feces 
protocol Trouw Nutrition, The Netherlands) as previously described [54]. 
It was scored per litter prior to weaning and per animal post weaning. The 
scale ranges from 0 to 3, 0 being the ideal well shaped stool with soft but 
solid consistency and 3 being a severe diarrhea with light colored watery 
defecation. Intermediate scales go from 1 with soft sticky stool to liquid 
consistency.
 Appetite was rated only in weaner piglets based on belly fill and 
eagerness when the feed was given to them. Feed intake was calculated by 
weighing the feed left, on days 30, 33, 38, 45, and daily during the Salmonella 
challenge on days 52, 53, 54 and 55. The body weight was measured (DMS-
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00293 SRC Weighing procedure, Trouw Nutrition, The Netherlands) at 
birth, 24 hours after birth, on days 10, 17, 23, 30, 33, 38, and 45, prior to 
challenge with STM, and at the moment of sacrifice. Feed efficiency was then 
calculated in weaner piglets as ratio of feed intake and weight gain. 
Rectal temperature was measured (SOP DMS-00731 protocol, 
Trouw Nutrition, The Netherlands) early in the morning, on day 25 prior 
to vaccination and repeatedly after 2h, 4h, 6h and 24h following the 
administration of the vaccine. Similarly, rectal temperature was assessed 
daily during the STM challenge starting on day 52 until day 55 (sacrifice). 
Finally, fecal samples were collected on day 23 prior to weaning and prior to 
vaccination, on day 52 prior to challenge and at 24, 30, 48 and 72 hours post 
STM challenge for counting the number of live STM present (CFU count).
File S2
After a 1:1 dilution in RPMI (Lonza, Basel, Switzerland) supplemented with 
10 % heat inactivated Fetal Calf Serum (hiFCS) (HyClone, GE Healthcare 
Life Science, Utah, USA), the cells present in 0.5 mL blood were pelleted 
and incubated for 30 minutes in 100 μL in FACS buffer (PBS + 10 % hiFCS 
(v/v)) supplemented with 10% (v/v) mouse serum (Sanquin, Jackson lab, 
Amsterdam, The Netherlands) and containing the antibody mix (Supporting 
Table S3). Next, the cells were incubated with a biotinylated antibody 
(streptavidin-Brilliant Violet 785) for 15 minutes to label the CD56 antibodies. 
The erythrocytes were then lysed with 2 mL FACS Cell Lysing Solution (BD 
Bioscience, Breda, The Netherlands) and the leukocytes were fixed with 
300 μl CellFIX (BD). Washing was performed between all incubation steps 
and every incubation step was carried out at 4 ⁰C in the dark.
Stained cells were analyzed using the LSR-II Flow Cytometer System 
(BD Bioscience, Breda, The Netherlands), using FACS Diva software. 
Analysis was performed using FlowJo version 10 software (FlowJo, LLC, 
Oregon, USA). Approximately 5x106 cells were recorded, and frequency of 
each population was expressed as % of the parent population. The gating 
strategy for monocytes, NK cells and T lymphocytes are displayed in 
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All singlets were selected based on size in forward side scatters (FSC) 
of area (A) and width (W). Lymphocytes were selected using FSC/CD172a 
plots as CD172a negative cells. NK cells were selected from the lymphocyte 
plot as CD3- cells and CD56+ cells. The T cells are CD3+ cells, within which 
CD4+ and CD8+ were selected. Expression of CD45RO+ was measured within 
both these populations using the zebra plots so that lower limit of the gates 
was set on the upper line of the center core. 
Figure S1. Long-chain inulin-type fructan (lcITF; Frutafit® TEX!) 
HPAEC profile. Peaks represent fructose (F) and glucose (G) monomers, dimers 
and fructans oligomers present in the formulation of lcITF. GFn and Fn chains 
respectively terminated by a glucose or fructose molecule with n the number of 
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Figure S3. Enhancement of antibody titers after vaccinated by lcITF/
LaW37 occurred already on day 44 after birth in contaminated animals. 
Arrow indicates the start of the challenge with STM DT12. Significant differences with 
CTRL/NV tested with Kruskal-Wallis, followed by a Dunn’s test in GraphPad Prism 
(p<0.05), are indicated by * and trend (p<0.1) by #. CTRL = control; NV = non-
vaccinated; V = vaccinated; lcITF = long-chain inulin type fructans; LaW37 = 





Figure S4. Diarrhea scores were less frequent and less severe in inulin and 
inulin/L. acidophilus treated naturally infected piglets. Non-vaccinated 
animals had significantly higher diarrhea than lcITF/Vaccinated and lcITF/LaW37/
Vaccinated groups during STM challenge (days 52 to 55). Daily scores were combined 
as incidence of diarrhea for a weekly period, during the STM-challenge, and for the 
total post-weaning period. Feces consistency was analyzed with a χ2 homogeneity 
test of the GENMOD procedure in SAS. Significant differences are indicated by *. 
Data are expressed as mean ± SEM. 
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Table S1. Composition of the piglet weaner synthetic diet low in fi ber.
Tables
Table S2. Nutritional values of the synthetic diet for a swine net energy 
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Scope: Restriction of antibiotics in livestock feeding, prompt the research 
interest towards alternative strategies for disease prevention and growth 
enhancement. The aim of this study was to determine whether vaccination 
and Salmonella Typhimurium (STM) challenge, in the presence and absence 
of immune stimulating dietary supplementation, influence vaccination 
efficacy and microbiota colonization. Piglets received either prebiotic long 
chain inulin-type fructan (lcITF) or a synbiotic combination of lcITF and the 
probiotic strain L. acidophilus W37 (LaW37). Additionally, we investigated 
if possible impact on microbiota changes are associated with improved host 
health during stress periods such as weaning and STM challenge. Methods 
and Results: Fecal samples from pre-weaning, post-weaning and challenge 
periods were characterized for their bacterial composition through 16S 
rRNA gene sequencing. Results revealed that significant enhancement 
of antibody titer against STM was associated with microbial composition. 
Early life supplementation with the synbiotic seemed to modulate piglets’ 
fecal microbiota as abundance of lactobacilli tended to be increased on 
day 10 after birth. This effect was also observed on day 30 but not at other 
time-points. On day 30 the animals treated with the prebiotic had increased 
abundance of Catenibacterium which was also not observed at other time-
points. After STM-challenge, the microbiota composition of the placebo 
group that received vaccination (CTRL/V) and synbiotic (lcITF/LaW37/V) 
group was more similar compared to the non-vaccinated placebo (CTRL/
NV) and the prebiotic (lcITF/V) groups and were characterized with higher 
abundance of Provetallaceae population and lower Lactobacillaceae in their 
feces. Conclusion: Collectively, our results describe comprehensively the 
dynamics of fecal microbiota establishment in neonatal piglets under the 
influence of dietary interventions, weaning, vaccination and STM challenge. 
Moreover, we show that health-associated bacteria were promoted at specific 
time-points, during dysbiosis period, for both dietary interventions.
Abstract
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Application of antibiotics in livestock feeding has been practiced for decades 
to prevent pathogenic infection and promote animal growth [1]. Although 
effective in livestock, the extensive use of antibiotics has contributed to the 
global threat of antibiotic resistant pathogens [2]. The global health issues 
associated with antibiotic resistant species have led to tighter regulations 
on antibiotics administration. In 2006, the European Union totally banned 
the sub-therapeutic use of antibiotics in livestock feeding [3] (http://europa.
eu/rapid/press-release_IP-05-1687_en.htm). This ban, however, has led 
to increase use of antimicrobial agents and a rise of resistant Salmonella in 
pigs subsequently occurred [4]. Pigs are mostly asymptomatic but presence 
of Salmonella in pigs is an important risk for meat contamination. Currently, 
salmonellosis causes diarrheal diseases in over 130 million humans yearly 
(http://www.who.int/mediacentre/factsheets/fs139/en/) and is responsible 
for 9.3% of 225 foodborne outbreaks in Europe [5]. Therefore, there is an 
urgent need for alternative strategies to prevent infection with Salmonella 
in livestock. Vaccination and improvement of feed strategies to support 
immunity of livestock are two examples of these strategies.
 Vaccination of piglets against Salmonella occurs via the oral route 
but is not fully effective as it confers only 20 to 50% protection [5, 6]. To 
improve efficacy of Salmonella vaccination, it has been proposed to combine 
vaccination with immune active food components [7]. Amongst the most 
extensively studied immune active agents are dietary fibers and lactic 
acid bacteria. Dietary fibers stimulate a stable and functional intestinal 
microbial community, and inulin-type fructans (ITF) have been shown 
to  support bifidobacterial growth and activity [8]. Direct introduction of 
live Lactobacillus acidophilus, has been associated with enhanced health 
status [9, 10], improved resistance to diseases [11, 12], reduced shedding 
of pathogens [13], reduction of disease symptoms  [14, 15], and support of 
intestinal immunity [7, 16, 17]. All these interventions, including vaccination, 
have been applied orally which implies that the vaccine and/or feed 
ingredients interact with the gastrointestinal microbiota of the piglets, thus 
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affecting the immune and metabolic status of the animals in later life [18-
21]. Although this is well recognized, the effect of Salmonella vaccination 
and dietary intervention on microbiota development has, to the best of our 
knowledge, never been studied.
 The colonization process of the intestines starts at birth, and in 
porcine livestock, the intestinal microbiota reaches an adult-like composition 
by 3 to 4 weeks post weaning. The adult pig microbiota is typically composed 
of genera Clostridium, Blautia, Lactobacillus, Prevotella, Ruminocaccus, 
Roseburia, the RC9 gut group and Subdoligranulum [22-24]. Members of 
the families Enterobacteriaceae and Bacteroidiaceae have been reported 
to be amongst the most abundant at birth; however, their proportion 
decreases with weaning, whereas the proportion of Prevotellaceae increases, 
becoming the most abundant family at the post-weaning stage [25]. During 
the vulnerable neonatal phase, piglets are protected by maternal antibodies 
while their intestinal immune system develops and matures [26]. Interactions 
between the gut microbiota and the developing gut are considered critical 
during this stage, as any perturbation can potentially lead to an impaired 
immune function later in life [18, 27]. Vaccination is commonly performed 
during the pre-weaning period, but it is, to the best of our knowledge, 
unknown whether it could affect the microbiota colonization process. In 
addition, our understanding of the dynamics of microbiota development 
at the time of weaning might also lead to more informed strategies to 
prevent colonization by potential pathobionts post weaning. For instance, 
Salmonella colonization of piglets often occurs during this period [28] and is 
associated with increased shedding, spreading throughout pig herds and is, 
ultimately, contaminating pork meat [5]. In this context, feed supplements 
such as prebiotic ITF and probiotic L. acidophilus could be instrumental 
in supporting maturation of piglets’ microbiota development and boosting 
immunity in early life. This, in turn, might lead to a better resistance of 
the animals against enteropathogenic infections via both increasing their 
response to vaccination against Salmonella, and protecting them against 
weaning associated stress.
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 In the present study, we assessed potential effects of specific pre- and 
synbiotic dietary interventions as well as oral vaccination before weaning 
on the early life development of piglets’ gut microbiota under the influence 
of dietary interventions and oral vaccination. Furthermore, we assessed the 
possible protective effects of these treatments during a Salmonella challenge 




The experimental protocol was designed in compliance with the guidelines 
for animal research, and experiments were performed under the DEC 
committee approval DEC 2012.III.05.041.
Supplements, vaccine and challenge compounds
Long chain inulin type fructans (Frutafit® TEX! Sensus, Roosendaal, the 
Netherlands) (lcITF) isolated from chicory roots was provided by Sensus 
(Roosendaal, The Netherlands) and is a polydispersed mixture of linear 
fructans oligomers and polymers linked by β(2-1) bonds. The number of 
fructose molecules determines the degree of polymerization (DP). Specific 
characteristics of the inulin used in our study had a DP ranging from 10 to 60 
and was characterized by high-performance anion exchange chromatography 
coupled with pulsed electrochemical detection (HPAEC-PED), which was 
performed on an ICS5000 system (Thermo Fisher Scientific, Waltham, 
MA, USA), equipped with a Dionex CarboPac PA-1 column (2 × 250 mm) in 
combination with a Carbopac PA-1 guard column (2 × 50 mm) (Supplementary 
Figure S1).
 The probiotic lactic acid bacterium Lactobacillus acidophilus 
W37 (LaW37) was obtained from Winclove Probiotics, Amsterdam, The 
Netherlands. 
 Salmonella Typhimurium (STM) strain DT12 (B; O1, 4, 5, 12) was 
isolated from a pig mesenteric lymph node (MLN) [29]. Inocula were 
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prepared as previously described [30] and were used to challenge the piglets. 
In short, bacteria were grown from glycerol stocks in Brain-Heart Infusion 
medium at 37°C until stationary phase. Cell count was confirmed with plating 
on Columbia Blood Agar medium.
 Salmoporc STM® is an oral live attenuated porcine vaccine licensed 
in Europe (IDT Biologica, Dessau-Roßlau, Germany).
Experimental design of the piglet trial
All animals used in this experiment were housed at Trouw Nutrition (Trouw 
Nutrition Research & Development, Sint Anthonis, The Netherlands). 
Twenty-nine Hypor*Maxter new born female piglets were selected from 
20 sows and cross-fostered 24 h after birth to ensure homogenization of 
microbiota and limit confounding factors such as genetic background and 
maternal antibodies. Piglets were randomly allocated to one of the following 
four treatment groups: placebo control non-vaccinated (CTRL/NV), placebo 
control vaccinated (CTRL/V), lcITF/V and lcITF/LaW37/V. Our study focused 
on prebiotic interventions with and without additional probiotic treatment, 
and we therefore decided not to include a probiotic-only group. Litter size 
was standardized to 12-14 piglets, and each litter was assigned to only one 
of the treatment groups to prevent contamination between treatments. The 
researchers and farm technicians were blinded for treatment when carrying 
out animal handling and analysis.
 Sows and suckling piglets were housed in farrowing pens with 
controlled temperature and humidity. At weaning, piglets were transferred 
to a health care unit for individual housing with ad libitum access to water 
and feed. The synthetic diet produced by Trouw Nutrition contained low 
fiber as adapted from Houdijk et al. 1998 [31] (Supplementary Tables S1 and 
S2).
 A 2 x 2 factorial design was followed so that each treatment and 
vaccination group (Table 1) could be compared to another one with only one 
variable parameter. LcITF and LaW37 supplementations were administered 
daily by oral gavage, starting on day 2 after birth. Glucidex 2 (Roquette 
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Corporate, Lestrem, France) and starch carrier (Winclove Probiotics, 
Amsterdam, The Netherlands) served as placebo for the control groups. 
LcITF and lyophilized LaW37 were prepared freshly and mixed within 1 h 
prior gavage at a respective concentration of 0.114 g/kg BW and 5x109 CFU/
piglet. 
Table 1. Treatment groups organized in a 2x2 factorial design
 Weaning of the piglets occurred on day 24 after birth and oral 
vaccination with one dose of Salmoporc STM ® (109 CFU) on day 25. Piglets 
were given three weeks to recover from weaning stress and develop their 
microbiota and immune system. As of day 52 after birth, piglets received a 
daily Salmonella challenge by oral administration of 109 CFU of STM DT12 
(GD Animal Health, Deventer, The Netherlands) for three constitutive days: 
52, 53 and 54. The study ended on day 55 when the animals were euthanized 
by an intra-cardiac injection of barbiturate.
 Blood was collected fi ve times, with sterile S-Monovette lithium-
heparinized tubes (Sarstedt AG & Co, Numbrecht, Germany), from the 
jugular vein on days 23, 25, 42, 52, 55 (Figure 1), prior to any other handling 
of the animals, for antibody titer.
 Feces were collected via rectal stimulation shortly after birth and a 
set time in the morning on days 10, 17, 23, 30, 51 and 55 after birth. Fecal 
samples were stored in sterile tubes at -20°C until they were processed.
 Diarrhea was scored daily in the morning as previously described 
[32]. It was scored per litter prior to weaning and per animal post weaning. 
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The scores ranged from 0 to 3, 0 being the ideal well shaped stool with soft 
but solid consistency and 3 being a severe diarrhea with light colored watery 
defecation. The intermediate score of 1 was used to report a soft sticky stool, 
whereas a score of 2 represented stools with a liquid consistency.
Figure 1. Experimental design. Female new born piglets were given daily 
oral gavages of placebo, lcITF or lcITF/LaW37 as of day 2 until sacrifi ce, on day 
55 after birth. Weaned piglets (day 24) received Salmoporc oral vaccinated on day 
25. Challenge with Salmonella Typhimurium (STM) DT12 was performed on days 
52, 53 and 54, via oral gavage. Blood samples (syringes) were collected on the day 
of weaning, a day post vaccination, 20 days post vaccination, prior and post STM 
challenge. Fecal samples (stars) were collected shortly after birth, on days 10, 17, 23, 
30, 51 and 55 after birth.
Serology
Blood plasma was collected after centrifugation at 2,000 × g for 10 min and 
was stored at – 80°C until further use. Anti-Salmonella antibodies were 
quantifi ed using Salmotype Pigscreen ELISA according to manufacturer’s 
instruction (Labordiagnostic Leipzig, Leipzig, Germany). The specifi c IgG 
levels were calculated using a reference standard method and are presented 
as S/P values. Stratifi cation of the data was performed according to OD% with 
the following cut-off  values: non-responders x < 40, low-responders 40 < x 
< 80 and high responders x > 100. Non-responders cut-off  was indicated 
by manufacturer’s instructions and based on non-vaccinated control group 
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responses. Cut-off value for low and high-responders was based on a naturally 
occurring gap in OD% of 20 between these two groups.
16S rRNA HiSeq sequencing of V4 region
Bacterial DNA was isolated from the fecal samples. Approximately, 0.1 g 
of fecal material was diluted in 600 mL of STAR buffer (Roche Diagnostics 
GmbH, Mannheim, Germany) and homogenized (Bertin Technologies, 
CNIM, Montigny-le-Bretonneux, France) (3 x 5.5 m/s for 30 s) with 
0.1 mm diameter zirconia/silica beads (Sigma) and 3 glass beads (2.5 mm). 
Subsequently, homogenized samples were incubated at 95°C for 15 min 
and centrifuged for 5 min (4°C/13,000 g). Obtained supernatants were 
pooled and DNA was purified using the Maxwell R 16 Instrument (Promega, 
Leiden, The Netherlands) as described in detail by van Lingen et al (2017) 
[33]. Purified DNA was quantified using a DeNovix DS-11 (DeNovix Inc., 
Wilmington, USA) spectrophotometer, and aliquots of 20 ng/mL for each 
sample were prepared using nuclease free water for later polymerase chain 
reaction (PCR) amplification steps.
 The PCR reactions were carried out in duplicates using 20 ng of DNA 
as template in each 50 mL reaction. One L from each of the primers 515-n 
and 806-n, targeting the V4 region of 16S ribosomal RNA (rRNA) gene 
region and uniquely barcoded per sample (10 μM each), was used along 
with, 1 x HF buffer (Finnzymes, Vantaa, Finland), 1 mL dNTP Mix (10mM 
each, Roche), 1 U Phusion® Hot Start II High Fidelity DNA Polymerase 
(Finnzymes, Vantaa, Finland) and 36.5 L of DNAse and RNAse free water. 
The amplification program included 30 s initial denaturation step at 98°C, 
followed by 25 cycles of denaturation at 98°C for 10 s, annealing at 50°C for 
10 s, elongation at 72°C for 10 s, and a final extension step at 72°C for 7 min. 
PCR products were visualized in 1% agarose gel, left to run in 135V for 25 
min, and PCR product size (~290 bp) was compared to a 1 kb DNA ladder 
(ThermoScientific, Waltham, MA, USA). PCR products from each sample 
duplicate were pooled, purified using magnetic beads CleanPCR kit (CleanNA, 
Alphen aan den Rijn, The Netherlands) and eluted in 30 mL of nuclease-free 
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water (Qiagen). The DNA concentration of each sample was determined 
with Qubit BR dsDNA assay kit (Thermo Fisher Scientific, Waltham, MA, 
USA) and 100 ng of purified DNA were used for the construction of amplicon 
libraries. In total 210 samples were sequenced, distributed in 4 libraries of 
70 samples, labeled with uniquely barcoded primers. Final amplicon pools 
were concentrated using magnetic beads and eluted in 25 mL of nuclease 
free water and the libraries were sent for Illumina HiSeq sequencing (GATC-
Biotech, Konstanz, Germany).
Data normalization and statistical analysis
Data filtering and taxonomy assignment were performed using the NG-Tax 
pipeline [34]. Sequences were assigned to Operational Taxonomic Units 
(OTU) excluding low abundant OTUs (less than 0.1%) from each sample 
and taxonomy was assigned using the Silva_111_SSU [35]. In addition, 
two distinct in house assembled mock communities [34] were sequenced 
along with the study samples, to control for sequencing quality. The 
mock communities were compared with their theoretical composition for 
quality control as control for the different libraries. Analyses of alpha and 
beta- diversity were performed using the publicly available microbiome R 
package version 1.1.2 [36]. Microbiota data was analyzed using permutation 
multivariate analysis of variance (PERMANOVA), Adonis, Kruskal-Wallis, 
and diversity indices at each time point that were calculated using QIIME. 
False discovery rate (FDR) –referred to as p-value in the results section- with 
conditional effect, was used to determine the significance of explanatory 
variables. The differences in relative abundance of specific microbial taxa 
across time were assessed with the nonparametric Wilcoxon Rank sum test. 
Sample groups containing less than 20 samples were bootstrapped followed 
by 100 permutations. Results from diversity analysis across time were tested 
for their normality with Shapiro-Wilk's test, and whiskers plots were created 
in PRISM5. Principal response curve analysis was performed as implemented 
in CANOCO 5 [37], to test for treatment effects. Different analyses were 
performed because during preweaning animals were separated in three 
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groups (Placebo, LcI,LCsdf) and post weaning in four groups [38]. For non-
parametric t-tests, reads were transformed to their relative abundances and 
tests were carried out with 999 permutations using QIIME. Diversity index 
group comparisons were done in GraphPad Prism 7.0a (GraphPad Software, 
Inc., La Jolla, CA, USA). Statistical significance was determined using the 
Benjamini–Hochberg false discovery rate (FDR). 
 Antibody titers were not normally distributed as confirmed by 
D’Agostino & Pearson normality test and were further analyzed using 
Kruskal-Wallis followed by Dunn’s multiple comparison test in GraphPad 
Prism version 7.0a (GraphPad Software). As results of Dunn’s test, p-values 
of 0.05 or smaller were considered statistically significant and p-values 
between 0.05 and 0.1 were defined as a trend. Data are expressed as mean ± 
standard deviation (SD).
 Diarrhea scores were tested in a Proc MIXED procedure of SAS 9.3 
Software Version 13. (SAS Institute Inc., Stata Corporation, College Station, 
TX, USA) according to SAS/STAT 9.3 User’s Guide using the following 
equation:  where T is the treatment effect for each 
group (1,2,3,4), and recipient sows that foster the piglet is taken as a random 
factor. Fecal consistency was analyzed with a χ2 homogeneity test of the 
GENMOD procedure in SAS. 
Results
The aim of this study was to determine whether vaccination and Salmonella 
Typhimurium (STM) challenge, in the presence and absence of immune 
stimulating dietary supplementation, influence vaccination efficacy and 
microbiota colonization. We followed the development of neonatal piglets 
from birth, for 55 days, to investigate whether dietary interventions were 
associated with alterations in the microbial communities in the gut during 
early life, weaning, vaccination, and pathogen challenge. Piglets received 
either prebiotic long chain inulin-type fructan (lcITF) or a synbiotic 
combination of lcITF and the probiotic strain L. acidophilus W37 (LaW37).
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 First, we confirmed that age was the main driving factor behind the 
development of the piglets’ microbial communities prior to and post weaning 
as determined by both phylogenetic (Unifrac) based distances (Figure 3.A; 
and Supplementary Figure S2.A) and non-phylogenetic dissimilarity index 
(Bray-Curtis) (Supplementary Figure S2.B). Distinct differences between 
the microbiota composition of the samples prior and post-weaning indicate 
the pivotal role of the diet which was further confirmed by alpha diversity 
measured by phylogenetic index (Supplementary Figure S3 and S4), where 
post weaning timepoints reveal more diverse communities on response to 
the more complex food they receive (Supplementary Figure S3). 
Enhanced vaccination efficacy and piglets’ health with 
supplementations
The immune status of the piglets and vaccination efficacy were investigated 
as measurement of possible health associated effects of the dietary 
interventions. Levels of specific antibodies against STM in piglets’ blood 
were used as measure for support of vaccination efficacy. Only the animals 
that received the combination lcITF/LaW37 had a significant increase of 
antibodies (Table 2). This was observed as of day 52 after birth (p=0.021) 
and was significantly enhanced upon STM exposure. It resulted in an 
antibody titer twice as high than in CTRL/V group, although not statistically 
significantly, and was significantly higher (p=0.0031) than in CTRL/NV. 
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Table 2. Antibody titer, presenting the percentage of animals which 
classifi ed as responders and quantitative data prior and post STM 
challenge.
 To evaluate protection of the vaccinated piglets, we scored 
salmonellosis associated diarrhea occurrence and severity during challenge 
with STM on days 52, 53 and 54 after birth. Most piglets were asymptomatic 
during the challenge. Animals in the CTRL/V and lcITF/LaW37/V groups 
experienced low incidence of salmonellosis associated diarrhea (Figure 3). 
This was diff erent in the CTRL/NV and lcITF/V groups in which respectively 
23% and 15% of the piglets had salmonellosis associated diarrhea, however, 
this diff erence was not signifi cant compared to CTRL/V and lcITF/LaW37/V 
groups.
 Diarrhea is a symptom of weaning stress [39], and we used  daily 
diarrhea scores to evaluate piglet’s health from the day of weaning (day 24 
after birth) until the end of the study (day 55). In the placebo groups, 40% of 
the piglets experienced diarrhea lasting three to 11 days within the fi rst two 
weeks post weaning (Figure 3) This diarrhea episode could not be prevented 
by lcITF/LaW37 but it was shorter and lasted at most fi ve days. Strikingly, 
piglets supplemented with lcITF alone did not experience post-weaning 
diarrhea, and diarrhea scores were signifi cantly lower than the scores in the 
placebo groups at all times.
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Figure 2. The development of microbial communities in neonatal piglets 
from birth to day 54 after birth. A) DCA plot illustrating the succession of 
microbial development in piglets. Percentages of variation are indicated for each axis 
B) Phylogenetic diversity of the developing microbial communities of piglets C) The 
microbial composition of neonatal piglets within each timepoint 
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Figure 3. Diarrhea scores after weaning were impacted by the dietary 
interventions. Incidence of diarrhea is expressed as % of animals, within each 
treatment group, experiencing low (score 1) to severe (score 3) diarrhea. Incidence 
is shown per weekly period following weaning (day 24 after birth) and challenge 
perid with Salmonella Typhimurium is presented separately (days 52 to 55 after 
birth). Statistical significances are presented per week where * is p<0.5 as calculated 
with MIXED procedure of SAS. CTRL/NV = non-vaccinated placebo control group; 




Eff ects of pre- and synbiotic dietary interventions on gut 
microbiota depended on the developmental stage of the piglets
We investigated whether dietary interventions would modulate changes 
in microbiota associated with weaning and the concomitant vaccination. 
Therefore, we evaluated the infl uence of the dietary interventions on early life 
microbiota development, prior to weaning, and how it changes as weaning 
occurs.
 Prior to weaning, animals were distributed within three groups, a 
placebo group and two dietary intervention groups receiving either lcITF 
alone or lcITF combined with LaW37. A clear separation can be observed 
between the samples collected on day 10 (R2=0.08, p=0.001) with those 
collected on day 17 and 23 (Supplementary Figure S5.A). In order to address 
more specifi cally the evolution of microbial composition under the infl uence 
of the diff erent dietary interventions throughout time, principal responses 
curve analysis (PRC) was performed (Supplementary Figure S6 and Table 
3). Although the model did not present a signifi cant eff ect, it revealed that 
the genus Lactobacillus was more abundant in the lcITF/LaW37 group 
compared to the placebo and lcITF groups. The OTUs that were mainly 
aff ected belonged to the genus Lactobacillus (Supplementary Figure S7). 
Diff erences weren’t signifi cant for other two timepoints and phylogenetic 
diversity did not show any diff erences.
Table 3. Results from Principal Response Curve during preweaning and 
postweaning timepoints
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 Weaning is considered to be the most sensitive period as piglets tend 
to develop enteric infections. In the present study piglets were weaned on 
day 23 and received an oral vaccine or a placebo on day 25. Samples were 
collected on day 30, one week after weaning, to assess possible differences 
in microbiota composition, driven either by vaccination or the combination 
of vaccination and dietary intervention. Introduction of solid food had 
a strong overall effect, regardless of the treatment group. As observed on 
Supplementary Figure S8.A, with weighted Unifrac distances, samples 
from day 30 separate from samples collected on post-weaning timepoints 
but also with day 51 and 55. and that specific enrichment in members of the 
Christensenellaceae family on day 30 was responsible for this separation 
(Supplementary Figure to add). 
Next, we evaluated the effect for the different treatment groups during 
the post weaning timepoints with the PRC. Contrary with the preweaning 
timepoint, model revealed a significant effect for the differently treated 
groups and major differences can be observed on days 30 and 55, but not 
on day 51. On day 30 taxa which are differentially abundant are Lactobacilli 
from the lcITF/LaW37/V.
In accordance, Adonis analysis of variance presented significant 
differences on day 30 after birth, as different treatments significantly 
impacted fecal microbiota (R2=0.20, p=0.007) (Table 4). It is apparent that 
dietary interventions were the main influencers for the differences observed 
on day 30 without influence of the vaccination. The lcITF/LaW37/V group was 
characterized by higher abundances of bacteria from the genus Lactobacillus, 
while the lcITF/V group presented higher abundances of Catenibacterium 
(Figure 4.B and 4.C). This significant effect of dietary interventions observed 
on day 30 was transient as no separation could be further observed on day 51. 
 Taken together, these data revealed that vaccination did not impact 
microbiota development but that dietary treatments did, although these 
effects could only be observed at specific time-points.
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Table 4. Eff ects of diff erent treatments during pre-weaning (dietary 
intervention) and post-weaning (dietary intervention and vaccination) 
with PERMANOVA and Adonis multivariate analyses of variance within 
each time-point. Asterisks indicate signifi cance for the eff ects. 
Bacterial communities are diff erently aff ected by the STM 
infection depending on the treatments
On the fi nal stage of this trial, animals from all the groups were orally 
infected with STM. Challenge was applied daily for three consecutive days 
after which fecal samples were collected. Interestingly, a strong eff ect of the 
diff erent treatments could be observed on day 55 as suggested by the PRC 
(Supplementary Figure S9 and Table 3). The groups lcITF/LaW37/V and 
CTRL/V shared a more similar microbiota composition, which signifi cantly 
diff ered from the CTRL/NV and lcITF/V groups (Figure 5). This diff erence 
between the groups was observed at the level of Prevotellaceae family. LcITF/
LaW37/V and CTRL/V groups presented high mean abundances of members 
from the Prevotellaceae, 0.23% and 0.26% respectively, while the CTRL/NV 
and lcITF/V groups had low mean abundances of 0.04% and 0.1% (Figure 
5D). The opposite was observed for the Lactobacillaceae family (Figure 5D), 
low in the lcITF/LaW37/V and CTRL/V groups and high in the CTRL/NV 
and lcITF/V groups, although not signifi cantly. This separation between the 
groups was further confi rmed using Adonis analysis. The lcITF/LaW37/V 
and CTRL/V groups shared high similarities (Figure 5.A and 5.D), and the 
CTRL/NV and lcITF/V groups had a signifi cantly diff erent composition than 
lcITF/LaW37/V and CTRL/V (R2=0.41; p=0.001) (Table 3). The OTU’s which 
were responsible for the separation belonged to the taxa from Prevotella1, 
Phascolarctobacterium, Prevotellaceae_NK3B31_group and Lactobacillus 
Impact of oral Salmonella vaccination and dietary interventions 




(Figure 5.B). This was further confirmed at the genus level (Figure 5.C).
Microbiota composition was most significantly impacted by the STM 
challenge. The changes observed for the lcITF/LaW37/V synbiotic group 
were more similar with the CTRL/V group  in comparison with the lcITF/V 
and CTRL/V groups. Taken together, this suggests that lcITF might have 
suppressive effects on the vaccination as upon STM challenge the dysbiosis 
state of the piglets was more pronounced in non-vaccinated animals and 
vaccinated animals that received lcITF than in vaccinated animals and 
vaccinated animals that received lcITF/LaW37.
Figure 4. Dietary intervention but not vaccination affect the microbial 
development of piglets one week after weaning, on day 30. Relative 
abundances of A) the genus Lactobacilus and B) Catenibacterium on day 30 one 
week post weaning/vaccination C) Composition of the microbial communities 
between the four treaded groups on day 30. The top-10 families are annotated on 
the right legend. 
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Figure 5. The effect of STM infection on the microbial composition of the 
piglets after three days challenge with the pathogen, on day 54. 
A) PCoA plot using the weighted Unifrac distances between the four treated groups. 
Separation can be explained by the different treatment groups (Adonis R2=0.41; 
p=0.001) B) The four taxa which drive the variation between the treatment groups 
C) Composition of the microbial communities between the four treaded groups on 
day 30. The top-10 families are annotated on the right legend.
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Microbiota composition is associated with lower STM-induced 
diarrhea and higher antibody titer
To confirm lcITF might have suppressive effects on the vaccination we further 
investigated whether the differences between microbiota compositions of 
the different groups were correlated with the piglets’ immune response. We 
observed lower diarrhea severity, as indicated by lower scores, as well as 
lower occurrence during challenge in CTRL/V and lcITF/LaW37/V groups 
(Figure 6). Moreover, these two groups were the only one to respond to 
the vaccination as their antibody titer increased upon secondary exposure 
(i.e. STM challenge). The opposite was observed for the CTRL/NV and 
lcITF/V groups. Interestingly, a negative correlation was found between 
antibody titer and diarrhea as shown Figure 6 (R2=-0.3; p=0.06). The taxa 
which was highly correlated with the occurrence of diarrhea was Dorea sp. 
but no significant difference was detected between the treatment groups. 
Although the correlation found is weak it is in line with the overall clustering 
consistently observed that separates CTRL/V with lcITF/LaW37/V from 
CTRL/NV and lcITF/V confirming that lcITF might have lowering effects on 
STM oral vaccination.
 Finally, we investigated whether microbiota composition of the 
animals with the highest antibody titers was outstanding and if it could 
explain for higher vaccination efficacy. As previously described, 75% of the 
animals that received lcITF/LaW37/V produced high amounts antibodies 
against STM while 33% and 25% of the animals in the CTRL/V and lcITF/V 
groups responded upon secondary exposure to STM. Therefore, we stratified 
the animals based on their antibody titer on day 55 as being high-, low- and 
non-responders towards the vaccination. As shown on Figure 7, a positive 
correlation between microbiota composition and the status of responders 
was observed (R2=1.15; p=0.035).
A striking finding was that the microbiota shift observed on day 30 
in animals treated with lcITF/LaW37/V was correlated with lower STM-
induced diarrhea (p=0.026) (Figure 7). This suggests that the transient effect 
of lcITF/LaW37/V on microbiota composition during weaning stress could 
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have benefi cial health eff ects later in life.
Because antibody titer was already enhanced prior to STM challenge, 
on day 52, in the lcITF/LaW37/V group, we further looked into possible 
microbiota changes prior to STM-challenge that could serve as microbial 
biomarkers and provide leads to explain enhancement of vaccination 
effi  cacy by lcITF/LaW37. However, no correlations could be found between 
microbiota composition and antibody titer suggesting that strong immune 
responses observed in the synbiotic group might also derive from other 
mechanisms than only microbiota changes.
Figure 6. Correlation on day 55 between A) daily diarhea scores and 
antibody titters and B) between Dorea genera and daily diarrhea scores
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Effects of the residential gut community on the development of the immune 
system has been well described [40], however the interplay between gut 
microbiota and vaccination has not yet been fully explored, especially in 
livestock animals. This is of importance, as any interference with microbiota 
composition might influence immunity and metabolism in later life [18]. 
Within this context, the present study examined the effects of dietary 
interventions on piglets’ microbiota throughout weaning, vaccination against 
Salmonella Typhimurium (STM) and STM challenge. The development of gut 
microbiota was monitored for a period of 2 months based on fecal community 
profiles obtained from NGS of PCR-amplified 16S rRNA gene fragments. 
Piglets were weaned on day 24, vaccinated on day 26 and challenged on days 
52, 53 and 54 after birth to identify possible taxa associated with vaccine-
mediated protection. Results from fecal samples suggested that weaning and 
STM-stress, but not vaccination itself, affected fecal microbiota composition. 
The subtle effects observed with the pre- and synbiotic dietary interventions 
on gut microbiota were specific and depended on the developmental stage of 
the piglets.
 Vaccination was given orally to newly weaned piglets and did not lead 
to any change in microbiota composition as compared to non-vaccinated 
animals. In line with a large body of literature, we observed a significant shift 
between pre- and post-weaning fecal microbiota composition. Weaning is 
indeed known to induce important intestinal dysbiosis [39]. However, by 
the age of 51-days old, the microbial Alpha diversity of all piglets resembled 
adult, sow-like diversity. This matches developmental studies reporting on 
piglets core microbiota [23]. Interestingly, we could pin point that members 
of the Christensenellaceae family were responsible for the separation of 
samples on day 30. Some of these bacteria are known butyrate producers 
are associated with pigs’ health Taken together these data show that gut 
microbiota development of the piglets throughout the whole study was not 
impaired by vaccination nor by any of the dietary supplementations.
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 Effects of dietary intervention were observed during dysbiosis 
periods. The most significant impact on microbiota composition later in life 
when animals received the STM-infection. Challenge with STM induced loss 
of diversity in all the groups, with Alpha diversity being lower for all groups 
on day 55 compared to day 51. Because this diversity dropped so abruptly 
it is safe to assume that the effect was due to challenge rather than normal 
development feature. This indeed matches previous findings [43, 44]. 
Moreover, differences in Alpha diversity were also observed between the 
groups and was lower in CTRL/NV and lcITF/V groups than in CTRL/V and 
lcITF/LaW37/V groups. Prevotellaceae and Lactobacillaceae were driving 
these differences and bacterial OUTs Prevotella1, Phascolarctobacterium, 
Prevotellaceae_NK3B31_group and Lactobacillus contributed to the 
variations. Changes in Prevotellaceae were previously observed in pigs 
infected with Salmonella [44]. The other time-point at which significant 
differences were observed between the groups was when piglets experienced 
weaning-induced stress. Piglets fed the synbiotic lcITF/LaW37/V had higher 
abundance of Lactobacillus than the other treatment groups. This is in 
line with a previous intervention, with lactobacilli, done at weaning, which 
induced ileal and colonic changes in pigs’ microbiota [45]. Also observed 
after weaning, the piglets fed the prebiotic lcITF had higher abundance 
of Catenibacterium, a fiber degrading bacterium previously reported to 
be increased in pig’s microbiota fed resistant starch [46]. Interestingly, 
piglets fed lcITF, after weaning, experienced less diarrhea suggesting that 
Catenibacterium might be health-associated. Interestingly, members close 
to this genus were reported to convert isoflavonoids into equol, an health-
associated SCFA [47].
 Increased abundances of Lacobacillaceae members in feces is 
associated with diarrhea and different dietary interventions are responsible 
for this depending on the time-point. The first time-point at which 
lactobacilli were increased in feces was on day 10 for the piglets fed lcITF/
LaW37. Although this effect was very subtle, as it could not be picked up 
by all analysis performed, it shows that only the animals specifically fed 
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LaW37 as supplement had enhanced abundance of lactobacilli. It is likely 
that the very immature microbiota of these neonate piglets could only handle 
the settlement of a lower number of lactobacilli in the ileal, the rest being 
excreted in feces. This transient effect attenuates as the microbiota matures 
and no differences were observed at other time-points pre-weaning. Weaning 
stress, as measured on day 30, revealed higher abundances of Lactobacillus 
in feces of animals fed lcITF/LaW37. No differences were observed further 
on, but after STM-challenge on day 55, animals in the CTRL/V and lcITF/
LaW37/V groups had lower relative abundance of Lactobacillaceae and of 
the OTU Lactobacillus. Interestingly, these data on lactobacilli are in line 
with scoring of diarrhea. On day 10, piglets were suckling and kept in herd, 
therefore diarrhea was not measured at this period for individual animals, 
but for the heard and no statistical significance could be found. However, on 
day 30 diarrhea was higher for piglets fed lcITF/LaW37 and on day 55 it was 
the opposite, moreover correlations analysis revealed that lactobacilli were 
positively correlated with diarrhea on day 55. An explanation is that fecal 
samples represent more a colon-like composition, where lactobacilli are low 
abundant in healthy situation [48]. However during dysbiosis period, like 
weaning-induced stress or STM challenge, feces composition will represent 
more the composition of the small intestine, where lactobacilli are typically 
more abundant [23]. Salmonella is known to invade ileal mucosa provoking 
diarrhea [49] therefore inducing loss of microbial diversity. Ileal microbiota 
composition can then be measured in fecal samples within the first days of an 
STM infection [43, 44]. 
 Dietary lcITF intervention specifically reduced post-weaning diarrhea 
but not STM-induced diarrhea. Incidence of diarrhea is an important 
consequence of intestinal dysbiosis that occurs during both weaning and 
STM-induced stress. In this study, we found that supplementation with 
lcITF significantly improved piglet’s health on that aspect during weaning-
stress compared to other treatment groups. Interestingly, this was not the 
case during STM-induced diarrhea. Because animals were all tested STM-
free at the start of the challenge, weaning-associated diarrhea episodes 
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were not due to salmonellosis. Most of the studies conducted during the 
weaning transition have reported a decrease in abundance of Lactobacillus 
spp. in favor of Clostridium spp., Prevotella spp. or facultative anaerobes 
such as Proteobacteriaceae [39]. Although Catenibacterium was specifically 
increased and might be contributing to protect piglets against weaning/
associated diarrhea, sequencing of 16S rRNA gene fragments amplified from 
piglets’ feces might lack sensitivity and specificity to unravel more responsible 
agents for the beneficial effects observed with lcITF. Our data suggest that 
supplementation with lcITF was most efficacious to prevent weaning-stress 
induced diarrhea which could be linked to higher abundances of fiber 
degrading bacteria but not STM-induced diarrhea.
 Animals that received CTRL/V and lcITF/LaW37/V were more 
protected against salmonellosis but microbiota was not solely responsible 
for this. These two groups clustered together with increased antibody titer 
against STM, higher Alpha diversity and lower diarrhea frequency with 
shorter duration as compared to the CTRL/NV and lcITF/V groups. Feces of 
piglets treated with CTRL/V and lcITF/LaW37/V was typically characterized 
by higher relative abundance of Prevotellaceae and lower relative abundance 
of Lactobacillaceae than the CTRL/NV and lcITF/V groups. CTRL/V and 
lcITF/LaW37/V had higher abundances of the OTUs Phascolarctobacterium, 
Akkermansia Prevotella1 and Prevotellaceae_NK3B31_group. This is in 
line with previous studies were the health associated butyrate producer 
Phascolarctobacterium was found in high abundance in feces of pigs fed 
resistant starch and other dietary fibers [46, 50]. Moreover, Prevotella 
typically colonizes the cecum and colon of healthy pigs [48] and higher levels of 
Prevotellaceae have been associated with health [51]. Also, lower abundance 
of the members of the Prevotellaceae is a characteristic consequence of 
STM infection in pigs. This corroborates the observations made in our 
study where groups with higher relative abundance of Prevotellaceae also 
experienced a stronger systemic reaction towards the STM-challenge as 
measured by increased vaccination efficacy which is in accordance with the 
diarrhea results of the present study. Salmonellosis diarrhea was higher 
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in lcITF/V with CTRL/NV groups that did not develop systemic immunity 
against STM after vaccination as measured by absence of circulating specific 
antibodies post challenge. In fact, we found a correlation between microbiota 
composition, diarrhea and antibody titer on day 55. Previous studies about 
lactobacilli effects on oral vaccination efficacy have shown promising results 
in line with ours [15, 52, 53] although these effects seem to be strain and 
vaccine specific [54]. Separation of the animals according to their response to 
the vaccine (high- low- non-responders) also indicated that levels of antibody 
titer and microbiota are linked. However, these correlations were weak and 
as no other link could be found between vaccination efficacy and microbiota 
at other time-points, it seems that changes in fecal microbiota cannot solely 
explain the doubled antibody titer measured in lcITF/LaW37/V as compared 
to the CTRL/V group which was similarly protected against STM-induced 
diarrhea and dysbiosis.
 The suppressive effect of lcITF supplementation on vaccination 
efficacy was not expected. Earlier findings were that lcITF supports Hepatitis 
B vaccination by increasing Th1 cells [55], and STM vaccination is also 
known to be Th1 driven. However, short-chain ITF was found, in the study of 
Vogt et al. 2017, to have suppressive effects against Hepatitis B vaccination. 
It should be noted, however, that there are major differences between this 
study that targeted systemic vaccination of young adults and our design with 
oral vaccination of very young piglets. Taken together, these discrepancies 
might suggest that lcITF exerts Th1-driven effects only in the presence of 
an matured immune system and/or not at mucosal level, or that different 
degradation patterns occur in piglets receiving lcITF dietary intervention 
leading to the degradation of lcITF into molecules that have a suppressive 
effect on vaccination efficacy, as previously observed for other types of ITF 
[55]. However, dietary lcITF intervention was not associated, until challenge, 
with impaired general health. 
 In conclusion, neither neonate dietary interventions nor vaccination 
during weaning stress, provided in an appropriate dosage, impaired the 
piglets’ immune and microbiota development. Interestingly, prebiotic 
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and synbiotic interventions were able to substantially modify later life 
immunity by respectively suppressing or supporting vaccination efficacy. 
Moreover, periods of stress such as weaning and STM-challenge were best 
to unravel subtle effects of neonate dietary interventions. Intervention with 
lcITF protected against non-STM driven diarrhea, which might indicate a 
protective effect in other regions of the intestine than in the ileum. Addition 
of LaW37 to lcITF drastically changed the effect of lcITF on vaccination 
efficacy, which was strongly enhanced. LaW37 is likely to drive changes in 
vaccination efficacy but the mechanisms behind this effect do not solely rely 
on changes in fecal microbiota composition.
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Figure S1. Long-chain inulin-type fructan (lcITF) HPAEC profile (red) 
compared to Frutafit DP10-60 reference (black). Peaks represent fructose 
(F) and glucose (G) monomers, dimers and fructans oligomers present in the 
formulation of lcITF. GFn and Fn chains respectively terminated by a glucose or 
fructose molecule with n the number of fructose moieties in the chain.
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Figure S2. The microbiota development of neonatal piglets. Data were 
processed using A) the weighted and B) the unweighted Unifrac distances, C) Bray 
Curtis dissimilarity index and D) Detrended correspondance analysis using the 
Bray-Curtis distances.
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Figure S3. Alpha diversity calculations of neonatal piglets per timepoints. 
Alpha diversity was estimated using A) the Phylogenetic diversity index and B) the 
unweighted Unifrac distances, C) Bray Curtis dissimilarity index and D) Detrended 
correspondance analysis using the Bray-Curtis distances.
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Figure S4. Alpha diversity measurements per group. Alpha diversity was 
estimated within each timepoint using the phylogenetic diversity index, for each of 
the groups, neamely CTRL/NV: control group receiving placebo and non-vaccinated; 
CTRL/V: control group receiving placebo and vaccinated; lcITF/V: intervention 
group receiving long-chain inulin type fructans and vaccinated; lcITF/LaW37/V: 
intervention group receiving the combination lcITF with L. acidophilus W37 and 
vaccinated.
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Figure S5. The development of piglet microbiota during preweaning. 
Graphs represent in A) DCA plot generated using the weighted Unifrac distances 
and in B) the OTU’s with the highest coeffi  cient of variation during preweaning.
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Figure S6. Principal response curve analysis prior to weaning. PRC testing 
for the effect of dietary intervention during the preweaning period revealed the 
microbial changes within samples collected on day 10, 17 and 21 after birth.
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Figure S7. PREMANOVA analysis did not show signifi cant eff ect for 
the variable treatment on day 10. Here we show the 5 taxa identifi ed with the 
highest coeffi  cients of variation. 
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Figure S8. The development of piglets’ microbiota post weaning. Graphs 
represent in A) the DCA plot generated using the weighted Unifrac distances and in 
B) the OTU’s with the highest coeffi  cient of variation during weaning on day 30, 51 
and 54 after birth.
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-Figure S9. Principal response curve analysis post weaning. The PRC revealed microbial changes one week after weaning and upon infection using the 




Table S1. Composition of the piglet weaner synthetic diet low in fi ber. 
Table S2. Nutritional values of the synthetic diet for the swine net energy 
of 11.0 mega Joules/kg BW.
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Scope: Resistant starches (RSs) are classically considered to elicit health 
benefits through fermentation. However, it was recently shown that RSs 
can also support health by direct immune interactions. We therefore 
hypothesized that the structural traits of RSs might impact the health 
benefits associated with their consumption. Methods and results: Effects 
of crystallinity, molecular weight, and chain length distribution of RSs were 
determined on immune Toll-like receptors (TLRs), dendritic cells (DCs), 
and T-cells cytokines production. To this end, we compared four type-3 RSs, 
namely Paselli WFR®, JD150®, debranched Etenia® and Amylose fraction 
V®, that were extracted from potatoes and enzymatically modified. Dextrose 
equivalent seemed to be the most important feature influencing immune 
signaling via activation of TLRs. TLR2 and 4 were most strongly stimulated. 
Especially Paselli WFR® was a potent activator of multiple receptors. 
Moreover, the presence of amylose, even to residual levels enhanced DC 
and T-cell cytokine responses. Paselli WFR® and Amylose fraction V® 
influenced T-cells polarization. Conclusions: We show here that chain 
length and particularly dextrose equivalent are critical features for immune 
activation. This knowledge might lead to tailoring and design of immune 
active RS formulations.
Abstract
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Resistant starches (RSs) are dietary fibers [1] classically considered to 
elicit health benefits through fermentation by the gut microbiota [2] that 
subsequently enhance production of vitamin B and K but also short chain 
fatty acids (SCFA) that modulate immunity [3]. However, it was recently 
shown that RSs not only serve as substrate for gut-microbiota but can also 
support health by directly interacting with specialized receptors on the 
immune cells [4]. RS are polymers of  amylose (linear chains) and amylopectin 
(linear and branched chains) that are an assembly of glucose monomers with 
alpha-glucosidic bonds [5]. RS can be found in different physico-chemical 
compositions such as in different crystallinity, particle size, structural order, 
helicity, molecular weight (MW), and differences in chain-length distribution, 
which includes degree of polymerization (DP), dextrose equivalent (DE), and 
degree of branching. All these factors might influence the interaction of RSs 
with immune cells or other physiological processes after consumption of RSs. 
The source, breeding method of the crop, and extraction method determines 
the physicochemical properties of the RS [6, 7]. There are five types of RS [5] 
[8, 9]. The first type is defined as inaccessible starch, the second as granular 
starch, the third as retrograded starch, the forth as modified starch and the 
fifth as an amylose-lipid complex. Type-3 is obtained by cooking and cooling 
process which makes it the most resistant form, fully resistant to human 
digestive enzymes [10]. The final physicochemical structural properties of 
the type-3 RSs are likely to provide direct immune effects [11, 12].
 Direct interaction with the immune system is expected to be regulated 
via binding of RSs to specialized immune cell receptors called pathogen 
recognition receptors (PRRs) that are expressed on many intestinal cells such 
as intestinal epithelial cells (IECs) and especially on immune cells in the gut 
[13]. As such, RSs have been shown to be able to interact with a subgroup of 
PRRs called Toll-like receptors (TLRs) [4]. It has been suggested that particle 
size might matter but also RS source, crystallinity, DE, and MW might impact 
the binding to TLR but these have not been studied yet. Although structural 
features responsible for PRR binding remain to be determined, RSs have 
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been shown to directly modulate cytokine secretion profiles of dendritic cells 
(DCs) and were able to skew T-cell polarization [4]. DCs are known to highly 
express TLRs and are one of the first immune cell types to come into contact 
with compounds present in the gut lumen. Their responses were found to 
be modulated by cross-talk with IECs [14–16]. DCs can subsequently trigger 
immune responses in other cells, such as T-cells [17]. Depending on the 
inflammatory signaling, T-cell skewing might be pushed towards regulatory 
T-cells (Treg), helper T-cells (Th) type 1, 2, or 17, each triggering a different 
immune response [17]. The cytokines and chemokines secreted upon such 
activation are specific [13], and we hypothesized that they might depend 
on RSs structural traits. Insights in the effector-structure relationship of 
RS effects on DCs might lead to tailored RS formulations for specific health 
benefits. 
 Here we determined the effect of crystallinity, molecular weight, and 
chain length distribution of RS on immune effects of DCs. We first determined 
the effects of these RS traits on TLR signaling as RS has been reported to 
bind to these immune receptors [4]. To this end, we compared four type-
3 RSs. The short molecular RSs, which were almost exclusively composed 
of amylopectin, Paselli WFRTM (WFR), JD150TM (JD), debranched EteniaTM 
(dEtenia) were enzymatically debranched [17]; while the large molecular RS 
Amylose fraction VTM (AmyloseV) was a fraction of the gelatinized starch 
which solely contained amylose. First, JD and dEtenia were compared 
because they predominantly differ in crystallinity; then JD and WFR mostly 
differed in DE; and finally, AmyloseV strongly differed from the other three 
RSs at all levels.  However, other parameters also varied aside from these 
major differences and we therefore compared how combinations of these 
structural traits might affect immune responses. TLR expressing reporter 
cells were exposed to all four RSs. Furthermore, effects of RSs on DCs 
secretory cytokine profile were measured with and without IECs; and the 
subsequent effect on T-cells skewing was further evaluated during exposure 
of immature/naive T-cells to DCs spent medium (DC-SM).
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Characterization of the resistant starches
The type-3 resistant starches (RSs) Paselli WFR® (WFR), debranched 
amylopectin JD150® (JD), debranched Etenia 457® (dEtenia), and Amylose 
fraction V® (AmyloseV) (Avebe U.A., Veendam, The Netherlands) were all 
derived from potato starch. The amylose was separated from potato starch 
that contains ~80% amylopectin and ~20% amylose, as previously described 
[18]. Briefly, starch was fractionated by solubilization in a hot magnesium 
sulphate solution. The amylose fraction precipitated upon cooling whereas 
the amylopectin remained in the water phase. The other three products, 
WFR, JD and dEtenia, were obtained via enzymatic debranching using the 
pullulanase Promozyme D2 of Novozymes at pH 4.7 and 60ºC. Prior to 
debranching, the starch was first gelatinizing at 160ºC with steam. After 
cooling down, the pH was set to 4.7 by adding 3 M acetic acid. WFR was 
prepared from maltodextrin with low dextrose equivalent (DE), JD from 
starch containing amylopectin only, and dEtenia from Etenia 457. Etenia 457 
was made from potato starch, as previously described [19], by treating the 
gelatinized starch with a 4-α-glucanotransferase. The four products differed 
in their crystallinity, chain length distribution (DE and DP), and MW.
The degree of partial crystal structures was determined by 
enzymatically degrading the non-crystalline fraction. The α-amylase 
digestion was performed at 40°C in 100 mM sodium acetate buffer of 
pH 5.0 supplemented with 5 mM CaCl2 using 6 units per mL of Bacillus 
licheniformis α-amylase (E-BLAAM; Megazyme, Wicklow, Ireland). 
Subsequently, the supernatant fraction was collected. The partly hydrolyzed 
starch/amylose present in the supernatant was further hydrolyzed to glucose 
using amyloglucosidase (Megazyme; E-AMGDF). The amount of glucose was 
quantified with the D-Glucose-HK kit (Megazyme; K-GLUHKR). The degree 
of crystallinity is defined as 100% minus the percentage of glucose formed. 
The DP was assessed by high pH anion exchange chromatography 
(HPAEC). The products were dissolved in DMSO:milliQ water (9:1) at 
a concentration of 500 mg/L. The HPAEC-PAD ICS5000 workstation 
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(ThermoFisher Dionex) was equipped with a Carbo-Pac PA-1 column (4 x 
250 mm), a PA-1 guard column and a pulsed amperometric detector with an 
AgCl/Gold reference electrode. The column was kept at 30ºC. The system 
was run with a linear gradient of 10 to 400 mM sodium acetate in 100 mM 
sodium hydroxide at flow rate of 1 mL/minute.
The products differ also in the percentage of reducing ends, which is 
expressed as dextrose equivalents (DE) where native starch has a DE value 
of 0 and dextrose of 100. The average molecular weight (Mn) of the reducing 
sugars in the hydrolyzed fraction of each of the RSs was quantified using the 
Luff-Schoorl reagent (VWR) and is expressed as dextrose equivalent (DE) in 
g/100 g. Dextrose, by definition, has a DE of 100 g/100 g and is the reducing 
sugar with the lowest MW.
 MW analysis was done by Size Exclusion Chromatography (SEC), as 
previously described [20], with minor modifications. Starch samples were 
dissolved in Dimethylsulfoxide (DMSO)-LiBr (0.05 M) at a concentration 
of 2 mg/mL by overnight rotating at room temperature (RT), followed by 
3 hours rotating in a ventilation oven at 80°C. All samples were allowed to 
cool down to RT, and were then filtered through a 0.45 μm PTFE membrane. 
The SEC system from PSS (Mainz, Germany) was applied to determine Mn 
and the polydispersity index, defined as MW/Mn. The system consisted of 
an isocratic pump, auto sampler without temperature regulation, online 
degasser, 0.2 μm inline filter, refractive index detector (G1362A 1260 RID 
Agilent Technologies), viscometer (ETA-2010 PSS, Mainz) and MALLS 
detector (SLD 7000, PSS, Mainz). DMSO-LiBr (0.05 M) was employed as 
the eluent. The samples were injected at a flow rate of 0.5 mL/minute into 
a MZ Super-FG 100 SEC column and two PFG SEC columns 300 and 4000. 
The columns were kept at 80°C, the viscometer at 60°C, and the refractive 
indicator at 45°C. A universal calibration curve was obtained using the 
pullulan standard kit (PSS, Mainz, Germany) with MW ranging from 342 
to 805,000 Da. Data were processed with the WinGPC Unity software (PSS, 
Mainz). A refractive index increment (dn/dc) value of 0.072 was used. DMSO 
(CHROMASOLV Plus, HPLC grade, > 99.7 %) was purchased from Sigma 
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Chemical Company and anhydrous lithium bromide (99 %) from Fisher 
Scientific. Note that the MW of AmyloseV was obtained via the MALLLS 
detector, which was not possible for the other compounds as they do not 
cause enough light scattering. Instead, the MW of JD, WFR and dEtenia was 
estimated from the calibration curve obtained with the pullulan standard kit.
 Contamination in DNA and RNA of the starch products was evaluated 
by using NanoDrop™ 1000 Spectrophotometer (Thermo Scientific, Breda, 
The Netherlands). This confirmed low levels of such contaminants. DNA was 
present in WFR (13.71 ng/mL), and AmyloseV (65.89 ng/mL), and RNA was 
found in AmyloseV (41.89 ng/mL), and dEtenia (6.33 ng/mL). Furthermore, 
contamination by endotoxins was measured using the Limulus Amoebocyte 
Lysate (LAL) to quantitatively determine the amount of LPS present in the 
samples. The LAL assay was carried out according to the manufacturers 
protocol from Pierce LAL Chromogenic Endotoxin Quantitation Kit, Thermo 
Scientific (Pierce Biotechnology, Rockford, USA). In short, the microplate 
was brought to 37ºC and 50 mL of standard or sample were added. After 5 
minutes incubation, 50 mL of LAL reagent was added followed by another 10 
minutes incubation. Then 100 mL of substrate solution was added and the 
microplate was further incubated for 6 minutes, after which the reaction was 
stopped with 25 % acetic acid. Absorbance was measured at 405-410 nm on 
a Bio-Rad Benchmark Plus microplate spectrophotometer reader (Bio-Rad 
Laboratories B.V, Veenendaal, the Netherlands) using Bio-Rad Microplate 
Manager 5.2.1 software. The average absorbance of each samples was then 
calculated based on the standard curve and concentration was expressed in 
Elisa Unit (EU)/mL which was approximately 0.1 ng endotoxin/mL. LPS was 
not detected in JD and very low amounts were present in dEtenia (0.076 EU/
mL). On the other hand, WFR and AmyloseV contained higher amounts of 
LPS, respectively 0.961 EU/mL and 0.728 EU/mL. 
Cell Culturing
THP-1-blue™ monocyte reporter and Human Embryonic Kidney (HEK)-
bluetm cell lines were cultured and used as previously described [21]. THP-1 
Chapter 6
202
were cultured in RPMI1640 medium (Gibco, Life Technologies, Bleiswijk, 
The Netherlands), containing 10% heat inactivated Fetal calf Serum (hiFCS) 
(HyClone, Thermo Scientific, Breda, The Netherlands), 2 mM L-glutamine, 
4.5 g/L glucose, 100 mg/mL Normocin™ (InvivoGen, Toulouse, France), 10 
mM HEPES, 1.0 mM sodium pyruvate, 1.5 g/L sodium bicarbonate (Boom 
B.V. Meppel, The Netherlands), and 0.5% Penicillin-Streptomycin (50 μg/
mL–50 μg/mL). THP-1 cell lines were passaged twice a week.
 HEK-bluetm cells were cultured using DMEM containing 10% hiFCS, 
2 mM L-glutamine, 4.5 g/L glucose, 0.2% NormocinTM, and 0.5% Penicillin-
Streptomycin (50 μg/mL–50 μg/mL). The cells were passaged when 
confluency reached 50%-90%.
 ATCC derived Caco-2 (HTB-37, 2012) cells were cultured as previously 
described [22] in Dulbecco’s modified Eagle’s medium (DMEM; Gibco-
Invitrogen, Bleiswijk, The Netherlands) supplemented with 10% hiFCS 
(HyClone), 4.5 g/L glucose, 0.58 g/L glutamine, 10% MEM non-essential 
amino-acids (Gibco, Thermo Fischer Scientific, Waltham, MA, USA), 0.5% 
Penicillin-Streptomycin (50 μg/mL–50 μg/mL) and no pyruvate. Cells were 
used within passage numbers 25 to 40.
 Primary DCs and autologous T-cells were purchased from MatTek 
Corporation (Ashland, MA, USA) and cultured according to manufacturer’s 
instructions. Briefly, cells were thawed in specific basal medium (MatTek), 
centrifuged at 250g for 10 minutes, pellet was resuspended in specific 
maintenance medium (MatTek), and seeded at the appropriate concentration 
as described below.
Reporter cells activation and inhibition assays
THP-1-blue™ cell line was used as previously described [21] to determine 
possible interaction of RSs with several PRRs. THP-1 monocytes express 
some PRR subtypes such as Toll-like receptor (TLR) and NOD-like receptors 
(NLR). THP-1-blue™ cells are derived from the human THP-1 monocyte cell 
line and carry an NF-κB-inducible Secreted Embryonic Alkaline Phosphatase 
(SEAP) reporter construct allowing the monitoring of NF-κB activation by 
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determining the activity of SEAP. This cell line also carries an extra insert for 
MD2 and CD14 that boosts TLR signaling. Levels of NF-κB-induced SEAP 
in the cell culture supernatant were measured with the detection reagent 
QUANTI-Blue™ (InvivoGen, Toulouse, France). The essential downstream 
signaling protein of most TLR subtypes is MyD88. Inhibition of this protein 
therefore leads to blockage of the TLR-dependent NF-κB pathway. The 
inhibition was induced using 50 μM Pepinh-MyD88 (InvivoGen).
 THP-1 activation and inhibition protocols were performed according 
to manufacturers’ instructions. Cell were seeded at a density of 1x106 / 
well and the agonist LPS (0.1 μg/mL) was used as a positive control. The 
THP-1 cells were incubated with the pepinh-MyD88 for 6 hours prior to 
exposure to the compounds. After 24 hours stimulation at 37°C 5% CO2, the 
secreted SEAP was measured by adding QUANTI-Blue™ and absorbance 
was measured at 650 nm after 1 hour with the Bio-Rad Benchmark Plus 
microplate spectrophotometer reader (Bio-Rad Laboratories B.V). Each 
condition was performed in triplicate and experiments were performed 3 
times on different days.
 Specific interaction of RSs with TLRs was investigated, as previously 
described [21], using HEK-blue cells overexpressing either TLR2, 3, 4, 5, 
7, 8, or 9. HEK-blue™, as THP-1-blue™ cells, carry an NF-κB-inducible 
SEAP reporter construct which allows for quantification of TLR activation 
using QUANTI-Blue. The HEK-bluetm cells were seeded according to 
manufacturer’s protocol as described in Table 1. The cells were kept O/N at 
37°C 5 % CO2 to attach to the plate, after which medium was replaced with 
medium containing 5 mg/mL, 1 mg/mL or 0.5 mg/mL of each RS. Culture 
medium was used as a negative control and specific agonists were used as 
positive controls according to Table 1. In the case of TLR4 activation, 100 μg/
mL polymyxin B was added to capture any LPS present in the samples as LAL 
assay revealed contamination in 2 of the 4 RSs [23]. TLR inhibition assays 
consisted of adding 10 μL of TLR specific agonist together with the RSs to 
investigate possible interactions between the two. Activation experiments 
included six replicates, inhibition experiments included triplicates, and each 
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of these experiments was repeated at least 5 times, on diff erent days.
Table 1: Cell seeding densities, positive controls and fi nal 
concentrations used in reporter cell stimulations.
DC and T-cells stimulation
To evaluate the direct immune eff ects of RSs on intestinal cells we used an IEC-
DC coculture system that we compared to separate IECs and DCs stimulations 
(Figure 1). These experiments were performed as previously described [21] 
and all experiments were performed 5 times, on diff erent days. For these 
experiments, Caco-2 cells were seeded at a density of 330,000 cells/well of 
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a ThinCert transwell with 33.6 mm2 membranes and 3 μm pore size (Geiner 
Bio-One International GmbH, Alphen aan den rijn, the Netherlands), and 
differentiated for 21 days at 37°C 5 % CO2. Medium was refreshed 3 times a 
week and on the day prior to stimulation with the RSs. Integrity of the Caco-
2 monolayer was confirmed by measuring trans-epithelial electric resistance 
(TEER) prior and post exposure to RSs.
Figure 1. Experimental design for DCs stimulation with the RSs JD, WFR, 
dEtenia and AmyloseV, in absence (A) and presence (B) of Caco-SM. 
Effects of type-3 resistant starches (RSs) on dendritic cells (DCs) directly exposed to 
these ingredients for 20 hours (A) were compared in a model for intestinal cellular 
cross-talk, where DCs were also exposed to the spent medium collected from Caco-
2 cells (Caco-SM) [21]. For this purpose, Caco-2 cells were cultured on transwells 
for 21 days in a separate plate and were incubated for 20 hours with the RSs. The 
Caco-SM collected was then transferred to the DCs that were separately cultured 
(B). In this setting, DCs were exposed concomitantly to this Caco-SM and to the 
corresponding, freshly prepared, RS. At last, T-cells cultured in a separate plate were 
exposed for 24 hours, in a 1:10 ratio, to the DC-SM.
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 DCs seeded onto a 96-well plate (40,000 DCs/well) were left to 
adhere O/N and were then exposed to 5mg/mL of RSs for 20 hours. Culture 
supernatants of triplicates were pooled and stored at - 80°C until further 
exposure to T-cells or analysis. Next, a similar experiment was carried 
out in the same way except that DCs were exposed to the freshly prepared 
RSs combined to Caco-SM collected on beforehand. The apical surface of 
the Caco-2 IEC monolayers was stimulated with Caco-2 medium or 5 mg/
mL RSs. The plates were incubated 24 h at 37°C 5 % CO2 and basolateral 
supernatants of the triplicates were pooled and used for further exposure 
to DCs. After 20 hours stimulation, DC-SM of triplicates were pooled and 
stored at -80°C until further exposure to T-cells or analysis. 
 T-cells autologous to the DCs were seeded onto a 96-well plate 
(40,000 T-cells/well), let to adhere O/N and exposed to DC-SM, diluted 1:10, 
for 24 hours at 37°C 5% CO2. Culture supernatants of triplicates were pooled 
and stored at -80°C until further analysis. 
Cytokine expression analyses 
The cytokines and chemokines produced by DCs give an indication about 
possible T-cell skewing as response to exposure to RSs. To measure the levels 
of this signaling molecules in the spent medium collected from DCs (DC-
SM), exposed or not Caco-SM, and T-cells, we used a Magnetic Luminex© 
premixed cytokine assay (R&D systems Inc, Minneapolis, USA). This kit was 
customized to simultaneously measure the following molecules in CC-SM 
and DC-SM: IL-12/23 p40, IL-1Ra, IL-1β, IL-6, MCP-1/CCL2, CCL3/MIP-
1α, CCL-5/RANTES, IFN-γ, IL-10 and TNF-α; and the following molecules 
in T-cell supernatant: IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γ and TNF-α. 
Besides, IL-8 in 1:4 diluted DC-SM was measured separately using a human 
CXCL8/IL-8 DuoSet ELISA kit (R&D systems).
 Luminex assays were performed according to the manufacturer’s 
instructions. Briefly, a concentration series of cytokine standards were prepared 
for the appropriate concentration range. The undiluted microparticle reagent 
mix specific for either DCs or T-cells was added to each well (50 μL/well), 
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washed, and standards, negative controls, and samples were all incubated 
O/N at 4°C shaking (duplos, 50 μL/well). After incubation, the plate was 
washed three times, a biotin antibody cocktail was added to each well (50 
μL/well) and the plate was further incubated while shaking for 1 hour at RT. 
The plate was washed 3 times and streptavidin-phycoerythrin was added to 
each well (50 μL/well). After 30 minutes incubation shaking at RT, the plate 
was washed three times and the microparticles were resuspended in 100 μL 
of wash buffer. Fluorescence was then measured within 90 minutes using 
a Luminex® analyzer MAGPIX and xPONENT 4.2 for MAGPIX software 
(Luminex Corporation, ‘s-Hertogenbosch, The Netherlands).
Statistical analysis
THP-1 and cytokine data were expressed as average with standard error of 
the mean (SEM) and HEK-blue data were expressed as average with standard 
deviation (SD). Statistical analyses were performed using GraphPad Prism 
version 7.0a (GraphPad Software, Inc., La Jolla, USA). Normality was 
assessed using D’Agostino & Pearson and ANOVA test was then used and 
followed by LSD for THP-1 and cytokines profiles, or Kruskal-Wallis test 
was used followed by Dunn’s multiple comparison for HEK-blue results. 
Differences between RSs and medium or agonist controls were considered 
statistically significant when p<0.05, and p<0.1 is a trend. p-values <0.05 
are denoted with *, p<0.01 **, p<0.001 ***, and p<0.0001 with ****.
Results
Characterization of type-3 resistant starches
The structural properties of the four type-3 small molecular RSs, namely 
WFR, JD, dEtenia, and of the larger RS AmyloseV are summarized in Table 2.
 Gelatinized starches start to retrograde upon cooling, resulting 
in partly crystalline material [24] thus containing crystalline material 
resisting enzymatic hydrolysis [1]. Crystallinity of the RSs was determined 
by quantifying the time required by α-amylase to degrade the RSs at 40°C 
(Table 2). WFR and JD both contained 7% of crystalline structures, dEtenia 
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contained 14% and AmyloseV contained 92%. 
 The dextrose equivalents (DE) was also quantified as this value is a 
measure of the amount of starch molecules, because each starch molecule 
carries one reducing end. As such, the DE gives the Mn of the products 
obtained after hydrolysis of the RSs [25]. It showed that WFR had the highest 
DE (8.1 g/100 g), whereas JD and dEtenia were intermediate (respectively 
4.2 g/100 g and 4.4 g/100 g), and AmyloseV had the lowest DE (1.2 g/100 g) 
(Table 2). 
 The chain length distribution analysis of the short products, i.e. 
WFR, JD, and dEtenia, revealed that WFR and dEtenia had a more uniform 
distribution. WFR range was DP1-27 with the highest abundance within 
DP6-16. dEtenia had a uniform distribution within DP1-22, whereas JD had 
a peak at oligosaccharides in the DP range 10-18 with the highest abundance 
within DP6-16, and also contained glucose (DP1) (Table 2).
 Finally, the MW of the starches were compared using GPC-MALLS-RI 
in DMSO. AmyloseV had by far the highest MW, estimated to be ~200,000 
g/mol, whereas WFR, JD, and dEtenia had much lower MW in the range of 
2,000 to 4,000 g/mol (Table 2). 
JD and dEtenia stimulate TLR4 but stimulation is not dependent 
on crystallinity
The starches JD and dEtenia originate from the exact same native starch 
source and underwent enzymatic debranching. The only difference during 
the production of these two compounds was the cooling process. Therefore, 
the crystallinity of JD was around 7% and that of dEtenia was double 
while other structural traits were similar (Table 2). As these two RSs differ 
predominantly in crystallinity, they were used for determining possible 
effects of this characteristic on immune signaling.
 As RSs might influence TLR signaling [4] we first compared effects of 
the two RSs with different crystallinity on TLR activation. First, we determined 
whether these two RSs signal via TLRs. This was done by incubating JD and 
dEtenia at a concentration of 5 mg/mL with THP-1 monocytes, a cell line that 
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expresses all TLR subtypes (Figure 2). To evaluate if activation of THP-1 is 
solely TLR-mediated, we also performed this experiment during blockade of 
the essential downstream signaling protein MyD88.
Both JD (7-fold; p=0.017) and dEtenia (6-fold; p=0.046) significantly 
activated THP-1 cells (Figure 2.A). In presence of the MyD88 blocker Pepinh-
MyD88, this activation was lost for both RSs (Figure 2.B), confirming TLR 
dependency. Next, to determine which TLR was activated, we tested the two 
RSs on HEK-Blue reporter cell lines that only express one TLR. We also 
assessed possible dose-dependent effects by testing 3 different concentrations 
of each RS: 0.5, 1, and 5 mg/mL. Only TLR4 was activated by these 2 RSs at 5 
mg/mL (Figure 3.C). However, no difference could be observed between JD 
and dEtenia. No inhibition could be observed for either of these 2 RSs.
Figure 2: RSs JD150 and debranched Etenia stimulated monocytic THP-1 
cells in a TLR dependent manner. To determine whether immune activation of 
the two RSs JD and dEtenia was TLR dependent we determined activation of THP-1 
cells in fully functional THP-1 cells (left). We also used THP-1 cells where MyD88 was 
inhibited by 50 μM Pepinh-MyD88 (right, as indicated by ‘MyD88 blockade’). Data 
were normalized so that medium control is 1, and activation levels were expressed 
as fold change induction of NF-κB/AP-1 pathway as compared to medium control ± 
SEM with n=3 and triplicates. Data were analyzed using GraphPad Prism ANOVA 
test followed by LSD test, and differences were considered statistically significant 
when p<0.05 *, p<0.01 **, p<0.001 *** and p<0.0001 ****.
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Figure 3. Effect of crystallinity on TLR signaling: RSs JD150 and 
debranched Etenia only activated TLR4 which was not influenced by 
their crystallinity degree. RS JD150 had a crystallinity of 7% and debranched 
Etenia (dEtenia) of 14%. TLR signaling was determined by adding these 2 RSs to 
various HEK-cells expressing only one TLR: TLR2 (A), TLR3 (B), TLR4 (C), TLR5 
(D), TLR7 (E), TLR8 (F) and TLR9 (G). Both JD and dEtenia were shown to stimulate 
TLR4 (C). The agonist used was LPS. The activation levels triggered by the RSs were 
compared to the medium control. Data were normalized so that medium control 
is 1, and activation levels were expressed as fold change induction of NF-κB/AP-1 
pathway as compared to medium control ± SD with n=5 and triplicates. Data were 
analyzed with GraphPad Prism Kruskal-Wallis test followed by Dunn’s multiple 
comparison and differences were considered statistically significant when p<0.05 *, 
p<0.01 **, p<0.001 *** and p<0.0001 ****.
To exclude that the TLR4 activation of the two starches was caused by a 
possible contamination with LPS we added 100 μg/mL polymyxin B to the RSs 
to capture any LPS present in the samples [23]. As shown in Supplementary 
Figure S1, addition of polymyxin B fully blocked the effect of LPS agonist 
control (Figure S1.A) but only had a small reducing effect on TLR4 activation 
by JD (Figure S1.B) and dEtenia (Figure S1.C). The activation was still 
significant. This demonstrates that the observed TLR4 effects were truly 
induced by the RSs.
 Next, to determine whether the TLR activation has any functional 
meaning, we tested whether the two RSs JD and dEtenia can trigger different 
responses in dendritic cells (DCs), which highly express TLRs [26]. DCs 
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encounter starches in the intestine via extruding their dendrites through the 
epithelial layer [27]. The secretion of the human cytokines and chemokine 
IL-12/23 p40, IL-1Ra, IL-1β, IL-6, IL-8, MCP-1/CCL2, CCL3/MIP-1α, CCL-
5/RANTES, IFN-γ, IL-10, and TNF-α was measured after 20 hours exposure 
of DCs to 5 mg/mL of the two RSs. The production of IL-1β, CCL3/MIP-1α, 
CCL-5/RANTES, IFN-γ, IL-12.23p40, and IL-10 was below detection levels 
at all occasions. As shown in Table 3, dEtenia had no effect on DCs while JD 
increased IL-8 production (p=0.007).
 As it is recognized that the crosstalk between DCs and IECs is essential 
for maintaining gut homeostasis and DC phenotype, we investigated how 
IECs, stimulated with starches, can impact DC behavior across an epithelial 
barrier [4, 14, 28]. Therefore, we repeated this experiment and exposed DCs 
to one of the RSs together with the Caco-2 spent medium (Caco-SM) collected 
after Caco-2 cells were themselves exposed to that same RS for 20 hours 
(Figure 1). Statistically significant differences were observed in production 
of cytokines and chemokines by DCs exposed to this combination for 20 
hours (Table 3). The production of IL-1β, CCL3/MIP-1α, CCL-5/RANTES, 
IFN-γ, IL-12.23p40, and IL-10 was below detection levels at all occasions. JD 
increased IL-1ra (p=0.003), IL-12/23p40 (p<0.0001), and IL-8 (p=0.003). 
dEtenia increased IL-1ra (p=0.0003), IL-12/23p40 (p<0.0001), and TNF-α 
(p=0.025). No statistically significant difference was observed between the 
2 RSs. 
 Finally, we evaluated the impact of DC responses to the RSs on T-cells 
polarization. To this end, T-cells were exposed to 1:10 ratio of DC-SM. The 
human Th1 cytokines IL-2, IFN-γ, and TNF-α; Th2 cytokines IL-4 and IL-6; 
Th17 cytokine IL-17, and Treg cytokine IL-10 were measured after T-cells 
were exposed to DC-SM for 20 hours (Table 4). The production of IL-17, 
IFN- γ, and TNF-α was below detection levels at all occasion. No statistically 
significant difference could be observed.
 Comparing the RSs JD and dEtenia that have different crystallinity 
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Higher dextrose equivalent is associated with stronger immune 
activating effects
Next, we compared the two RSs WFR and JD that both have a crystallinity of 
7 % but greatly differ in chain length distribution, as DE of WFR is 8 g/100 
g, which is double compared to JD (Table 2). We therefore applied the same 
screening platform to identify the possible influence of combined higher DE 
and DP on immune activities of these two RSs.
 Activation of THP-1 by WFR reached a 16-fold (p<0.0001) increase, 
double of JD (Figure 4.A). Unlike JD, WFR still activated THP-1 cells when 
these were blocked with Pepinh-MyD88 (Figure 4.B). While JD activated 
TLR4 only (Figure 5.C), and only at 5 mg/mL, WFR activated all tested TLRs 
(Figure 5.A, B, C, D, E, F and G) in a dose-dependent manner. Activation by 
WFR was at least as high as the agonist control, except for TLR3 (Figure 5.B) 
and TLR4 (Figure 5.C).
Figure 4: RSs WFR and JD150 differentially stimulated monocytic THP-
1 cells. To determine whether immune activation of the two RSs WFR and JD was 
TLR dependent we determined activation of THP-1 cells in fully functional THP-1 
cells (left). We also used THP-1 cells where MyD88 was inhibited by 50 μM Pepinh-
MyD88 (right, as indicated by ‘MyD88 blockade’). Data were normalized so that 
medium control is 1, and activation levels were expressed as fold change induction 
of NF-κB/AP-1 pathway as compared to medium control ± SEM with n=3 and 
triplicates. Data were analyzed using GraphPad Prism ANOVA test followed by LSD 
test, and differences were considered statistically significant when p<0.05 *, p<0.01 
**, p<0.001 *** and p<0.0001 ****.
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Figure 5: Effect of Dextrose Equivalent (DE) on TLR activation: RS 
Paselli WFR virtually activated all TLRs. WFR had a DE of 8 g/100 g and 
JD150 of 4 g/100 g. TLR signaling was determined by adding these two RSs to 
various HEK-cells expressing only one TLR: TLR2 (A), TLR3 (B), TLR4 (C), TLR5 
(D), TLR7 (E), TLR8 (F) and TLR9 (G). WFR activated all TLRs and JD was TLR4 
(C) dependent only. The activation levels triggered by the RSs were compared to the 
medium control. Data were normalized so that medium control is 1, and activation 
levels were expressed as fold change induction of NF-κB/AP-1 pathway as compared 
to medium control ± SD with n=5 and triplicates. Data were analyzed with GraphPad 
Prism Kruskal-Wallis test followed by Dunn’s multiple comparison and differences 
were considered statistically significant when p<0.05 *, p<0.01 **, p<0.001 *** and 
p<0.0001 ****.
To exclude that the TLR4 activation of the two starches was caused 
by a possible contamination with LPS we added 100 μg/mL polymyxin B to 
the RSs to capture any LPS present in the samples (Supplementary Figure 
S1.A), and although addition of polymyxin B had a small impact of TLR4 
activation by JD (Supplementary Figure S1.B) and WFR (Supplementary 
Figure S2), the remaining activation was still statistically significantly higher 
than medium control. This demonstrates that the observed TLR4 effects 
were predominantly caused by the RSs themselves.
 Also, here we determined effects of the differences in starch structure, 
in this case DE difference, on DC responses. The secretion of the human 
cytokines and chemokines IL-12/23 p40, IL-1Ra, IL-1β, IL-6, IL-8, MCP-
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1/CCL2, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-10, and TNF-α was 
measured after 20 hours exposure of DCs to 5 mg/mL of the two RSs. The 
production of IL-1β, CCL3/MIP-1α, CCL-5/RANTES, IFN-γ, IL-12.23p40, 
and IL-10 was below detection levels at all occasions. As shown in Table 
5, average production of chemokine CCL-2/MCP-1 (p=0.004) and pro-
inflammatory IL-8 (p<0.0001) were significantly higher in DCs exposed to 
WFR as compared to JD. Besides, WFR, and not JD, increased the production 
of the pleiotropic cytokine IL-6 (p=0.031) by DCs.
The effect of WFR was more pronounced even when DCs were 
exposed to both the RSs and Caco-SM (Table 5), mimicking the situation in 
the gut where the RS first encounters IECs. The production of IL-1β, CCL3/
MIP-1α, CCL-5/RANTES, IFN-γ, and IL-10 was below detection levels at 
all occasions. Many cytokines differed between WFR and JD (Table 5). The 
average increased production of IL-1ra (p=0.0002), CCL-2 (p<0.0001), and 
IL-6 (p=0.0006) was higher when DCs were exposed to WFR as compared to 
JD. WFR, but not JD, increased production of TNF-α (p<0.0001).
Finally, there was some effect of WFR on T-cell polarization as 
presented in Table 6. WFR increased IL-6 (p=0.001) production by T-cells 
when exposed to the DC-SM. This average increased production of IL-6 was 
statistically significantly higher in DCs exposed to WFR as compared to JD 
(p=0.016).
 The influence of higher DE as represented by the RS WFR considerably 
impacted the results with greater activation of THP-1, which were activated 
in MyD88 dependent and independent ways. Moreover, stronger immune 
activity by WFR as compared to JD could also be observed in DCs directly 
exposed to the RSs in absence and presence of Caco-SM and on T-cell 
skewing.
 Moreover, we observed that small changes in degree of polymerization 
(DP) do not affect immune effects.
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High molecular weight drastically changes immune effects of RSs 
in relation to other traits
The foregoing studies demonstrated that crystallinity in the tested range did 
not have significant immune effects. However, differences in DE, did. Finally, 
we evaluated the potential of a structurally different type-3 RS, AmyloseV. 
This pure amylose fraction did not contain amylopectin, unlike the short 
molecular RSs previously tested, and it therefore differs in crystallinity, DE, 
MW. Also, due to the absence of short molecular structures in the AmyloseV 
sample, DP measurement could not be performed. The comparison of 
AmyloseV with the most immune active short molecular RS, namely WFR, 
was used to study the influence of high MW combined with low DE on 
immune signaling. 
 First, we evaluated the effects of the large molecular AmyloseV on TLR 
signaling using THP-1 cells with and without blockade of MyD88. AmyloseV 
activated THP-1 cells by 16-fold (Figure 6.A), and the activation remained the 
same despite blockage of MyD88 (Figure 6.B), demonstrating that activation 
is not only TLR dependent. However, by studying effects of AmyloseV on 
TLR expressing HEK-cells, we identified that AmyloseV activated TLR2 and 
4, in a dose-dependent manner (Figure 7). Activation of TLR2 by AmyloseV 
was remarkably high with 26-fold increase (p<0.0001) (Figure 7.A), while it 
was only 20-fold at the same concentration of WFR (p<0.0001). Activation of 
TLR4 reached 14-fold with AmyloseV 5 mg/mL (p<0.0001), that was 3-fold 
higher than with WFR (p<0.0001) (Figure 7.C).
The effects on TLR4 were not caused by possible remnants of LPS in 
the samples as addition of 100 μg/mL polymyxin B had no effect on AmyloseV 
(Supplementary Figure S3) induced activation of TLR4.
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Figure 6: RSs WFR and AmyloseV stimulated monocytic THP-1 cells in 
a non-TLR dependent way. To determine whether immune activation of the 
two RSs Paselli WFR and Amylose fraction V was TLR dependent we determined 
activation of THP-1 cells in fully functional THP-1 cells (left) and in THP-1 cells 
where MyD88 was inhibited by 50 μM Pepinh-MyD88 (right, as indicated by ‘MyD88 
blockade’). Data were normalized so that medium control is 1, and activation levels 
were expressed as fold change induction of NF-κB/AP-1 pathway as compared to 
medium control ± SEM with n=3 and triplicates. Data were analyzed with GraphPad 
Prism ANOVA followed by Dunn’s test and differences were considered statistically 
significant when p<0.05 *, p<0.01 **, p<0.001 *** and p<0.0001 ****.
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Figure 7: RSs Paselli WFR virtually activated all TLRs and Amylose 
fraction V only activated TLR2 and 4. WFR had a low crystallinity, high DE 
and low Mw while AmyloseV had a high crystallinity, low DE and high Mw. TLR 
signaling was determined by adding these 2 RSs to various HEK-cells expressing only 
one TLR: TLR2 (A), TLR3 (B), TLR4 (C), TLR5 (D), TLR7 (E), TLR8 (F) and TLR9 
(G). WFR activated all TLRs and AmyloseV activated TLR2 (A) and TLR4 (C). The 
activation levels triggered by the RSs were compared to the medium control. Data 
were normalized so that medium control is 1, and activation levels were expressed 
as fold change induction of NF-κB/AP-1 pathway compared to medium control ± 
SD with n = 5 and triplicates. Data were analyzed with GraphPad Prism Kruskal-
Wallis test followed by Dunn’s multiple comparison and differences were considered 
statistically significant when p<0.05 *, p<0.01 **, p<0.001 *** and p<0.0001 ****.
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 Exposure of DCs to these two RSs without Caco-SM showed strong 
immune effects of AmyloseV. The production of IL-1β, CCL3/MIP-1α, CCL-
5/RANTES, IFN- γ, and IL-10 was below detection levels at all occasions. 
AmyloseV triggered higher average production of CCL-2 (p=0.0003), IL-
1ra (p=0.0002), IL-12/23p40 (p=0.021), and TNF-α (p=0.0006) by DCs as 
compared to WFR (Table 7). 
When DCs were exposed to the RSs directly in combination with 
Caco-SM, AmyloseV induced a strong DC response. AmyloseV led to higher 
average production of IL-6 (p=0.024), IL-12/23p40 (p<0.0001), TNF-α 
(p<0.0001), and IL-8 (p=0.050) by DCs than when they were exposed to 
WFR (Table 7).
AmyloseV induced T-cell polarization via modulation of DCs, which 
was also observed with WFR but not with the other 2 RSs. Both AmyloseV 
and WFR increased pleiotropic IL-6 by 10-fold compared to medium controls 
(Table 8).
Effects of lower MW starch WFR were stronger on TLRs while 
AmyloseV triggered higher response of DCs with and without presence of 
Caco-SM. Interestingly, WFR and AmyloseV were strong immune activators 
although their molecular structures strongly differed in DE, DP, Mw and 
crystallinity. Therefore, it seems that the structural traits we identified 
behind the immune activity of short molecular type-3 RSs (i.e. WFR, JD and 
dEtenia in the present study), do not necessarily apply to the category of large 
molecular type-3 RSs such as the tested AmyloseV. For allowing comparison 
of the THP-1 and TLR activating activities of all four RSs studied here, we 
have combined the data in Supplementary Figures S5 and S6.
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In this study, we examined the impact of the structural traits: crystallinity, 
chain length distribution, and MW on the ability of type-3 RSs to exert direct 
immune effects. Immune effects of the different RSs were measured via 
PRR activation, DC cytokines production, with and without presence of IEC 
medium, and T-cell polarization. DE seems to be the most important feature 
influencing immune signaling while crystallinity and MW did not seem to 
impact immune signaling. Surprisingly, the four tested RSs clearly differed 
by their ability to activate cells. JD and dEtenia had weak to moderate 
immune effects. The activation of TLR-dependent pathways by JD and 
dEtenia observed in THP-1 cells was solely due to TLR4 activation, and both 
these RSs had very limited effects on DC cytokine production. On the other 
hand, WFR and AmyloseV were strong immune activators. These 2 RSs 
activated several PRRs, triggered cytokine production in DCs, and affected 
T-cell polarization. Together these results indicate that the structural traits 
of RSs play an essential role in direct immune stimulation. Within the tested 
samples, a higher DE combined with lower DP are responsible for these 
direct effects while crystallinity and MW are of lesser importance.
 We show here with the current tested samples that crystallinity 
and MW are not the main structural features determining capacity of RSs 
to activate TLRs. This was concluded by first comparing JD and dEtenia, 
which crystallinities were respectively around 7 and 14%. Both these RSs 
solely activated TLR4. Interestingly, these two RSs originate from the same 
starch source and underwent only minor changes during production in order 
to increase the crystallinity of dEtenia as compared to JD. The minor role of 
crystallinity in TLR activation was further underlined when comparing JD 
to WFR, as they both have a 7% crystallinity, yet WFR activated all TLRs. 
Moreover, increasing crystallinity to 92% with AmyloseV confirmed that this 
parameter is not of great importance, as AmyloseV activated several TLRs 
too. Also, we found evidence that MW was of minor importance for TLR 
activation. The strong TLR activator WFR and the weakly activating JD have 
the same MW, suggesting that MW cannot be the sole determinant for the 
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degree of TLR activation.
 In the current set of comparisons, we found that changes in chain 
length distribution might influence TLR activation. WFR and JD share the 
same degree of crystallinity and MW but differ in DE, the higher DE being 
here the stronger immune activator. However, DE is not the only determinant 
for chain length distribution which is also closely dependent on DP. This is 
important as chain length distribution is used to characterize RSs and is 
known to influence digestibility [29]. JD had a DP range of 6-20 which is 
only a minor difference from that of WFR and dEtenia which ranged from 1 
to respectively, 22 and 27. As DP-values were so similar while WFR had much 
stronger immune effects compared to the other two small molecular RSs, 
we feel we can conclude that DP cannot explain the differences in immune 
stimulating effects. However, the broader and higher DP range was associated 
with higher DE which we hold responsible for immune activating activity of 
RS as WFR with a high DE value activated virtually all TLRs. Although small 
variations of DP, as tested in our study, do not seem to influence immune 
activity of small molecular type-3 starches, an association between immune 
activity and chain length distribution was found [30]. The broader and higher 
DP range was linked to higher DE and higher immune activity. WFR with a 
high DE value activated virtually all TLRs. This was, to the best of our knowledge, 
never shown before. Interestingly, enhanced IL-6 production, along with 
CCL-2, by DCs was specifically observed, in the present study, with WFR. 
This illustrates that short molecular type-3 RSs effects on different cells and/
or receptors will be specifically triggered by certain structural traits such as 
higher chain length distribution and DE in particular [31].
 Our data also suggest that the combination of high MW and high 
crystallinity could influence DC responses. Induction of anti-inflammatory 
IL-1ra, and pro-inflammatory IL-12p40 and TNF-α were specifically 
observed for AmyloseV, in absence of IECs. This was typical for AmyloseV 
and not observed with other RSs, not even with the PRR activator WFR. 
AmyloseV was solely made of amylose and was the largest molecular 
RS tested in this study. It particularly differed from the other three RSs 
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(WFR, JD and dEtenia) because of its high crystallinity, high MW and low 
DE. Also, AmyloseV distinguishes itself from the others by the absence of 
short molecular structures. Therefore, AmyloseV cannot be compared to 
the other three RSs tested in this study in a step wise fashion, isolating a 
single structural trait at a time. However, comparing AmyloseV to the other 
three RSs suggested that conclusions drawn on influence of chain length 
distribution might only be relevant for short molecular RSs and not for 
pure amylose fraction, represented here by AmyloseV. DC responses to 
the exposure to JD and dEtenia, which share the same DE, was unchanged 
with exception of increased IL-8 production upon incubation with JD. 
WFR increased the production of CCL-2/MCP-1, IL-6, and IL-8. WFR was 
the most immune active debranched compound, while AmyloseV increased 
the production of all tested cytokines by DCs. This confirms that, although 
chain length distribution is likely to influence immune activity of the tested 
debranched RSs, other traits might be of importance as well.
 Furthermore, immune effects of RSs were also assessed on DC 
cytokine production in presence of IEC medium. Presence of IEC medium 
after exposure to the RSs strongly influenced DC responses to these RSs. 
However, none of the investigated structural traits crystallinity, MW, nor 
chain length distribution seemed to explain the effects observed. dEtenia 
was unable to stimulate DCs without presence of IEC medium but increased 
IL-1ra and IL-12 production when IEC medium was also added. JD increased 
IL-8 production in absence of IEC medium and increased IL-8 along with 
IL-1ra and IL-12 in presence of IEC medium. This was also observed with 
WFR. Conditioning of DC responses by IEC medium has been reported 
before [14–16, 31] and was shown to be essential to study RS effects on DC 
responses [4]. In this study, RS was reported to decrease IL-12 production in 
presence of IECs. This, the current, but also another study showed that IEC 
medium conditioned DCs towards a noninflammatory state [15, 16] therefore 
confirming the importance of taking cross-talk into account. Moreover, this 
did not apply to AmyloseV which was highly immune active both in presence 
and absence of IEC medium.
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 The high immune activity of WFR was also observed on PRR activation 
and T-cell polarization while the other 2 debranched RSs had no effects 
confirming previous findings about its direct effects on immune receptors 
and cells. To a lesser degree, this was also observed for the fractionated RS 
AmyloseV which activated both TLR2 and 4 while WFR activated virtually all 
TLRs. This could only partly be explained by LPS contamination as addition 
of polymyxin B, i.e. an LPS inactivator, had limited effects on TLR activation. 
Interestingly, WFR and AmyloseV contained, although in different amount, 
some amylose which might correlate with the activation of TLR2 and 4. A 
previous study described activation of TLR2 by 2 different RSs including a 
type-3 RS [4], and, as also observed in our study for WFR and AmyloseV, 
other PRRs than just TLRs. Interestingly, it seems that activation of more 
than 2 TLRs by a single RS molecule, as observed for WFR, is unique and 
dependent on structural traits such as chain length distribution.
 Effects observed on T-cells were similar for WFR and AmyloseV 
although AmyloseV displayed unique effects on DCs by increaseing the 
production of virtually all cytokines tested. AmyloseV and WFR both 
activated TLR2, however AmyloseV, in absence of IEC medium, is the only 
RS that activated IL-1ra, IL-12, and TNF-α. We have no explanation for 
this unique effect of AmyloseV, but release of cytokines in DCs similar to 
those present in IEC medium might be a possible mechanism. WFR and 
AmyloseV are the only two RSs that induce T-cell polarization, as observed 
by increased IL-6 production. It is possible that this is due to the TLR2 
activating capacity of these RSs. TLR2 activation is involved in induction of 
Treg [4, 32] and shaping a tolerant microenvironment at mucosal sites [33] 
which corroborates our finding that production of pleiotropic IL-6 by T-cells 
is increased. Importance of chain-length distribution on TLR2 activation 
was previously reported for other dietary fibers [30] however it cannot relate 
to AmyloseV effects. It seems that WFR and AmyloseV both display unique 
and great effects on different levels of immune responses and that different 
structural traits are responsible for these effects.
 In conclusion, our results show that all tested RSs WFR, JD, dEtenia, 
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and AmyloseV can interact with TLRs in a dose-dependent manner and that 
chain length distribution might be determinant for differences in effects. Most 
importantly, we show that immune activity of type-3 starches are category 
dependent. Short molecular starches mostly composed of amylopectin differ 
from larger molecular starches solely made of amylose. AmyloseV is the 
large molecular starch we had available for our study. This large molecular 
AmyloseV strongly supported immunity, and its effects were most specific on 
stimulation of cytokine production by DCs even in absence of Caco-SM, in 
the contrary of small molecular RSs. Within the category of short molecular 
RSs, a higher chain length distribution, which was characteristic for WFR, 
with a stronger difference on DE than DP, was associated with stronger 
and broader PRRs activation, DC cytokines and T-cell IL-6 production as 
compared to the other two short molecular RSs. Although no characteristic 
structure could be related to the effects observed on T-cells, TLR2 activation 
is involved, as both WFR and AmyloseV induced a similarly strong increase 
of IL-6 production by T-cells and activated TLR2. Further investigation is 
therefore crucial to determine the mechanisms of action of RSs, however we 
have shown for the first time, to the best of our knowledge, that responsible 
traits for immune activity amongst short molecular type-3 starches are 
chain length distribution and DE in particular. These traits determined PRR 
activation. Amylose content, which is presented in WFR in very low amounts 
and is the main molecule present in AmyloseV, enhanced DC and T-cell 
responses. Although crystallinity and MW did not impact PRR activation in 
debranched RS, a combination of high crystallinity and MW might be key in 
direct DC stimulation as observed with AmyloseV. This knowledge may be 
used for tailoring RS formulations for immune stimulation such as during 




Figure S1. TLR4 activation by JD and dEtenia is not an artefact due to 
LPS contamination. The effect of polymyxin B on TLR4 activation by the agonist 
LPS (A) and the effect of the RSs on TLR4 activation in absence and presence of 
polymyxin B shows that possible endotoxin contamination is efficiently counteracted 
by coincubation with 100 μg/mL polymyxin B for JD150 (B) and debranched 
Etenia (C). Statistical significance compared to agonist control were calculated in 
Graphpad Prism using Kruskal Wallis followed by Dunn’s test with ** p<0.01 and 
**** p<0.0001.
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Figure S2. TLR4 activation by WFR is not an artefact due to LPS 
contamination. The effect of Paselli WFR on TLR4 activation in absence and 
presence of with 100 μg/mL polymyxin B shows that Paselli WFR does activate 
TLR4 independently of possible endotoxin contamination. Statistical significance 
compared to agonist control were calculated in Graphpad Prism using Kruskal 
Wallis followed by Dunn’s test with **** p<0.0001.
Figure S3. TLR4 activation by AmyloseV is not an artefact due to LPS 
contamination. The effect of Amylose fraction V on TLR4 activation in absence 
and presence of with 100 μg/mL polymyxin B shows that Amylose fraction V does 
activate TLR4 independently of possible endotoxin contamination. Statistical 
significance compared to agonist control were calculated in Graphpad Prism using 
Kruskal Wallis followed by Dunn’s test with **** p<0.0001.
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Figure S4. PRR activation by the four tested starches. To determine whether 
immune activation of the three short molecular RSs JD, dEtenia, WFR and the large 
molecular RS AmyloseV was TLR dependent, we determined activation of THP-1 
cells in fully functional THP-1 cells (left). We also used THP-1 cells where MyD88 was 
inhibited by 50 μM Pepinh-MyD88 (right, as indicated by ‘MyD88 blockade’). Data 
were normalized so that medium control is 1, and activation levels were expressed 
as fold change induction of NF-κB/AP-1 pathway as compared to medium control ± 
SEM with n=3 and triplicates. Data were analyzed using GraphPad Prism ANOVA 
test followed by LSD test, and differences were considered statistically significant 
when p<0.05 *, p<0.01 **, p<0.001 *** and p<0.0001 ****.
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Figure S5. TLRs activation by the four tested starches. TLR signaling was 
determined by adding the RSs JD, WFR, dEtenia and AmyloseV to various HEK-
cells expressing only one TLR. WFR and Amylose activated TLR2 (A), none activated 
TLR3 (B), all activated TLR4 (C), WFR was the only one to activate TLR5 (D), 
TLR7 (E), TLR8 (F) and TLR9 (G). The activation levels triggered by the RSs were 
compared to the medium control. Data were normalized so that medium control 
is 1, and activation levels were expressed as fold change induction of NF-κB/AP-1 
pathway as compared to medium control ± SD with n=5 and triplicates. Data were 
analyzed with GraphPad Prism Kruskal-Wallis test followed by Dunn’s multiple 
comparison and differences were considered statistically significant when p<0.05 *, 
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Immune activity of long-chain inulin and LAB on barrier 
integrity
Mucosal immunity contains the majority of the human body’s immune cells 
and is at the origin of the immune development. The mucosal barrier is an 
interface between the outer world and the host. The antigen load encountered 
by the host cells at this interface is not only huge but also diverse, ranging from 
volatile compounds present in the air, to food compounds, microorganisms 
and their fermented and excreted products. Building tolerance towards 
the beneficial and balancing inflammatory processes against the threat is 
an intricate process which is both crucial and challenging, especially for 
immature systems in development. Therefore, some mucosal sites are solely 
dedicated to this. The follicle associated epithelium (FAE), where the Payer’s 
Patches (PP) can be found, gather a high number and diversity of immune 
cells responsible for innate and adaptive immunity, such as DCs and T-cells, 
but these cells can also be found in the lamina propria throughout the 
gastrointestinal tract. Dietary fibers such as long chain inulin type fructans 
(lcITF) and LAB (LAB) are part of the diet and can therefore have effects on 
the host immune system.
 LcITF had no impact on barrier strength (Chapter 2) as previously 
shown in another in vitro human gut epithelial model [1], confirming the 
robustness of this finding. Moreover, lcITF did not impact genes that could 
indicate for strengthened barrier, nor for stimulation of immune reactions. 
We further tested lcITF on TEER during an STM challenge in vitro (data 
not shown) and no effect could be found. However, barrier integrity is 
only one of the mechanisms at play to maintain barrier function in vivo. 
Mucus and/or modification of the epithelial glycocalix play crucial roles in 
maintaining the gut barrier function and preventing pathogenic adherence 
to the cells, and can be favorably modulated by LAB and dietary fibers [2]. 
Such functions might, for instance, explain why lcITF was shown to reinforce 
barrier function via upregulated tight-junction proteins in diabetic mice [3] 
and in mice with acute pancreatitis [4]. Discrepancies between in vitro and 
in vivo results might be explained by microbiota driven effects [5] rather 
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than by direct effects of lcITF on gut barrier as it was shown to exert both 
[6]. This hypothesis is supported by the fact that, in Chapter 5, lcITF 
protected against weaning-induced stress which is associated with impaired 
barrier function [7]. However, this protection was not found during STM-
induced stress therefore suggesting that the type of stressor applied might 
be determinant in vivo. Others have addressed the limitations of the in vitro 
conventional single cell model by studying organoids, which can also include 
microbiota elements. Mechanisms of STM infection have been described in 
such model [8].
 The existence of profound strain differences amongst LAB [9] was also 
observed in this thesis (Chapter 2). The strain LaW37 strongly enhanced 
TEER and Caco-2 gene expression, and also supported barrier strength 
against STM that was accompanied by decreased cytokine stress responses, as 
measured by IL-8, as previously described [10-13]. Interestingly, LaW37 was 
found to support, in vivo, oral vaccination against STM (Chapter 4) showing 
that ingredients that display strong TEER enhancement and decrease STM 
induced stress do not necessarily decrease oral vaccination efficacy although 
the vaccine is a live STM bacteria. Also found in the piglet study, LaW37 
decreased diarrhea during STM challenge (see Figure 3 Chapter 5) while 
lcITF did not. Based on the results of Chapter 2, it was expected that LaW37 
would exert protective effects against STM infection while lcITF would not 
exert direct effects. However, concluding that decreased diarrhea observed 
in STM-challenged piglets that received lcITF/LaW37 was related to the 
capacity of LaW37 to enhance barrier tightness and tight-junctions cannot 
be concluded from this work as LaW37 control is lacking. However, studies 
with different designs have shown for other probiotics that reduced diarrhea 
was indeed associated with increased tight-junction and barrier function 
[14-16]. Moreover, this thesis does not elucidate which parts of LaW37, or 
which metabolites produced by LaW37, exert the effects observed on gut 
barrier. One of the mechanism that could protect piglets against STM is 
lactic acid production which kills Gram negative bacteria such as STM [17]. 





by L. brevis for instance reduces inflammation [18] while lipoteichoic acid, 
which is expressed by many LAB including L. acidophilus, can limit biofilm 
formation of pathogens [19].
 On the other hand, the strains LbW63 and LcW56, which had no 
effect on TEER were not further investigated for possible effects during STM 
challenge, as their effect on Caco-2 gene expression was moderate. However, 
others have shown that enhancement of TEER is not the only mechanism 
by which LAB can protect against STM-induced barrier dysfunction. For 
instance, they can compete with STM by displacing STM from the epithelial 
cells on which it is adhering [11] or by modulating enterocytes inflammation 
related signaling [13, 20]. 
 Moreover, performing microarray analysis on challenged Caco-2 
cells pre-incubated with ingredients would have given useful indication in 
regard to possible genes and factors that could have been investigated in 
piglets’ biopsy samples for instance. In fact, one can question the relevance 
of increased TEER observed with LaW37, prior to STM challenge, as the 
drop observed due to the challenge was the same as for the medium control. 
Comparison at the level of gene expression could validate that tight-junction 
proteins were still upregulated during STM challenge or could unravel other 
mechanisms possibly at play. Furthermore, the absence of a control group 
of piglets receiving solely LaW37 is lacking to conclude about the impact of 
barrier integrity during STM-challenge on the observed decreased diarrhea 
(Chapters 4 and 5).
Array data provide with a broad range of potential 
physiological effects of lcITF and LAB strains on enterocytes
The increased barrier integrity observed with LaW37 involved tight junction 
genes that are not conventionally measured (Chapter 2). Therefore, our 
data suggest that a more extensive investigation of tight-junction regulation 
is important as the most commonly investigated genes, claudin-1, occludin 
and ZO-1 [12, 21-24], were not differently regulated by LaW37. A broader 
screening of relevant genes might eventually lead to identification of novel 
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bacterial or fiber formulations that effectively prevent enteropathogen 
induced barrier disruption. Although the effects of lcITF and the strain 
LbW63 and LcW56 were moderate, some changes could be instrumental for 
further research on intestinal health.
 Changes related to possible direct immune effects of lcITF were also 
measured in the array data and related to differential expression of the gene 
ULBP2. This is a MHC class 1 molecule related to antigen presentation. It 
is a ligand of NK cells receptor NKG2D, and was downregulated by lcITF 
in Caco-2 cells. This ligand expression has been found to be stress-induced 
and to stimulate NK cells toxicity [25], which was so far never connected 
with ITF. However this change might be related to the increased NK cells 
frequency previously reported in humans after lcITF intake [26], and in 
piglets (Chapter 4). LcITF also influenced genes that are unrelated to 
immune signaling. Most other changes observed after exposure of Caco-2 
to lcITF were related to energy metabolism. Interestingly, downregulation 
of a group of 6 genes indicated decreased fatty-acid oxidation. Existing 
studies about beneficial metabolic health effects of lcITF are very scarce 
[27], however, ITFs were found to lower circulating low density lipoprotein 
cholesterol (LDL) [28]. To the best of our knowledge these are new findings 
that demonstrate that effects of ITF goes beyond bifidogenic effects and 
open possibilities for further research on direct health effects of lcITF and to 
dietary fibers in general.
 Moreover, direct effects were also found for the LAB strains that 
did not affect TEER. LbW63 upregulated the genes related to metabolism 
pathways especially increased lipid metabolism related processes. Although 
the strain LbW63 was not studied before, no other strains of L. brevis have 
yet been reported to have effects on regulating these pathways. LcW56 had 
different direct effects on Caco2 cells than LbW63. Possible changes in 
amino-acid metabolism and cell proliferation were observed. Interestingly, 
L. casei was reported to decrease cell proliferation and increase apoptosis 
in Caco-2 cells [29] which could be related to the changes observed in our 





changes at the levels of inflammation and was previously reported for another 
Lactobacillus [30]. Therefore, even if effects are strain dependent, LAB seem 
to affect Caco-2 gene regulation at levels that encourage future research.
Synbiotic effects via synergistic direct immune effects is a 
new concept
The combination of a prebiotic with a probiotic is defined as synbiotic 
regardless of its mechanism [31]. The possible direct immune mechanisms 
behind health effects provided by synbiotics remain to be elucidated as most 
studied microbiota-dependent effects [31-37]. This thesis investigated the 
effects of the combination lcITF/LaW37. It has been shown that LaW37 can 
partially utilize lcITF and grows on short chain ITF (Markus Boger personal 
communication). LcITF activated TLR2 and 5 in a dose-dependent manner, 
as reported before [38] and TLR3, although not in a dose-dependent 
manner (Chapter 3). LcITF also inhibited the activation of TLR2 by the 
agonist (Figure 3 Chapter 3). The capacity of lcITF to both activate and 
inhibit activation of TLR2 indicates that competitive binding against the 
agonist is likely to be the mechanism behind this effect. This has been 
observed for other dietary fibers such as pectin which was shown to prevent 
ileal-inflammation [39]. Moreover, LaW37 activated TLR2 and 3 which 
corroborates observation of others [40], effects of L. acidophilus on TLR2 
were also found in an organoid model [41], and did not inhibit any TLR. 
Interestingly, the combination lcITF/LaW37 had synergistic effects on TLR2 
and 3 activation but also on TLR2, 5 and 8 inhibition. This was not dose-
dependent and seems to depend on one of the ingredients. TLR5 inhibition 
is only observed at the highest concentration of LaW37 and TLR8 inhibition 
only at the highest concentration of lcITF. However, as these inhibitory 
effects were not observed for the ingredients alone, a synergistic effect of 
the combination was necessary to inhibit activation of TLR5 and 8. This 
reinforces the message carried in Chapter 3 that the final outcome of such 
a synergistic effect might depend on the strength by which the individual 
ingredients modulate immune responses.
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 Pro-inflammatory responses promoted by LaW37 have been 
previously reported for various LAB strains [42]. Differences in DCs responses 
was however subject to variation depending on the presence or absence of 
IECs medium, as previously reported [43-45]. Finally, polarization of T-cells 
upon exposure to DCs medium was also evaluated (data not shown), however 
ingredients had no effects. This was previously tested for lcITF where T-cells 
production of IL-6 and IL-10 were decreased while IFN-γ was increased [43]. 
Such discrepancies could be explained by the use of DCs and autologous 
T-cells isolated from the same donor, for all experiments, in order to reduce 
variations. The results from the piglet trial described in Chapter 4 indicate 
that lcITF/LaW37 had a strong effect on STM oral vaccination which could 
not be predicted from Chapter 3 results. This emphasizes that further testing 
using multiple donors might be necessary to conclude on the repeatability of 
this in vitro model. 
 The cells used for the preselection of immune active ingredients in 
both Chapter 2 and 3 are human and not pig cells, i.e. Caco-2, DCs derived 
from human umbilical cord and T-cells from autologous donors, while the 
in vivo assay was performed in piglets. The ultimate goal of this thesis was 
to predict possible in vivo outcomes that can easily be translated to humans 
to open the possibility to perform a clinical trial. However, this has not been 
performed within this thesis and cells equivalent to Caco-2 such as IPEC-J2 
cells which are derived from pigs could also be considered. These cells have 
been used to study pre- and probiotics effects on porcine gut barrier also 
showing that probiotics (review [46]), including lactobacilli, strengthened 
tight-junctions and protected against LPS induced barrier disruption, which 
was validated in neonate piglets in the same study [47]. This suggests that 
the knowledge gathered from Caco-2 cells is in line with other models as 
previously suggested by work on array data performed in our group [48].
 The term synbiotic is usually understood as being the combination 
of a beneficial bacteria and a dietary fiber that the bacteria can utilize to 
increase its effects towards intestinal health [31-34]. However, this was 





combination of a dietary fiber with a LAB can also be synergistic on direct 
immune functions and provide complementary effects on the host. Assessing 
in vivo effects of the combination lcITF/LaW37 revealed, in Chapter 5, that 
changes of microbiota are not strongly involved with the enhancement of 
vaccination efficacy suggesting that lcITF/LaW37 might have direct immune 
effects on the host. The validation of in vitro preselection that defined lcITF/
LaW37 as a synergistic combination was limited. Although synergistic 
effects were observed in vitro, none of them were specifically measured in 
piglets, and the absence of a LaW37 control group prevents from drawing 
hard conclusions. This was previously discussed as direct effects observed 
with LaW37 on barrier integrity (Chapter 2) could be related to decreased 
diarrhea during STM challenge of piglets, however this could only be shown 
with addition of non-vaccinated control groups that would receive dietary 
interventions. In line with this, it seems that LaW37 is the agent mainly 
responsible for supporting vaccination efficacy and maintaining a higher 
microbial diversity upon challenge, while animals fed lcITF were weakened 
during STM challenge and reacted as non-vaccinated while they actually 
were vaccinated. Moreover, during STM challenge in vitro (Chapter 3), 
no added effects of the combination lcITF/LaW37 were observed, which 
should probably be explained by the strong effects of LaW37 on DCs cytokine 
response in the presence of STM infection. This is an indication that LaW37 
might indeed be most responsible for the effects observed on piglets fed the 
combination lcITF/LaW37 but it cannot be proved. Interestingly, a similar 
study conducted on pigs against STM concluded that LAB intervention was 
more efficacious to increase anti-body titer on its own than when combined 
with the prebiotic lactulose alone [49]. However this synbiotic selection was 
based on improved growth of the probiotic with lactulose [50] and no direct 
immune synergistic effects of these two ingredients have been published, to 
the best of our knowledge. Our data emphasizes, again [51], the importance 
of carefully selecting dietary supplements for enforcing specific desired 
immune responses but further assessment of LaW37 alone as compared to 
the combination with lcITF is needed.
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Validation of the in vitro screening platform to select 
immune active compounds based on their structural traits
As discussed, the preselection assays used in Chapter 3 revealed very 
limited effects of lcITF. This was surprising as previous work performed in 
our lab showed that lcITF was able to modulate DCs response and T-cells 
polarization [43]. The potential of ITF to activate TLRs is dependent on their 
chain length, as previously showed in our group [1]. It is likely that structural 
traits of other dietary fibers strongly impact their immune activity as we also 
showed in our lab that particle size of resistance starches (RS), along with 
other structural traits, might be responsible for their immune activities [52]. 
Therefore, we further used this in vitro platform to test other dietary fibers 
in order to evaluate the repeatability and capacity of these assays to measure 
immunomodulatory effects of dietary fibers. To do so we used DCs and 
T-cells cells from the same donor as used in Chapter 3. We could confirm, 
in Chapter 6, that different chemical traits of RS are involved in some of the 
direct immune effects observed. 
 Concluding on the importance of particle size could not be confirmed 
in this thesis. However, investigation of chain length distribution effect was 
possible as 3 out of the 4 RSs studied in Chapter 6, namely JD, WFR and 
dEtenia were debranched starches with short chain. As JD and dEtenia have 
already been compared in Chapter 6, (paragraph 3.2) and showed no major 
difference in possible immune effects, WFR was the most immune active of 
these 3 starches and was characterized by a higher chain length distribution. 
Activation of TLR4 was, however, a common effect observed for all tested 
starches and only WFR activated several PRRs. dEtenia was the RS the least 
active on DCs response at all occasions while WFR displayed a broad range of 
stimulating effects on DCs and T-cells. This suggests that high chain length 
distribution might be influencing immune effects, although further assays 
should be conducted on bigger variation of DP as the highest DP range was 
of WFR and reached 27. Interestingly within the type-3 starches tested in 
this thesis the amylose fraction AmyloseV, a much larger molecule than 





on DC cytokines productions. No structural traits could be linked between 
WFR and AmyloseV except the presence of amylose in both these samples 
although in very different amount. This therefore suggests that structural 
traits responsible for direct immune interactions with receptors and cells are 
likely to be different for sub types of type-3 starches. This finding questions 
the impact of previous research directly comparing type-2 to type-3 starches 
[52] and careful structural analysis on starches should be carried out before 
conclusion about traits responsible for high immune activity.
 New synbiotic combinations could be derived from Chapter 6 
findings. RS are dietary fibers that can have similarly strong effects on DC 
as LaW37 and should therefore be considered for developing new synbiotics 
but could also be combined with lcITF as they have complementary direct 
immune effects. 
In vivo assessment of synbiotic immune activity on piglets’ 
vaccination against Salmonella Typhimurium
Salmonella serovars are very divers and target different hosts, provoking 
different types of illnesses. Salmonella Typhi is well-known, as the 
responsible agent of the Typhoid fever which solely infects primates and 
is responsible for about 222 000 deaths annually http://www.who.int/
immunization/diseases/typhoid/en/. Salmonella Typhimurium (STM) 
is accountable for sickness in humans, pigs and most mammals causing 
mild to mortal diarrheic infections depending on the host and its immune 
status. While pigs are mildly affected and usually asymptomatic towards 
STM, consumption of contaminated pork meat by humans causes serious 
illness. Currently, salmonellosis causes diarrheal diseases in over 130 million 
humans yearly (http://www.who.int/mediacentre/factsheets/fs139/en/) 
and is responsible for 9.3% of 225 foodborne outbreaks in Europe [53]. To 
prevent such undesirable infections, antibiotics and antimicrobial agents 
have been used routinely causing a dramatic increase of multi-drug resistant 
Salmonella [54]. Therefore, there is an urgent need for alternative strategies 
to prevent infection with STM in livestock. Vaccination and improvement of 
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feed strategies to support immunity of livestock are two examples of these 
strategies. Vaccination is based on adaptive immune mechanisms which 
develop through time as new antigens are presented by DCs to educate T-cells 
and B cells. Memory builds-up together with a higher protection towards the 
antigens contained in the vaccine, in this case a live STM [55]. The same 
processes happen when natural infections occur therefore supporting the 
maturation of the immune system. Vaccination of piglets against STM 
occurs via the oral route and is not fully effective as it confers only 20 to 
50% protection [53, 56]. To improve efficacy of STM vaccination, it has been 
proposed to combine vaccination with immune active food components [9], 
such as lcITF and LaW37, as contamination occurs via water or food which 
is a shared route. 
 In Chapters 4 and 5 we observed that vaccination efficacy was 
improved by the synbiotic but not by lcITF alone. The lack of effect of lcITF 
on vaccination efficacy was unexpected as a previous study from our group 
has suggested that lcITF could improve suboptimal vaccination protocols 
in adults [26]. Th1 driven mechanisms were observed, in that study, at the 
systemic level and lcITF was therefore hypothesis to be able to support 
STM vaccination, as it also depends on Th1 skewing [57]. Improvement of 
oral vaccination efficacy was, however, rarely studied in piglets. Although 
probiotic supplementations have been successful in previous studies in 
humans and pigs [49, 58-61], the impact was rarely as strong as what we 
observed. A third of the required vaccination protocol was provided to the 
piglets and the challenge was equivalent to a secondary exposure. After two 
to three doses this STM vaccination confers 20 to 50% protection to the 
piglets [16] and we observed 75% protection in the lcITF/LaW37 group. A 
possible explanation for the strong effect of lcITF/LaW37 is that synergy was 
observed at two levels (Chapter 3), 1) on direct immune effects for TLR2 
and 3 activation and TLR2, 5 and 8 inhibition, which are likely to be involved 
in immune signaling as response to oral vaccination [62], and 2) when DCs 
were exposed to both the synbiotic and Caco-2 medium with high production 





not show synergistic effects indicates that cross-talk might be necessary. 
This might explain why prediction of systemic effects by T-cells as done in 
Chapter 3 could not predict the outcome in more complex systems like in 
vivo although oral vaccination memory correlates with cells released in the 
blood stream [63].
 Interestingly, a group of genes related to differentiation towards 
follicle associated epithelium (FAE) like structure [64], was particularly 
enhanced in enterocytes exposed to LaW37 (Chapter 2). FAE is a typical 
structure of the ileum where Payer’s patches are mostly found, with about 
10% of cells within these special structures being M cells [64]. This was a 
new finding that could be modulatory for oral vaccination processes as 
FAE, although they do not transport antigens, might contribute to antigen 
sampling by sensing luminal pathogens and their products [65]. As transfer 
and presentation of antigens from the lumen to immune cells is at the basis of 
vaccination mechanisms, others have closely studied these specific structures 
in order to possible improve oral vaccination efficacy as their efficacy is often 
low [66] such as STM oral vaccination [67]. Moreover, the role of FAE is also 
important in the context of STM infections [68] and the use of LaW37 could 
therefore be instrumental in supporting development of more effective oral 
vaccination against STM. However this was not investigated further in this 
thesis, and in vitro work should be considered to verify the functionality of 
such changes in gene expression as previously performed to validate particle 
transport of a new M cell model [69].
 The interplay between gut microbiota and vaccination has not yet 
been fully explored, especially in livestock animals. This is of importance, 
as any interference with microbiota composition might influence immunity 
and metabolism in later life [70]. During the STM challenge differences 
between groups were drastic. Microbiota composition of the vaccinated 
piglets that received the placebo and the lcITF/LaW37 intervention clustered 
although the antibody titer of the lcITF/LaW37 group was twice as high. 
Fecal microbiota composition did not fully explain why the synbiotic group 
had developed much higher protection against STM after vaccination than 
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the placebo group did. An explanation might be due to the fact that fecal 
samples reflect more colon-like microbiota while LAB mostly affect the 
ileum composition [71]. Therefore, we looked at the microbiota composition 
in different parts of the gut and at SCFA in these parts (data not shown in 
this thesis). As no difference could be found, it confirmed our hypothesis 
that direct immune effects are likely to be involved in supporting vaccination 
efficacy in piglets. However, the results in Chapter 5 are based on fecal 
microbiota only and actual settlement of LaW37 in the piglet’s flora could not 
be measured. Most of the ileum samples were missing upon STM challenge 
as STM infection targets the ileum, inducing clearance mechanisms. This is 
of great importance as probiotics can cause major shifts in the composition 
of the microbiome of the small intestine [72] which will not be measured in 
fecal samples.
 The method used in Chapter 5 does not allow for detection of low 
abundant bacteria and could also not detect latent presence of Salmonella. 
STM infection first occurs in the ileum and measurement of barrier integrity 
and protection against STM should be first investigated in the ileum. Also, 
as already discussed, collection of lumen samples in the ileum upon sacrifice 
was impossible in this thesis. Therefore, performing ex vivo STM challenge 
in piglets ileum would allow investigation of barrier integrity, direct immune 
effects, local microbiota changes and confirmation that LaW37 has settled as 
part of the ileal microbiota like previously done using the SISP model [73] 
or in Ussing chambers [74]. This would be an interesting step to confirm the 
effects observed in Chapter 2 for LaW37, but also that microbiota changes 
are not fully responsible for increased vaccination efficacy as suggested in 
Chapter 5.
 Furthermore, the choice of time-points at which fecal samples are 
collected is crucial. In Chapter 5 we revealed that on day 10 after birth the 
group fed the synbiotic seemed to have a higher abundance of LAB, this was 
also observed 5 days post-weaning. Another transient effect was the increased 
abundance of a fiber degrading bacteria Catenibacterium in the group fed 





would capture a similar picture with possibly stronger effects. Also possible is 
that other species were changed along with LAB but due to lower abundance 
in the gut these bacteria might already be depleted. This is suggested by the 
fact that during the STM challenge fecal samples were collected at a time-
point very close to maximal stress, during dysbiosis, and drastic differences 
could then be observed between the groups. In general, our data suggest that 
subtle effects of dietary fibers and LAB will depend on the developmental 
stage of the animals, but also at which moment the analysis is performed, a 
higher window being during intense dysbiosis.
STM contamination in vivo as opportunity to measure effects 
of lcITF
A wild-type STM contamination infected the piglets around the time of 
weaning and drastically impacted the outcome of the dietary intervention, 
especially regarding the lcITF intervention. In non-contaminated animals, 
health-related effects observed in piglets, prior to STM challenge, were 
mostly associated with lcITF, as previously reported for piglets fed 
fructooligosaccharides [75]. LcITF was also beneficial to prevent weaning-
associated diarrhea but not to support vaccination efficacy, while LaW37 
had no additional effect on diarrhea at weaning but strongly enhanced 
vaccination efficacy (Chapter 4). Moreover, microbiota composition of the 
non-vaccinated piglets and those who received lcITF (vaccinated) clustered 
away from the other two groups. Interestingly, non-vaccinated and lcITF 
vaccinated animals did not develop an antibody titer suggesting that lcITF 
actually suppressed vaccination efficacy in animals with an immature immune 
system, most likely because they have not well developed Th1 responses yet. 
Such suppressive effect was previously observed in a clinical trial with a short 
chain ITF [26]. This was, however, unexpected as lcITF was previously found 
to increase antibody titer in an hepatitis B vaccination in young adults [26]. 
The suppressive effects observed in piglets on STM oral vaccination were not 
observed when lcITF was combined with LaW37, which strongly increased 
the antibody titer after secondary exposure to the antigens.
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 The outcomes on vaccination efficacy were drastically changed 
for the contaminated animals. Remarkably, lcITF increased NK CD56dim 
population under natural STM infection and was observed around the time 
of the contamination. Interestingly, this effect of lcITF on NK cells was a 
direct consequence of the infection. Consequences of this wild-type STM 
contamination were observed later on too as contaminated animals that 
received lcITF had increased anti-body titer and reached a similar protection 
as other vaccinated groups. It seems that the maturity of the immune system, 
that increases as animals face new antigens and infections, plays a role in how 
lcITF will drive their response towards the vaccination, or towards a STM 
challenge. Moreover, when looking at the diarrhea scores a big difference 
can be observed for contaminated and non-contaminated animals. In the 
contaminated animals, those receiving either of the dietary interventions 
had less diarrhea at all occasions than either of the placebo group (Figure 
S4 in Chapter 4). This is in line with the previous statement that facing 
naturally occurring STM contamination might drive the maturation of the 
immune system and illustrates that effects of food ingredients on immunity 
are very specific and cannot be effective without a rational design [26, 51, 
76]. As contaminations often occur in practice, future research might benefit 
from taking them into account.
Advising pre- pro- and synbiotic supplements for livestock 
management
Preselection of pre- and probiotics such as lcITF and LAB is a necessary yet 
insufficient tool for advising supplementations that are specific. In Chapter 4 
we showed that diarrhea, which is an important observation as its prevention 
is a critical parameter to avoid spreading of diseases within pig herds and is 
also a major issue during abrupt weaning [77], can be significantly decreased 
during weaning stress by lcITF but not by lcITF/LaW37 while the opposite 
is observed during STM challenge. Chronic dietary intervention on neonatal 
piglets with lcITF and lcITF/LaW37 is not only safe, it is also efficacious in 





antibiotic treatments, thereby limiting the undesirable effects associated with 
it, such as increasing multi-resistant bacteria and preventing salmonellosis 
occurrence in humans [78, 79]. Moreover, effects of LAB previously reported 
on STM often showed to be transferrable to other pathogenic bacteria such 
as Listeria and E. coli [80-82] which are highly problematic in the porcine 
industry for instance [83].
 The in vitro models used in Chapters 2 and 3 have already been 
used in our labs to unravel chemical structures that might be determinant 
in immune effects of RS [52] and ITF [1] for instance. Although it has been 
suggested for ITF that chain length is the major factor that will determine 
their direct immune effects [1], we showed in Chapter 6 of this thesis, that 
chemical structures matter as a whole and a single trait cannot predict the 
immune effects of RS. Preselection using in vitro assays seems even more 
important as we showed that molecules that can be thought to be similar at 
first, all type-3 RS, all extracted from potato, showed to be highly immune 
active or had low effects on TLRs, DC and T-cells responses. Such indications 
will increase the chance to succeed with improvement of specific feed 
formulation for instance.
Translation to clinical studies
Another application for the use of immune active dietary fibers and/or LAB 
is to support human health, via supplements or via incorporation in the 
formulation of food products. In order to be approved and obtain an health 
claim, granted by the European Food Safety Authority, the concerned active 
agents need to be tested in clinical trials, preferably on healthy individuals 
[84]. Using suboptimal oral vaccination protocols is a recognized model 
that can be safely performed and deliver results that can be measured at the 
systemic level [63] (Chapter 4). 
 Previous studies of pre and probiotic effects on various types of 
vaccinations have shown high variability in their results depending on the 
type of vaccination, duration and type of interventions, health status of the 
volunteers [85, 86]. This variability was also observed in this thesis. Moreover, 
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as concluded from Chapter 3, effects of a combination of ingredients 
might depend on the strength by which the individual ingredients modulate 
immune responses. And it has been shown in many reviews about pre and 
probiotic that interventions lack consistency because of high variability in 
doses, combination, duration, and timing of intervention being possibly the 
most critical factor [31, 87]. Another observation was about the storage of 
probiotic strains, all in vitro work performed in this thesis used glycerol 
stocks while the in vivo piglet study used freeze dried storage. Variability 
was observed for freeze-dried storing when open, therefore daily doses were 
packed separately for the piglet trial. However, variability between glycerol 
stocks and freeze-dried material was observed in vitro. Testing different 
concentrations is not sufficient and more details should be given when 
publishing about probiotics. Future research could also be tried on adapting 
the dosage and ratio applied for the lcITF/LaW37 combination but also when 
testing new combinations with RS.
 Moreover, testing whether the synergistic effects observed in vitro 
in human cells (Chapter 3), along with the strong effects of lcITF/LaW37 
on oral STM vaccination, can be reproduced in adults. This would allow to 
pinpoint which of the host or the vaccination had the most influence of this 
variation. It would also help understanding how specific the type of vaccination 
used has to be and whether the effects of the synbiotic combination can be 
translated from piglets to humans.
 Oral vaccination was chosen over parenteral vaccination as it has 
not been much investigated yet. As reviewed by Zimmermann, 2018 [87], 
probiotic interventions to support oral vaccination efficacy were never 
performed in neonates, but they have been studied twice in children with 
one being successful, and 3 times in adults which were all successful. LAB 
supplementation on oral vaccination against Cholera measured an increased 
anti-body titer [88], and poliovirus-specific IgA titer was statistically 
significantly increased [89]. On the other hand, this review [87] reported 12 
studies of probiotic interventions on influenza vaccination in adults with 5 





it seems that oral vaccinations are being underrepresented, and further 
research would be needed. Moreover, prebiotics to support vaccination 
efficacy have been extensively studied in influenza vaccination protocols 
as well [86] while oral vaccinations were, to the best of our knowledge, not 
studied so far.
Potential applications for infant formula and human 
vaccination
Apart from obtaining EFSA claims, other important industrial and medical 
applications can be derived from the findings compiled in this thesis. Pigs 
are an accepted model for prediction in human [90] as they share high 
similarities in gastrointestinal anatomy, physiology [91] and immunity [92]. 
Piglets can be, to some extent, used as a model for early life immune and 
microbiota development. For this reason, advanced human-microbiota 
associated pig models have been specifically developed [93]. Such models are 
useful to preselect pre and probiotic that could support infants microbiota 
and immune development but also to test their effects on vaccination [94]. 
Improving preselection of pre and probiotic and targeting relevant vaccination 
protocols is crucial as food ingredients exert subtle effects that are not 
always measurable. Numerous studies about allergies management [95, 96], 
prevention of obesity [97] or improvement of child growth [98], along with an 
increasing number of vaccination studies have been performed in infants and 
children with pre and probiotics dietary interventions. However, the success 
of these interventions greatly varies. In regard to probiotic interventions to 
support vaccination, although oral vaccinations were less often studied than 
parenteral vaccinations, they were most often successfully enhanced by the 
probiotic [87]. It is therefore safe to assume that the combination lcITF/
LaW37 is a good candidate to be further used in clinical studies focusing on 
early life. This can be instrumental for improving formula when trials include 




 As mentioned in Chapter 1, vaccination against Salmonella is also 
available for humans. This vaccine targets S. Typhi and, although it is usually 
performed systemically, it also exists as oral vaccination (Ty21a). Oral 
vaccination protocols are most often used in developing countries where 
sanitary conditions can be low, the most common being against Poliomyelitis, 
Typhoid fever (Ty21a) and cholera (WHO www.who.int/ith/ITH-Chapter6.
pdf?ua=1). However, they only confer a limited protection, especially in 
developing countries due to malnutrition [100]. Combining immune active 
food supplementation that could support safe oral vaccination in children 
has rarely been tried. A study reported no effect of B. breve on cholera 
oral vaccination [101] while another one showed that protection against 
rotavirus was increased by L. casei [102]. This strategy has, to the best of our 
knowledge, not been tried with dietary fibers. Further research is needed in 
this filed as dose, types, duration of interventions, choice of vaccination and 
target groups differ as greatly as outcomes vary.
Conclusions
In this thesis we evaluated the capacity of dietary fibers and of three LAB to 
affect mucosal immunity in vitro and if it could be translated on systemic 
immunity in vivo. Effects of these agents were also evaluated on microbiota 
development of the piglets. The use of in vitro models to mimic mucosal 
barrier and immunity may be imperfect, it, however, led to the selection of 
immune active ingredients which, combined, displayed immunomodulatory 
effects in vivo. The dietary fiber and the LAB selected in vitro had different, yet 
complementary, direct immune effects. LcITF did not show effects on barrier 
integrity and had limited effects on DC responses. However, it activated 
specific TLRs in vitro and it supported piglets’ health through weaning stress 
in vivo. LaW37 enhanced TEER, had a consequent impact on Caco-2 gene 
expression, activated specific TLRs and had a pronounced pro-inflammatory 
effect on DC responses. Combining these ingredients showed that more than 
just additive effects could be seen with synergistic effects in vitro on TLR2 





this combination increased vaccination efficacy in vivo as measured by 
doubled antibody titer. The hypothesis that impacting mucosal immunity 
with immune active feed-based interventions can be reflected at a systemic 
level was validated by the use of an oral vaccination against STM in piglets. 
Moreover, this thesis shows that ingredients that strengthen gut barrier do 
not prevent from oral vaccination efficacy although it is based on live invading 
bacteria such as STM. Importantly, immune effects in vivo could be only 
partially linked to changes on microbiota composition confirming that direct 
immune effects might be at play in vivo although the dietary intervention did 
impact microbiota composition. Finally, the in vitro platform used to select 
the synbiotic combination was further applied to assess the capacity of other 
dietary fibers, RS, to directly stimulate immune processes, and revealed that 
two of these ingredients were most promising for further research, namely 
Amylose fraction V and Paselli WFR. Taken together, the results gathered 
in this thesis show that specific dietary fibers and LAB will target specific 
physiological processes and that in vitro screening is not only instrumental 
in selecting ingredients with direct immune effects, but also synergistic 
combinations. We also showed that oral vaccination is a suitable and safe 
challenge to be used to further assess these effects in vivo. Effects on mucosal 
immunity by dietary compounds on oral vaccination can be measured at the 
systemic level making it a suitable model for further clinical trials. In light of 
these results we can conclude that microarray data were good predictors, as 
well as TLRs and DCs responses in presence of Caco-2 medium while T-cells 
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Much attention has been given by the scientific community to dietary fibers 
and lactic acid bacteria to modulate immunity and enhance well-being of 
consumers. In clinical and animal trials, the impact of these ingredients was 
mainly attributed to microbiota mediated effects. However, direct effects of 
these ingredients on immune cells were recently brought to light and this 
thesis aimed at further understanding the mechanisms behind the direct 
immune activities of dietary fibres and lactic acid bacteria. Inulin type 
fructans (ITF) are recognized prebiotic dietary fibres with barrier protective 
effects. This was accomplished by activation of host cell signalling in the 
intestinal epithelium independently of microbiota. Moreover, long-chain 
ITF (lcITF), which was used in this thesis, was found to enhance T-helper 
1 (Th1) cells in Peyer’s Patches of mice and in humans during vaccination 
protocols. Another type of dietary fibre with recognized prebiotics effects 
and recently shown to exert direct immune effects are resistant starches 
(RS). These direct effects were related to binding and activation of Toll-like 
receptors (TLRs), modulation of dendritic cells (DCs) responses and skewing 
of T-cells. Finally, direct introduction of live lactic acid bacteria such as 
lactobacilli have, on the other hand, been associated with enhanced health 
status, improved resistance to diseases, reduced shedding of pathogens and 
of reduction of disease symptoms in pigs, and support of intestinal immunity. 
In this thesis we selected three strains with reported anti-pathogenic effects, 
namely Lactobacillus acidophilus W37 (LaW37), L brevis W63 (Lb W63) 
and L. casei W56 (LcW56).
 The strategy applied throughout this thesis made use of a screening 
platform of in vitro tests that aimed at mimicking the mucosal interface and 
immunity. As detailed below, a broad range of models were used to mimic 
the epithelial barrier, the immune cells in the lamina propria, and their 
receptors. LcITF and 3 strains of lactobacilli were used to select a synbiotic 
combination that could be tested in vivo, in a piglet vaccination model. 
We first selected in vitro models that represent the gut mucosal situation. 
Enterocytes Caco-2 differentiated cells mimic the intestinal barrier and were 
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used to assess gut permeability and barrier integrity. TLRs expressing HEK-
blue cells are sensing receptors highly expressed by DCs, their activation or 
inhibition indicates for pro- or anti-inflammatory effects. DCs and T-cells 
are immune specialized cells, present in the lamina propria, that react 
differently in presence and absence of enterocytes and bridge mucosal to 
systemic responses. Ultimately, measurement of T-cell responses can help 
predict responses to oral vaccination. These assays were performed with 
and without a STM challenge in order to assess the functionality of immune 
effects during infection and more generally during stress. Further testing 
the selected synbiotic in vivo allowed to evaluate direct immune effects in 
presence of microbiota and of multiple other factors such as mucus and 
complex epithelium composition, which could not be all tested in vitro.
 Barrier integrity, as mimicked by Caco-2 cells, was not affected by 
lcITF. Moreover, gene expression of Caco-2 cells was mildly impacted by the 
exposure to lcITF and no effect could be observed on tight junctions which 
matches the absence of effect on barrier strength. In Chapter 2 we also 
showed that lcITF triggered differential regulation of 128 genes in Caco-2 
cells. To the best of our knowledge, it is the first time that such a direct effect 
of lcITF on gut epithelial cells was reported. We also demonstrate in Chapter 
2, using the Caco-2 model, a profound strain-dependent effect. The strains 
LbW63 and LcW56 were ineffective in enhancing TEER, and even lowered 
TEER to some extent, while LaW37 strongly enhanced barrier tightness via 
upregulation of 26 tight-junction related genes. In fact, profound differences 
were not only observed for TEER. LaW37 regulated genes involved in various 
processes and actually changed about 30-fold more genes than the other 2 
strains. The strain that enhanced barrier function, i.e. LaW37, also limited 
STM barrier disruption and decreased cellular stress in epithelial cells as 
shown by decreased IL-8 secretion. This potent effect of LaW37 makes it a 
relevant candidate to protect against enteropathogens such as Salmonella. 
Moreover, a group of genes related to differentiation towards follicle 
associated epithelium (FAE) like structure was particularly enhanced in 





 LaW37 was selected to be combined with lcITF and further 
investigated as potential synbiotic. The possible direct immune mechanisms 
behind health effects provided by synbiotics remain to be elucidated as most 
studies revealed microbiota-dependent effects in humans. We therefore 
focused on studying direct immune effects excluding the impact of bacterial 
growth using the dietary fibre source. The combination lcITF/LaW37 had 
synergistic effects on immune cell receptors TLR2 and 3 and on DC responses 
(Chapter 3) that are likely to be another mechanism for synbiotic effects. 
Effects of lcITF alone were observed on activation of TLR2, 3 and 5. LaW37 
activated TLR2 and 3. Synergistic effects were observed on TLR2 and 3 
activation but also on TLR2, 5 and 8 inhibition. While lcITF had no effects 
on DCs, LaW37 strongly induced secretion of all measured cytokines with a 
tendency to promote pro-inflammatory responses. Interestingly, depending 
on the context, this effect was unchanged or dampen by the addition of lcITF 
although lcITF alone had no effect. For instance, during STM challenge, no 
added effects of the combination were observed but pro-inflammatory effects 
induced by LaW37 were dampened by addition of lcITF without challenge. 
This confirms our hypothesis that responses will differ in situations of stress. 
Besides, our study also shows that DCs directly exposed to the ingredients 
without addition of Caco-2 medium react differently than DCs that are 
concomitantly exposed to the ingredients and to Caco-2 medium. In the first 
case, direct effects of LaW37 were dampened by addition of lcITF; while 
enhancing effects on IL6 and IL8 were observed in presence of IECs. This 
confirmed the existence of a crucial cross-talk between the different cells that 
compose the mucosal interface.
 The synbiotic lcITF/LaW37 was proven to enhance oral vaccination 
efficacy in neonatal piglets despite the immaturity of their immune system 
and, at the same time, contributed to enhance survival rates, general health 
scores before weaning, feeding efficiency during weaning stress and protection 
against weaning associated diarrhoea (Chapter 4). However, during STM 
challenge, diarrhoea was lower in animals that received the synbiotic but 
not for lcITF alone. The impact of dietary interventions on the microbiota 
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of piglets can play a role in the immune effects observed in Chapter 4 since 
effects of the residential gut community on the immune system development 
is well established. Results from faecal samples suggested that weaning and 
STM-stress, but not vaccination itself, affected faecal microbiota composition. 
Dietary interventions had subtle effects on microbial composition, yet specific 
changes were observed for lcITF alone or combined with LaW37. This study 
(Chapter 5) focused solely on non-contaminated animals and showed that 
stress period characterized by dysbiosis, such as during the first days of life, 
weaning and pathogen challenge, offered the opportunity to measure the 
subtle effects of the dietary interventions. On day 10 after birth the group 
fed the synbiotic seemed to have a higher abundance of lactobacilli, and 
5 days post-weaning the prebiotic group had higher abundances of fibre 
degrading bacteria. During the STM challenge differences between groups 
were more drastic than at other time-points. Microbiota composition of the 
non-vaccinated piglets and of those that received the prebiotic (vaccinated) 
clustered away from the other two groups. Interestingly, non-vaccinated and 
prebiotic vaccinated animals did not develop an antibody titre suggesting 
that lcITF might dampen vaccination efficacy in animals with an immature 
immune system. The state of development of the Th1 responses of these 
piglets is, most likely, not yet fully matured which can explain the lake 
of effects from lcITF. On the other hand, microbiota composition of the 
vaccinated piglets that received the placebo and the synbiotic vaccinated 
group clustered together although the antibody titre of the synbiotic group 
was twice as high. Therefore, faecal microbiota composition did not fully 
explain why the synbiotic group had developed much higher protection 
against STM after vaccination than the placebo group did.
 Because in vitro assays were able to demonstrate direct immune 
effects that were confirmed to also occur in vivo, we used the same screening 
platform to evaluate the potential of other dietary fibres. This platform also 
allowed to evaluate the impact the chemical structure in relation to possible 
direct immune effects. In Chapter 6 different chemical structures of four 





Two RSs were highly immune active and presence of amylose, even at 
trace level, was their only resemblance. Crystallinity and molecular weight 
(MW) taken independently of each other did not seem to influence immune 
responses while chain length distribution and especially dextrose equivalent 
(DE) level seemed to matter. We could confirm that different chemical traits 








Er is veel aandacht besteed door de wetenschappelijke gemeenschap aan 
voedingsvezels en melk zuur bacteriën om het immuunsysteem te moduleren 
en het welzijn van consumenten te verbeteren. In klinische en dier studies 
is de impact van deze ingrediënten vooral toegeschreven aan de microbiota 
gemedieerde effecten. De directe effecten van deze ingrediënten werden pas 
recentelijk aan het licht gebracht en het doel van dit proefschrift is om de 
mechanismen achter de directe immuun activiteiten van voedingsvezels en 
melkzuur bacteriën te begrijpen. Inuline type fructanen (ITF) zijn erkende 
prebiotische voedingsvezels met barrière beschermende effecten. Dit wordt 
bewerkstelligd door activatie van de gast cel signalering in het intestinale 
epitheel, onafhankelijk van de microbiota. Bovendien is eerder gevonden 
dat lange keten ITF (lkITF), welke zijn gebruikt in dit proefschrift, de 
T-helper 1 (Th1) cellen verhogen in Peyer’s Patches van muizen en in mensen 
tijdens vaccinatie protocollen. Een ander type voedingsvezel, met erkende 
prebiotische effecten en de recentelijk aangetoonde eigenschap om directe 
effecten uit te oefenen op het immuunsysteem, is resistent zetmeel (RZ). 
Deze directe effecten zijn gerelateerd aan de binding en activatie van Toll-
like receptoren (TLRs), modulatie van dendritische cel (DC) responsen en T 
cel polarisatie. Aan de andere kant is het direct introduceren van levende 
melkzuur bacteriën zoals lactobacilli geassocieerd met een verbeterde 
gezondheidsstatus, een verbeterde resistentie tot ziekten, een verminderde 
afstoting van pathogenen, een vermindering van ziekte symptomen in varkens 
en ondersteuning van het darm immuniteit. In dit proefschrift selecteren 
we drie stammen met gerapporteerde anti-pathogene effecten, namelijk 
Lactobacillus acidophilus W37 (LaW37), L brevis W63 (Lb W63) en L. casei 
W56 (LcW56).
 De strategie die is toegepast in dit proefschrift maakt gebruik van 
een screening platform van in vitro testen die zijn gericht op het nabootsen 
van de darm immuniteit. Zoals in detail beschreven hieronder zijn een brede 
reeks van modellen gebruikt om de epitheel barrière, de immuun cellen in de 
lamina propria en hun receptoren na te bootsen. LkITF en 3 stammen van 
Chapter 7
284
lactobacilli zijn gebruikt om synbiotische combinatie te selecteren die in vivo 
kan worden getest in een biggen vaccinatie model. We hebben eerst in vitro 
modellen geselecteerd die deze mucosale situatie representeren. De darme 
epitheel Caco-2 cellijn bootsen de intestinale epitheel barrière na en werden 
gebruikt om de darm permeabiliteit en barrière integriteit te beoordelen. 
TLRs zijn sensorische receptoren die in hoge aantallen voorkomen op DCs en 
hun activatie of inhibitie geeft een indicatie voor pro-of anti-inflammatoire 
effecten. DC en T cellen zijn immuun gespecialiseerde cellen, die aanwezig 
zijn in de lamina propria. Deze immuun cellen reageren verschillend in de 
aanwezigheid of afwezigheid van enterocyten en zijn de brug tussen het 
darm en het systemische immuun systeem. Uiteindelijk kan de respons tot 
orale vaccinatie worden voorspeld door het meten van T cel responsen. Deze 
assay werden uitgevoerd met en zonder STM ‘challenge’ om de functionaliteit 
van immuun effecten gedurende infectie te bepalen en meer algemeen 
gedurende stress. Het verder in vivo testen van de geselecteerde synbiotica 
gaf de mogelijkheid tot het evalueren van de directe immuun effecten in de 
aanwezigheid van microbiota en van verscheidene andere factoren zoals 
mucus en de compositie van het complexe epitheel, wat niet kan worden 
getest in vitro.
 De barrière integriteit, zoals nagebootst met Caco-2 cellen, was niet 
aangetast door lkITF. Verder was de genexpressie van Caco-2 cellen licht 
beïnvloed door de blootstelling aan lkITF en geen effect werd waargenomen 
op barrière sterkte. In hoofdstuk 2 hebben we ook laten zien dat lkITF een 
verschillende regulatie van 128 genen in Caco-2 cellen stimuleren. Zover wij 
weten is dit de eerste keer dat een dergelijk direct effect van lkITF op de darm 
epitheel cellen is gerapporteerd. Daarnaast hebben we ook in hoofdstuk 2 
laten zien dat er een duidelijk bacterie stam-afhankelijk effect bestaar door 
gebruik te maken van het Caco-2 model. De stammen LbW63 en LcW56 waren 
ineffectief in het verhogen van de TEER en verlaagden de TEER zelfs tot een 
zekere mate, terwijl LaW37 barrière sterkte verhoogd door de upregulatie van 
26 tight junction gerelateerde genen. LaW37 reguleerde genen die betrokken 





de andere twee stammen. De stam die de barrière functie verhoogde, 
i.e. LaW37, limiteerde ook de STM-geïnduceerde barrière disruptie en 
verlaagde de cellulaire stress in epitheel cellen zoals is aangetoond met een 
verlaging van IL-8 uitscheiding. Dit potente effect van LaW37 maakt de 
bacterie een relevante kandidaat om de darm barrière te beschermen tegen 
enteropathogenen zoals Salmonella. Daarnaast leidde LaW37 stimulatie tot 
een toename in genen die gerelateerd zijn aan differentiatie naar ‘follicle 
associated epithelium (FAE)’- achtige structuren.
 LaW37 was geselecteerd om te worden gecombineerd met lkITF 
en deze combinatie werd verder onderzocht als potentieel synbiotica. Het 
mogelijk directe immuun mechanisme achter de gezondheidseffecten die 
worden verstrekt door synbiotica moet nog worden opgehelderd, aangezien 
de meeste studies positieve effecten wijten aan effecten op  microbiota. 
Daarom focussen wij ook op directe effecten los van effecten op microbiota. 
De combinatie lkITF/LaW37 had een synergetisch effect op de immuun cel 
receptoren TLR2 en TLR3 en op DC responsen (Hoofdstuk 3). Dit toont 
and da took directe effecten verantwoordelijk kunnen zijn voor synbiotische 
effecten. De effecten van lkITF alleen werden geobserveerd door TLR2, TLR3 
en TLR5 activatie en ook op TLR2, 5 en 8 inhibitie. Terwijl lkITF geen effecten 
had op DCs, induceerde LaW37 de uitscheiding van alle gemeten cytokines 
met de neiging om pro-inflammatoire responsen te promoten. Afhankelijk 
van de context was dit effect onveranderd of verminderd door toediening 
van lkITF, ondanks dat lkITF alleen geen effecten had. Er was bijvoorbeeld 
gedurende de STM challenge geen toegevoegd effect van de combinatie 
gemeten, maar de pro-inflammatoire effecten, die zijn geïnduceerd door 
LaW37 werden verminderd door toevoeging van lkITF zonder challenge. Dit 
bevestigd onze hypothese dat responsen zullen verschillen afhankelijk van de 
stress situaties. Daarnaast laat onze studie ook zien dat DCs die niet worden 
blootgesteld aan toegevoegd Caco-2 medium verschillend reageren dan 
DCs die gelijktijdig zijn blootgesteld aan de ingrediënten en zijn toegevoegd 
aan Caco-2 medium. In het eerste geval zijn directe effecten van LaW37 
verminderd door toevoeging van lkITF, terwijl toegenomen effecten op IL6 
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en IL8 zijn gemeten in aanwezigheid van IECs. Dit bevestigd de aanwezigheid 
van een cruciale crosstalk tussen verschillende cellen die de mucosale 
interfase samenstellen.
 Het is aangetoond dat de synbiotica lkITF/LaW37 de orale 
vaccinatie efficiëntie verhoogt in neonatale biggen ondanks hun immature 
immuunsysteem. Verder dragen ze op hetzelfde moment bij aan het verhogen 
van de overlevingskans, de algemene gezondheidsscores voor het spenen, 
de voedingsefficiëntie gedurende stress door spening en een bescherming 
tegen spening geassocieerde diarree (Hoofdstuk 4). Gedurende een STM 
challenge was echter het aantal dieren met diarree lager in de synbiotisch 
behandelde dieren, maar niet in de dieren die alleen zijn behandeld met 
lkITF. De impact van een voedingsinterventie op de microbiota van biggen 
kan een rol spelen op het immuun effect dat is geobserveerd in hoofdstuk 
4, aangezien de effecten van residente darm gemeenschappen op de 
ontwikkeling van het immuunsysteem goed is vastgesteld. De resultaten van 
fecale monsters suggereren dat spenen en STM-stress, maar niet de vaccinatie 
zelf, de fecale microbiota compositie beïnvloeden. Voedingsinterventies 
hadden een subtiel effect op de microbiota compositie, maar toch waren er 
specifieke veranderingen geobserveerd voor lkITF alleen of gecombineerd 
met LaW37. Deze studie (Hoofdstuk 5) richt zich volledig op de niet- 
gecontamineerde dieren en laten zien dat de stress periode, gekarakteriseerd 
door dysbiose zoals gedurende de eerste dagen van hun leven, spening of 
pathogeen challenge, een mogelijkheid boden tot het meten van een subtiel 
effect van die voedingsinterventies. Op dag 10 na de geboorte leek van de 
groep die was gevoed met de synbiotica een grotere overvloed van lactobacilli 
te bevatten en op 5 dagen post-spening had de prebiotische groep een grotere 
overvloed van vezel afbrekende bacteriën. De verschillen tussen de groepen 
waren drastischer gedurende STM challenge dan op andere tijdspunten. 
De microbiota compositie van de niet- gevaccineerde biggen en de biggen 
die prebiota (gevaccineerd) ontvingen, clusterden weg van de andere 
twee groepen. De niet-gevaccineerde en prebiotisch gevaccineerde dieren 





efficiëntie mogelijk kan verminderen in dieren met een immatuur immuun 
systeem. De staat van ontwikkeling van de Th1 responsen van deze biggen is 
hoogst waarschijnlijk nog niet volledig ontwikkeld dat het gebrekkige effecten 
van lkITF kan verklaren. Aan de andere kant, de microbiota compositie 
van de gevaccineerde biggen die placebo ontvingen en de synbiotisch 
gevaccineerde groep clusterden samen ondanks de antilichaam titer van de 
synbiotische groep twee keer zo hoog was. De fecale microbiota compositie 
verklaarde daarom niet volledig waarom de synbiotische groep een verbeterde 
bescherming ontwikkelde tegen de STM na vaccinatie dan de placebogroep.
 Aangezien in vitro testen de directe immuun effecten demonstreerden 
deze effecten ook in vivo werden bevestigd, gebruikten we hetzelfde 
screening platform om de potentie van andere voedingsvezels te bepalen. 
Dit platform stond ook toe om de impact van chemische structuren in 
relatie tot mogelijke directe immuun effecten te bepalen. In hoofdstuk 6 
werden verschillende chemische structuren van vier type-3 RZen met elkaar 
vergeleken op TLR, DC responsen en T cel polarisatie. Twee RZen waren erg 
immuun reactief in aanwezigheid van amylose, zelfs op spoor niveau, en dat 
was hun enige overeenkomst. De kristalliniteit en moleculair gewicht (MG), 
die onafhankelijk van elkaar werden getest, bleken geen invloed te hebben 
op immuun responsen, terwijl keten lengte distributie en vooral het dextrose 
equivalent (DE) niveau belangrijk bleken te zijn. We konden bevestigen dat 
verschillende chemische behandelingen van RZen zijn betrokken in sommige 
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using designated a male candidate... Even though our interactions were few, 
I knew I could always find you when in doubt, and this gave me a lot of peace. 
You feel a bit like a rock in the ocean, a hand given when I was drowning 
(I know you like birds more than fish but I couldn’t find better metaphors). 
For this and giving me my first chance in science, I would like to thank you. 
Jurriaan, where to start? I know how to end though because you have been 
one of my role models to learn a very human and kind way to manage a team. 
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back to finishing your own PhD with the insane hours we had to process 
the piglets’ blood and do some flow cytometry experiments. Thank you for 
being a true support and bringing a bit of fun in these dark days (literally). 
But of course, how not to end with the best touch of it all, the cherry on the 
cake, the pineapple and the pen, the –I’d like to call- YOU YOU YOU crew 
for the best coffees in Groningen: Suzie, Martin, Renata, Tamara (you 
won’t get the you you you joke but you are still in there) and Luis. Without 
you guys I might have reached despair in some occasions, but instead we 
just sang awkwardly loud and made it all light and fun. Girls I don’t forget 
you, Chengcheng, Chunli, Christina, Yuanrui, Shuxian, Sandra and 
Gea: always helpful, collaborative and supportive! Martin, a special mega 
huge thanks, as big as the summary was long!
 The team at FBR left only positive and kind feelings in my memory. 
I am still wondering how it is possible to gather such friendly, compassionate 





Marit, Balaji, YongFu, Priscilla, Lonneke, Isabelle, Danny and 
Shanna. Diane, you remember when you ended-up helping me aliquoting 
all these tubes of piglets’ plasma on December 31st while you just happened 
to, fortunately for me!, come by the lab that day… Well I cannot thank you 
enough because the building would have closed and I would have never 
made it without you! Monic and Renata, you have been so busy isolating 
immune cells for the piglets’ trial, making extra-long days as the transporter 
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thank you for that. Els, some special words for you because you were the 
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beginning of both a new social life and professional network of amazing 
people. Then, there was the PhD week, when I met such a fun girl in the toilet 
right at the beginning and she was so obviously going to be my friend, hein 
Pauline. Tibo, Edo, I could not even make up my mind who to ask to be my 
paranymph because you are both so important to me… You have been there 
like my brothers, throughout so many things. One being so much calmer and 
better at supporting me emotionally than the other, and I will obviously not 
mention names here, to keep the illusions for those you might still believe 
you both are super calm. A hint though, it is not the one that calls himself a 
genius. Vale who smiled at me and came to pick me up for dancing at this 
awkward party where I was too bored and shy to move from the couch. You 
radiate your energy, may it be positive or negative, and no one can meet you 
without loving you! Rafaaaaaaa Vitalicaaaaaa Over a year of life together 
at Paradise Bennekom and much fun, I still wake up dreaming of the smell 
of your Bolognese on Sundays. You are the living proof that first impressions 
can be so god damn wrong and I am so happy we both got to meet and live 
together (yeeesss Edo, yes I hear you from here, it’s all on you!!). Then there 
is you Amandine, the one true highlight of my friendship with Martin. The 
brightest of all drama queens, the top of the bill for the funniest bitching 
sessions. Two grannies on a bench in the streets of a Mediterranean country: 
that’s us, we don’t need the age, the bench nor the sun (although), we are 
self-entertained, an endless pleasure that is. Of course, there are also the 
friends that were there and shared some of my PhD life in good old Waggo, 
the Droev team I’ll simply call you ;) Nata <3, Berta the greatest laughs are 
on you, Maria holala what have we done… You 3 especially will always stick 
as friends and I know we will meet again beauties, I feel it in my guts! Not to 
thank you all for so many coffees, dinners, alcoholic beverages and fantastic 
dinners would be too rude even for me. THANK YOU! All! Also those I forget 
now because I am so stressed and because I should have written this while 
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better! When life brought me to Groningen I really thought my life would end. 
At least that. And Laure you were my ray of light, the French flag, the feeling 
of home, our incredibly sweet landlord and gorgeous house. Your bring me 
stability, compassion, kindness on a daily base and although your moving 
with Gabi makes me truly happy for you must know that I sincerely going 
to miss you. And because, as usual, life has indeed stopped when I believe it 
would. Not. I almost don‘t want to leave Groningen anymore! Theater is back 
into my life and that is quite on you, Marina. My true hobby, my best mean 
of expression, my mental health, it is all there, expressed in theatre, and you 
helped a lot to relight this old fire. Julian, Robert, Casper, Rick, Rafael, 
Jon, Magnus and Sylvia, our future will be improvised and that’s for the 
best. I had lots of fun, lots of rollercoasters, and grew a lot with you all. Thank 
you, lots of luck to all of you for these new life pages that we are about to turn.
 La famille ! Parce que comme dirait la mamie, c’est le plus important, 
la santé et qu’on s’aime. Et c’est vrai. D’ailleurs je devrais m’arrêter là car tout 
est dit. Mais vous me connaissez trop bien… Et quand je dis la famille je la vois 
au sens large du terme, car oui mes cailles bichettes et criquettes vous êtes, 
présentes dans la distance, jamais d’indifférence et toujours cette harmonie 
quand on se trouve. J’ai nommé Alice, Loriane et Lisa, celles que je traine 
depuis le lycée, ensemble on a tout traversé : mes piliers ! Et puis il y a Lucile, 
Yvane, Louise (yes hun you appear in the French text part I’m sooo sorry 
–to read with the proper London accent I put on so well when we get pissed 
eh!- But yeah, you are one of these few people that stick despite the distance), 
Marie (he oui ces festoches ensemble c’est une tradition qui va perdurer! 
Elle sent bon notre affaire!) et bien-sûr Manon (ma criquette, tu sais comme 
tu es spéciale, une vraie inspiration, la source de beaucoup d’ambition et de 
rêves. Je suis convaincue que la vie m’a mise sur ton chemin pour devenir 
une meilleure personne et je nous souhaite de nous voir davantage). Et puis 
il y a vous, qui me permettez de garder les idées au clair, qui m’apportez un 
soutien sans faille, qui savez écouter sans juger, mais aussi me secouer les 





Maman, Jean, les grand-parents, Marion, Thom, Ana, Thibaud & 
Co, Flo, Thierry, Marie, Véro, Maud & Co, Maurine, Michel & Co. Je 
vous aime. Célia Caille Face de crabe, je profite donc de ton autorisation 
exceptionnelle pour étendre ces remerciements de quelques lignes ! Ton œil 
critique de lynx et ce sens aiguisé du faucon pour le détail vont donc me 
sauver de quelques bourdes magistrales ; et quant à tes choix graphiques je 
sais que je te remercierai encore dans 15 ans et peut-être même plus encore 
que je te remercie aujourd’hui ! Ça a bien de la g***** cette thèse (« oh mais 
qu’est-ce qu’elle est vulgaire ») et c’est clairement grâce à toi et au coup de 
crayon aguerri de tes amis qui m’ont fait ce superbe cadeau ! Je suis fière de 
pouvoir présenter cette thèse et je vous en suis tellement reconnaissante ! 
Merci les artistes, merci la manageuse. Qu’est ce que je ferais sans toi (mais 
restons focus thèse dans ces remerciements !) … <3
 Tib’Edo (with all the plays on words you find appropriate eheh!) Suzie 
Georgette, I could not hesitate, you had to be the ones by my side because 
you have been the ones by my side all along. So much laughter! Thibaut, 
tu sais que le choix a été cornélien et j’espère que mon rôle en tant que 
paranymph t’as donné un bon aperçu de ce que tu représentes dans ma vie, 
mon meilleur pote, un peu comme un frère, je pourrais partir en voyage avec 
toi du jour au lendemain car avec toi c’est toujours cool, pas besoin de parler 
beaucoup, c’est facile, comme des vieux qui s’engueulent, s’apprivoisent, et 
se connaissent depuis toujours ! Edo hun, how not to elaborate, I thought 
many times about when this time will come, when I will have to put on paper 
what you have meant for me since we moved in together. I invaded your 
house and life with all my stuff, with my cat and my sorrow. I found in you 
the feeling of home I was missing so much. You have been the shoulder on 
which I could rest. You are a beautiful person, someone everyone should try 
to be like, someone that should be known. Those you get the chance to meet 
you never leave your side because being close to you is the guarantee of a 
peaceful, fun and kind environment. You made me discover the best in me 
even if you might not have realized it. I can never be exactly like you but I 
aim at growing this way. Suzie, this light in the darkness, this smile, this 
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honesty, this bright mind of yours that I will miss so much. Without you, 
it is simple, I would have probably not made it through, and certainly not 
with the smile. I want to be there for you as you have been there for me. 
You will be a mother at the image of the friend you are. Loving, caring, and 
fucking amazing! The gratitude I want to express cannot go through words. I 
feel just lucky life brought you on my way, it was not to teach you French, it 
was to learn from you to grow up. Paranymphs, so formal, I just love you so 
informally, whatever that means!
 Jan my love, I will not sell you a line in this thesis because god knows 
what I could end up writing. You are the one who went through the worst 
patch of it all, you remained there, calm and fun, hilarious and thoughtful. 
You are the one who never doubted and I thank you so much for that and for 
all the rest. You are there, for the best and worst, as they say. What would you 
be without my singing, what would I be without your rice. Life is just better 
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